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In the progression of modern society, the inevitable exhaustion of fossil 
resources becomes an increasingly concerning matter. These resources are not only the 
basis of the energy production of the world but also the precursor for many important 
platform chemicals. Therefore, development of green and renewable alternatives to the 
chemicals used in the current industry has become necessary. Within this context, the 
aim of the present thesis was the development of new efficient methodologies for 
obtaining high added-value products starting from biomass, a renewable source. The 
bio-based building blocks obtained were subsequently employed for the synthesis of 
polyfunctionalized chemicals and of polymers. 
The first part of the thesis focuses on the utilization of a bio-based meso diol 
for the synthesis of sugar derived structures, through the coupling of biocatalysis and 
multicomponent reaction (MCRs). These two different approaches are able to satisfy 
the requirements of an ideal approach, regarding selectivity (stereocontrol), efficiency 
and sustainability and their union with renewable feedstocks in a single integrated 
general strategy represents a powerful tool to achieve a sustainable synthesis. In 
particular, the work focused on the synthetic elaboration of the chiral molecules 
obtained through enzymatic desymmetrization to give enantiomerically pure building 
blocks to be used in diastereoselective Passerini reactions. In order to establish the 
synthetic usefulness of this new method, we demonstrated its application to the 
diversity-oriented synthesis of chiral, bio-based, oxygen heterocycles and to the target-
oriented synthesis of Bengamides, a wide family of natural products of marine origin. 
The second part of the thesis is dedicated to the synthesis of a lactam- based 
monomer derived from bio-based starting materials and its subsequent polymerization.  
The project involved the synthesis and polymerization of 3-methylene-2-piperidone 
(3M2Pip) monomers, targeting the synthesis of well-defined hydroxyl end functional 
P(3M2Pip), i.e. HO-P(3M2Pip). Once obtained end-functionalized 3M2Pip-based 
polymers we will use them as a macro-initiator for the synthesis of degradable 
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In this chapter, a general overview of the concepts of Bio-economy and Green 
Chemistry will be provided. These two philosophies afford a general guideline for the 














Nowadays fine chemicals industries are still mostly based on fossil fuels 
reservoir. In the progression of modern society, the inevitable exhaustion of fossil 
resources becomes an increasingly concerning matter. These resources are not only the 
basis of the energy production of the world but also the precursor for many important 
platform chemicals. With the consumption of fossil resources on the horizon, 
alternatives have to be developed. 
In this context, the development of a Green Chemistry plays an essential role. 
Based on the Twelve Principles, proposed by Anastas and Warner[1], Green Chemistry 
has been defined as “efficient use of (preferably renewable) raw materials, which 
eliminates waste, avoids the use of toxic and/or hazardous reagents and eliminates 
solvents in the manufacture and application of chemical products”. 
 
1. Prevent waste 7. Use of renewable feedstocks 
2. Atom economy 8. Reduce derivatives 
3. Less hazardous synthesis 9. Catalysis (vs. stoichiometric) 
4. Design benign chemicals 10. Design for degradation 
5. Benign solvents and auxiliaries 11. Real-time analysis for pollution prevention 
6. Design for energy efficiency 
12. Inherently benign chemistry for accident 
prevention 
 
Table 1.1 Twelve Principles of Green Chemistry 
 
More recently, a mnemonic, PRODUCTIVELY, has been proposed by 
Poliakoff et al.[2] which captures the spirit of the twelve principles of Green Chemistry. 
Although attention continues to be focused on waste minimisation and 
avoiding the use of toxic and/or hazardous reagents and solvents, the last decade has 
witnessed a growing emphasis on using starting materials derived from renewable 
sources instead of non-renewable fossil feedstock – crude oil, coal and natural gas – 
for the production of fuels, bioplastics and chemicals. These materials wholly or partly 
derived from renewable, biological sources, may be termed as bio-based products[3].  




Bio-based products are included in concepts of bio-based economy and circular 
economy, which have received support from policymakers and advisors at national 
and supranational levels. Bio-economy is a new concept that officially came into light 
for discussion at the beginning of the 21st century. However, it was not until the second 
decade of the 21st century that it has attracted a great interest of scientists shaping 
development strategies. According to European Commission[4], "The bio-economy 
comprises those parts of the economy that use renewable biological resources from 
land and sea such as crops, forests, fish, animals and micro-organisms to produce 
food, materials, and energy". 
Utilization of bio-based building blocks derived from renewable resources and 
of green processes is the principle which bio-economy focuses on to reach the goal of 
sustainable global development. 
 
 
1.2. Biomass for the production of fine chemicals and biopolymers 
 
From a chemical point of view the most important renewable resource is 
biomass. The term biomass is defined as any organic matter that is available on a 
renewable basis, including dedicated energy crops and trees, agricultural food and feed 
crop residues, aquatic plants, wood and wood residues, animal wastes and other waste 
materials. Biomass represents an abundant, widely available and sustainable carbon 
renewable resource and the perfect equivalent to petroleum for the production of fuels 
and fine chemicals with net-zero carbon emission. This material is generated from 
available atmospheric CO2, water and sunlight through biological photosynthesis. 
Through bio-refinery, each of the different components of given natural resource is 
isolated by chemical and biochemical means with the aim of turning them into useful 
products. Thus, interesting chemicals, monomers and polymers could replace 
progressively petrol-based counterparts. These new bio-based products are not 
necessarily identical to those produced starting from oil; they could be in principle 
even superior, for example for biodegradability.  
Broadly, biomass can be categorized as first, second, third and fourth generation. The 
biomass-based chemicals and fuels generally are produced by sugar and starch-
containing crops such as beet, corn and grain, the so-called first-generation biomass. 
These crops are also used for food and animal feed, resulting in an undesirable 
competition between food and chemicals. It is therefore important the search for 
alternative non-edible feedstocks. Second generation biomass consists of non-food 
parts of crops and other forms of lignocellulosic biomass such as wood, grasses and 
municipal solid wastes. Finally, third and fourth generation can be used as they include 
micro-algae and microorganism derived feedstocks. 




Lignocellulosic biomass materials are receiving increased attention as a 
renewable, economical, and abundant alternative to fossil resources for the production 
of bio-based chemicals and polymers[5]. It represents the most abundant and renewable 
biomass on earth, it is significantly cheaper than crude oil and it can be produced 
quickly and at a lower cost than other agriculturally important feedstocks. A distinct 
advantage of this biomass is that its utilization for chemical, material or biofuel 
production does not directly interfere with food supplies, as lignocellulosic material is 
non-edible by humans. 
The three main components of lignocellulose are cellulose (40–50%), 
hemicellulose (25–35%) and lignin (15–20%). The composition of the three main 
fractions may vary according to plant type, varieties, part and maturity. Other 




Figure 1.1 Schematic representation of woody biomass composition 
Taken from Alonso et al. [6] 
 
Cellulose is a non-branched water-insoluble polysaccharide consisting of D-
glucose subunits linked by β-(1→4) glycosidic bond. Hemicellulose is a polymeric 
material, although lower in molecular weight than cellulose, consisting of C6-sugars 
(glucose, mannose and galactose) and C5-sugars (mainly arabinose and xylose). 
Lignin is an amorphous heteropolymer constructed of phenolic monomer units linked 
in a three-dimensional structure. 
 
Among the different components of lignocellulosic biomass, carbohydrates, in 
particular, are promising because they are inexpensive, readily available, provide great 
stereochemical diversity and form by far the largest natural source of carbon. Many 
types of bio-based building blocks can be produced or extracted from carbohydrates 
through biological, chemical, thermal, or mechanical treatments. These building 









Scheme 1.1 Platform chemicals from cellulose 
Taken from Donate [7] 
 
Currently, the industrial production of bio-based compounds mainly involves 
polymers. Synthetic polymers, or plastics, are essential materials to modern society. 
Industrial polymerization technologies make it possible to produce versatile polymers 
with highly tunable properties and a broad range of applications. No other class of 
materials can have such diverse properties and versatile applicability. The polymers 
that currently dominate the market (polyolefins such as polyethylene and 
polypropylene, or polyesters such as polyethylene terephthalate) derived from non-
renewable oil and gas resources, are environmentally persistent, costly to degrade, 
which make them unsustainable. Thus, the development of high-performance 
polymers and novel monomers from renewable feedstocks is a crucial step toward a 
global economy that is less dependent on fossil resources and has been a field of 
increasing study. 




In the fine chemicals area, there is also increasing interest in Green chemistry. 
Up to now, research has been focused mainly on the use of biomass for the production 
of large quantities of low-cost commodities, such as bioplastics, whereas the 
preparation of high added-value compounds, such as Active Pharmaceutical 
Ingredients, potential new drugs, nutraceutical additives, cosmetics ingredients and so 
on has been much less investigated so far. Thanks to the high value of these bio-based 
products, also natural starting material obtained in relatively small quantities may be 
exploited. Within this context, a whole new chemistry has to be developed, alternative 
to the classic organic synthesis, which starts mainly from mineral oil. 
 
 
1.3. Aim and outline of this thesis  
 
Owing to the importance of biomass, the aim of the present thesis was the 
development of new efficient methodologies for obtaining high added-value products 
starting from renewable sources. The bio-based building blocks obtained were 
subsequently employed for the synthesis of polyfunctionalized chemicals and 
polymers. 
In Chapter 1, a general overview of the concept of Green Chemistry and bio-
economy is provided. Moreover, the importance of using biomass as a source of bio-
based starting materials is illustrated. 
The results obtained are then organized in two main sections. 
The first section (Part A), which includes Chapters 2, 3 and 4, will deal with 
two different projects developed within the BioOrganic Chemistry Group[8] at the 
Department of Chemistry and Industrial Chemistry of the University of Genova, under 
the supervision of Prof. Renata Riva. The group is deeply involved in Diversity 
Oriented Synthesis of libraries of drug-like molecules, especially using 
multicomponent reactions (MCRs). Recently, the group is becoming active in new 
fields, such as flow chemistry and photoactivated reactions and in the chemical 
contribution to bio-economy as well. 
These Chapters will discuss the application of bio-based building blocks to the 
organic synthesis of sugar derived structures. Particularly, in Chapter 2, the advantages 
of coupling biocatalysis, multicomponent reactions and the use of bio-based building 
blocks will be described. In Chapter 3 and 4 the diversity-oriented synthesis of chiral, 
bio-based, oxygen heterocycles and the target-oriented synthesis of Bengamides, a 
new class of antitumor natural products of marine origin, will be explored. 
The second section (Part B), which includes Chapter 5, will be focused on the 
project developed in the Free Radical Group[9] at Stellenbosch University (South 
Africa) under the supervision of Prof. Bert Klumperman and Dr. Rueben Pfukwa, 




during the period (6 months) I spent as visiting Ph.D. student. The research of this 
group focusses on the use of reversible deactivation radical polymerization (RDRP) as 
a versatile tool to create carefully designed polymers with complex architectures that 
can be employed in the biomedical field such as hydrogels or drug delivery systems.   
This Chapter will describe a further application of bio-based building blocks 
in the field of materials science. Particularly, after a brief introduction on the 
BIODEST Project, the synthesis of a novel lactam-based monomer and its use for 
preliminary polymerization reactions will be presented. 
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In this section, the first part of my doctoral research work, carried out in the 
BioOrganic Chemistry Group at the University of Genova, will be discussed.  
I worked on two different projects united by the possibility of using a bio-based 
building block, diol, derived from biomass, to prepare high added-value compounds, 
through the coupling of biocatalysis and multicomponent reactions (MCRs). The 
validity of our synthetic strategy was demonstrated by the application to the diversity-
oriented synthesis of polyfunctionalized oxygen heterocycles and to the target-oriented 








CHAPTER 2.  





In the past century, the main purpose of organic chemists was to find pathways 
for the synthesis of many complex molecules. Since then, many novel methodologies 
have been discovered, making concrete the possibility to obtain almost every needed 
molecule. However, over the past few decades, the purpose has been shifted to how 
these complex molecules can be prepared. Chemists have to be progressively more 
devoted to the achievement of an ideal and “greener” synthesis[1]. According to P. A. 
Wender and R. J. Ternansky[2] “an ideal synthesis is generally regarded as one in 
which the target molecule (natural or designed) is prepared from readily available 
inexpensive starting materials in one simple, safe environmentally acceptable, and 




Figure 2.1 Features of an ideal synthesis  
Taken from Dõmling and Ugi[3] 
 
Within this context, coupling biocatalysis with multicomponent reactions is of 
particular interest. These two different approaches are able to satisfy the requirements 
of an ideal approach, regarding selectivity (stereocontrol), efficiency and 
sustainability[4]. 
In multicomponent reactions (MCRs) often multiple covalent bonds and 
several stereocentres are formed in a single reaction step with a high tolerance of 
different functional groups. Consequently, the use of protection groups can be avoided, 
which reduces the number of reaction steps significantly. Moreover, since 
multicomponent reactions are based on the condensation of three or more substrates in 
a single product, a relevant chemical complexity and diversity level is inserted in the 
final products, as the structure of the reacting substrates can be varied at will. This 
synthetic methodology is highly convergent and efficient and responds to the criteria 




of atom[5] and step economy. In addition, MCRs are usually experimentally simple to 
perform and need mild conditions. Considering all these features, it is not surprising 
that MCRs are widely recognized to be more sustainable synthetic methodologies 




Figure 2.2 Comparison between a stepwise and a multicomponent approach. 
 
Recently, Orru [6] and co-workers compared the general features of MCRs with 
Green Chemistry principles, demonstrating their close correlation, as summarized in 
Table 2.1. 
 
Table 2.1 Correlation between Green Chemistry principles and MCRs features 
 
Green Chemistry Principles 
MCRs features with related 
advantages and drawbacks 
Waste Production 
✓ Convergence and step economy allow for solvent 
reduction 
✓ Low MW and innocuous by-products 
Atom Economy 
✓ At least 80% of atom economy 
× Synthesis of isocyanide is not green (IMCRs) 
Less Hazardous Synthesis 
✓ Reagents and by-products are in most cases not 
hazardous 
Design for Safer Products ✓ Not relevant (product not process) 
Benign Solvents and 
Auxiliaries 
✓ Simplified product isolation and purification 
(crystallization instead of chromatography) 
✓ Step economy allows solvent reduction 
Energy Efficiency 
✓ Usually mild conditions 
✓ Compatibility with microwave heating and flow 
technologies 
Renewable Feedstocks 
✓ Valuable use of renewable starting materials towards 
molecular complexity 
Reduce Use of Derivatives 
✓ Chemoselectivity and tolerability toward different 
functional groups; in most cases protecting groups are 
not required 
Catalysis 
✓ Some examples of organocatalysts and enzymes used 
× Stereocontrol through asymmetric catalysis is still an 
open issue 
Design for Degradation ✓ Not relevant (product not process) 




Real-Time Analysis for 
Pollution Control 
✓ Possibility of coupling MCRs with flow conditions 
Inherently Safer Processes ✓ Mild and safe conditions 
 
Although the increasing number of applications of MCRs in target‐oriented[7] 
and diversity‐oriented synthesis[8], they suffer from a main limitation, which 
dramatically restricts their purpose: the overall poor stereocontrol in most of these 
reactions. This is a huge limitation in particular for the synthesis of Active 
Pharmaceutical Ingredients, in which the obtainment of a single enantiopure 
stereoisomer is of vital importance. To overcome this weakness there are two different 
possibilities[9]: 
1) Perform asymmetric catalytic MCRs starting from achiral substrates; 
2) Perform the reaction on chiral enantiomerically pure substrates taking 
advantage of the substrate controlled diastereoselection achieved during 
the MCR step.  
The first approach benefits from the use of only small amounts of chiral 
catalysts. However, catalytic asymmetric methods to control the stereochemical 
outcome of MCRs are scarce. This is probably due to the fact that it is a very 
challenging result to obtain, in particular in isocyanide-based multicomponent 
reactions (IMCRs), in which one of the substrates is a molecule carrying isocyanide 
functional group. In the second approach, the chiral compound could be used both as 
a chiral auxiliary or as an effective substrate of the reaction. The chiral auxiliary 
approach results to be disadvantageous because it doesn’t follow the atom economy 
principle, it introduces more manipulation in the procedure and wastes a possibility to 
introduce an additional diversity input.  For this reason, the use of a chiral substrate is 
considered preferable for both atom and step economy together with the introduction 
of an additional diversity input. These can be derived easily and economically from 
the chiral pool (i.e., amino acids or sugars) but the available structures are quite 
limited. Consequently, methods for the generation of optically pure compounds to 
employ as MCRs inputs are required. 
Within this context, biocatalysis is a promising method. Biocatalysts are 
among the most powerful tools in organic synthesis because of their great 
advantages[10]. Enzymes are characterized by impressively high efficiency and 
selectivity and they can catalyse a broad spectrum of reactions, also some impossible 
to emulate in classical organic chemistry. Biocatalysis has many attractive features in 
the context of Green Chemistry: mild reaction conditions (pH, temperature and 
solvent), environmental compatibility, biodegradability of enzymes. Moreover, the use 
of enzymes generally avoids the protection and deprotection steps required in 
traditional organic syntheses. This affords shorter processes, generate less waste and 
is environmentally more attractive than conventional routes[11]. Biocatalytic processes 
can be performed with isolated enzymes or as whole-cell biotransformations. Isolated 




enzymes have the advantage of not being contaminated with other enzymes present in 
the cell, while the use of whole cells is less expensive since it avoids separation and 
purification of the enzyme. 
Two main combinations of biocatalysis with MCRs are possible[12]: 
(A) Biocatalysis can provide the enantiopure chiral inputs to use in MCRs.  
(B) MCR was performed, followed by a kinetic resolution of the racemic products or 




Figure 2.3 Combination of biocatalysis and MCRs 
 
The main scope of this Part A was, therefore, to further investigate this field. 
In particular, my work is focused on the possibility of using biocatalysis for the 
synthesis of enantiopure chiral substrates that can be used to direct the stereochemical 
outcome of Passerini multicomponent reaction starting from bio-based compounds. 
In the following paragraphs, the enzymatic methodology and multicomponent 
reaction exploited in this work will be described in detail. Finally, the synthetic plan 
elaborated during this thesis will be mentioned. 
 
 
2.2 IMCRs: Passerini reaction 
 
A large and important class of MCRs are the Isocyanide - based Multi-
Component Reactions (IMCRs), which are widely used nowadays to efficiently 
prepare complex molecules, both in target-oriented synthetic projects and in 
combinatorial and diversity-oriented applications. The importance of IMCRs deals 
with the great potential of isocyanide molecule[13]. 
 
2.2.1 Structure and reactivity of isocyanide 
 
Isocyanides are one of the most intriguing functional groups in organic 
chemistry. They are the only class of stable organic molecules with a formally divalent 
carbon atom, which can react with electrophiles and nucleophiles, participates in 
radical reactions[14] or act as a ligand to metal centres[15]. The attractions of these 
functional groups are offset by several disadvantages. These compounds are generally 




well known in the synthetic organic community but mostly because of their strong 
repulsive odour, described from Gautier[16] as “reminiscent of artichokes and 
phosphorus at the same time”, rather than their unique reactivity. This class of 
compounds showed, however, to have only slight toxicity, apart from few exceptions. 
Moreover, few isocyanides are available from major commercial suppliers and they 
are typically not simple to prepare.  
The reactivity of isocyanides can be explained with the representation of the 
electronic structure. Isocyanides are considered as resonance forms between divalent 
carbon form and zwitterion (Scheme 2.1). The carbene-like reactivity is reflected in 
the resonance structure 2.2, while the linearity of the bond is represented by the 
resonance structure 2.1. However, structure 2.3 with a donor-acceptor double bond and 





Scheme 2.1 Resonance structures of isocyanide 
 
Synthetically, the most important property of isocyanides is their unique ability 
to react simultaneously with nucleophiles and electrophiles at the isocyanide terminal 
carbon atom (α-addition) in a single reaction[3], leading to adducts such as 2.4 (Scheme 
2.2). Most other functional groups react with nucleophiles and electrophiles at 





Scheme 2.2 Reaction of isocyanide with nucleophile and electrophile 
 
The difference between nitriles and isocyanides functions can be easily 
revealed by the comparison of the frontier orbitals (Figure 2.4). On isocyanide, a 
nucleophile attacks the carbon atom as it has the largest coefficient in the LUMO (π*) 
orbital. Moreover, an electrophile interacts with the HOMO (σ) orbital, which is only 
developed on the same terminal atom. So, both nucleophile and electrophile attacks 
will occur on the terminal carbon. Nitriles, in contrast, are attacked by nucleophiles at 
the carbon atom (higher π* orbital coefficient) and by electrophiles at the nitrogen 
atom (higher π orbital coefficient), displaying thus a “classical” reactivity at two 
centres. 







Figure 2.4 Frontier orbitals of isocyanide and cyanides.  
Taken from Dömling, and Ugi[3] 
 
Due to their ability to engage in multiple-bond forming reactions, isocyanides 
have found wide applications in multicomponent chemistry. 
 
2.2.2 Passerini reaction (P-3CR) 
 
Passerini reaction, discovered by Mario Passerini in 1921 in Italy[17], is the first 
example of a multicomponent reaction with an isocyanide as basic moiety. It involves 
the reaction of a carbonyl compound (a ketone or aldehyde), an isocyanide, and a 
carboxylic acid to afford α-acyloxycarboxamide scaffolds, under mild conditions and 




Scheme 2.3 Passerini reaction 
 
In the last decades, in order to expand the scope of this procedure, different 
approaches such as intramolecular modification or post-condensation 
transformations[18], have been explored. 
 
2.2.2.1 Mechanism  
 
The mechanism of Passerini reaction has been widely discussed[19]. The main 
problem is that intermediates from a MCR are typically not isolated, thus causing 
difficulties to obtain a more precise mechanism proposal for the transformation. The 
classical accepted mechanism is depicted in Scheme 2.4 [20]. 
 






Scheme 2.4 Classical mechanism 
 
At first, the carboxylic acid and the carbonyl compound form a six-membered 
adduct (2.5) stabilized via hydrogen bonding; then this cluster reacts with the 
isocyanide in a concerted way to give the cyclic transition state 2.6 involving all three 
components. Finally, the intramolecular acyl transfer (the so-called Mumm 
rearrangement) occurs, affording the final Passerini 3CR product 2.7. Some 
experimental and theoretical evidences support this mechanism: the reaction takes 
place efficiently in apolar solvent, and with high concentration of reactants.  
Recently, some theoretical studies have been carried out, giving new 
interesting contributions in the elucidation of Passerini reaction mechanism.  
Maeda et al.[21] suggested that an additional carboxylic acid molecule may be 
involved in the final Mumm rearrangement, forming a bicyclic intermediate (Scheme 




Scheme 2.5 Passerini mechanism proposed by Maeda 
 
Using DFT calculations, Ramozzi and al.[22] confirmed the role of a second 
carboxylic acid molecule as catalysts. Nevertheless, their calculations indicate the 
nitrilium ion as a relevant intermediate for the Passerini reaction. It is stable in solution, 
and its formation is the rate-determining step of the process. Consequently, the better 
efficiency of the Passerini reaction in aprotic solvents is not due to the nonexistence 
of the nitrilium, as always explained, but rather due to the absence of hydrogen bonds 




network with the solvent during the formation of the nitrilium, which would otherwise 
decrease the reactivity of the reactants. Thus, from these results, they propose a new 




Scheme 2.6 Passerini mechanism proposed by Ramozzi 
 
2.2.2.2 Stereocontrol in Passerini reaction 
 
In Passerini reaction, one stereogenic centre is always formed in the process, if 
the oxo-component is an aldehyde (except for formaldehyde) or a non-symmetric 
ketone. In the absence of a chiral source in the reaction medium, the resulting product 
can only turn out to be racemic. As previously described, to obtain chiral products an 
asymmetric catalytic reaction or a diastereoselective approach can be performed. For 
our purpose, the second approach will be explored. Considering Passerini reaction 
mechanism, since all the three reagents are involved in the rate-determining step[23], 
theoretically asymmetric induction may be achieved when at least one of them is 
chiral. 
The diastereoselectivity induced by chiral carbonyl compounds is usually 
rather scarce or moderate. This outcome is quite surprising since it is well-known that 
aldehydes with a stereogenic centre at the α-position are often responsible for good 
stereochemical control during nucleophilic additions. A possible explanation may be 
the low stereochemical requirements of the involved nucleophile, i.e. the isocyanide. 
Anyway, some good results are obtained using chiral 2,3-epoxy aldehydes 2.12, in 




presence of tosylmethyl isocyanide (TosMIC) and benzoic acid[24], or chiral lactams 
2.13 in the synthesis of β-lactam-triazole hybrids as reported by Alcaide and co-
workers[25]. 
Chiral isocyanides usually react with low stereoselectivity. The only exception 
so far reported has been the rigid and chiral camphor-derivative 2.14[26], which can be 
considered a chiral auxiliary and removed after the condensation reaction to give the 
corresponding carboxylic acid or ester. 
Among the different chiral acids tested for the Passerini reaction, galacturonic 




Scheme 2.7 Passerini reaction with chiral substrates 
 
 
2.3 Enzymatic desymmetrization  
 
Due to the increasing demand for chiral substrates to conduct 
diastereoselective multicomponent reactions, biocatalysis represents a fundamental 
tool in organic synthesis. Different strategies exist to obtain enantiomerically pure 
compounds. Among them, kinetic resolution and desymmetrization are of particular 
interest. 
In the first approach (Scheme 2.8), the substrate is a racemic mixture. The 
enzyme can differentiate the two enantiomers, converting one of the two at a higher 
rate. The maximum yield in kinetic resolutions is 50% because the starting material is 
racemic and this is, of course, the main drawback. To overcome this problem, a method 
called dynamic kinetic resolution (DKR), have been developed. The aspects of this 
approach will not be further discussed, as they are not object of this thesis. 
 






Scheme 2.8 A kinetic resolution 
 
The second possibility is to use an achiral substrate (prochiral or meso 
compounds, which are prostereogenic) and to selectively convert it into a single 
enantiomer. Thus, if the substrate has two chemically identical but enantiotopic groups 
X and it undergoes the desymmetrization in the presence of an enzyme, a chiral 
discrimination between these two groups occurs. The transformation of group X into 
Y is not equivalent for both the groups and a chiral product is obtained (Scheme 2.9a). 
In contrast to a kinetic resolution, the theoretical yield of these conversions is 100%, 
because there is no more the limitation of the racemic substrate. Similarly, the enzyme 
can distinguish, the two chemically identical groups X, positioned on carbon atoms of 
opposite (R, S)-configuration in a meso substrates, leading to a single enantiopure 




Scheme 2.9 Enzymatic desymmetrization of a) a prochiral and b) of a meso-substrate 
 
Therefore, through the desymmetrization process, the symmetry elements that 
preclude chirality on the substrate are eliminated, thus achieving an enantioselective 
transformation. 
The kinetics of the reactions described above is not so simple (Scheme 2.10). 
A first enantioselective transformation of a prochiral or a meso substrate (S) leads to 
the production of two enantiomeric products (P and Q) at different rates, determined 
by the rate constants k1 and k2, respectively. The monoester resulting from the first 




acylation reaction can undergo a second acylation, to yield an achiral diacetate (R). 
However, enzymes usually show preference for the reactive groups with the same 
chirality. The optical purity of the product depends on four rate constants, k1 through 
k4. Therefore, it is possible to demonstrate that, if k1> k2, the second acylation will be 




Scheme 2.10 Kinetics 
 
Notably, the optical purity of the monoester becomes a function of the 
conversion of the reaction. This is because the “undesired” enantiomer deriving from 
the first acylation (Q), is acylated faster than P to the achiral diacetate, and is therefore 
“eliminated” in situ with the second acylation. Consequently, the e.e. of the desired 
enantiomer (P) is improved, reaching higher values at higher conversion, because of 
the transformation of the other enantiomer to an achiral species. Obviously, if the 
double-step occurs the yield will decrease. Thus, the reaction has to be stopped at an 
advantageous conversion in order to achieve an optimal compromise between yields 
and e.e. 
Another advantage of desymmetrization is the possibility to obtain both the 
enantiomers by performing a hydrolysis reaction of the other acyl group on the 
compound obtained by the protection of the hydroxyl group. This technique is often 
referred to as the “meso-trick” (Scheme 2.11)[28].  
 
 
Scheme 2.11 Interconversion between two enantiomers toward "meso-trick" 
 
Otherwise, both enantiomers can be accessible performing a complementary 
acylation or hydrolysis reaction, catalysed by the same enzyme.  This is possible 
because of the principle of microscopic reversibility[29], which states that if a certain 




series of steps constitute the mechanism of a forward reaction, the mechanism of the 
reverse reaction (under the same conditions) is given by the same steps traversed 
backwards. In the example reported in Scheme 2.12, lipase is used to catalyse the 




Scheme 2.12 Ester hydrolysis and esterification reaction 
 
The reverse reaction, the esterification, could not be performed in the same 
conditions of hydrolysis, because the reaction medium is aqueous and, therefore, the 
equilibrium would be completely shifted towards reagents. However, lipase-catalysed 
esterification must be performed in an organic solvent and some expedients, such as 
using anhydrous conditions (molecular sieves or Dean-Stark apparatus) or exploiting 
an acyl-transfer, have to be used to shift the equilibrium towards the complete ester 
formation.  
In the second case, the reaction performed is not exactly an esterification, but 
a transesterification (Scheme 2.13). Particular species of acyl donors, enol esters (e.g. 
vinyl ester), are used. These compounds carry an enol as leaving group. Therefore, 
once they transfer the acyl, an unstable enol is developed, which immediately 
tautomerizes to the corresponding aldehyde or ketone, thus making the 




Scheme 2.13 Irreversible enzymatic acylation using enol esters 
 
To conclude this paragraph, enantioselective desymmetrization appears as a 
powerful tool to rapidly provide complex building blocks bearing several stereogenic 
centres. Moreover, it is extremely interesting due to the mildness of the conditions and 
the high selectivity often obtained. 
 
 
2.4 Applications of Biocatalysis and Multicomponent Reactions 
 
Transesterifications, hydrolysis of esters, and some oxidations are the 
predominant reactions involved in the desymmetrization of meso substrates. These 
reactions can afford the chiral enantiopure reagents to be used in MCRs to direct the 




stereochemical outcome. Some examples given below will show the possibility of 
coupling desymmetrization reaction with a subsequent IMCR.  
2.4.1 Multicomponent reactions/Enzymatic desymmetrization 
 
The first systematic combination of a MCR and an enzymatic 
desymmetrization was reported in 2003 by Ostaszewski[30] (Scheme 2.14). After 
generation of enantiomerically enriched glutaric mono esters 2.17 by lipase- mediated 
desymmetrization, they were submitted to an Ugi 4CR reaction to afford final product 
2.18. Moderate to reasonable e.e. and excellent yields were obtained of desired 
carboxylic acids. Unfortunately, the Ugi reaction afforded a poor diastereoselection 
(as is typical if using chiral carboxylic acids[31]). A similar approach was used for the 




Scheme 2.14 Combination of enzymatic desymmetrization of an anhydride with a 
subsequent Ugi reaction 
 
Another component for Ugi and Passerini reactions that can be efficiently 
obtained, although not directly, by lipase-catalysed desymmetrization is the aldehyde. 
These compounds are not easily obtained directly in enantiopure form through 
biocatalytic methodologies but can be prepared by oxidation of chiral primary 
alcohols. An example reported by us[33] involves the desymmetrization of diol 2.19 to 
afford monoacetate 2.20, followed by oxidation to the corresponding aldehydes, which 




Scheme 2.15 Combination of enzymatic desymmetrization of diol with a subsequent 
Passerini reaction 
 




Similarly, starting from the same diol 2.19 an enzymatic desymmetrization and 
subsequent formation of chiral pyrrolines were performed affording the chiral 
substrates for a diastereoselective Ugi-Joulliè reaction[34] (Scheme 2.16). Noteworthy, 
both enantiomers of the final product are obtained starting from the monoacetate 2.20 




Scheme 2.16 Combination of enzymatic desymmetrization of a diol with a 
subsequent Ugi-Julliè reaction 
 
Starting from diol 2.27 our group reported another example of coupling 
biocatalysis and multicomponent reactions. In this case, this strategy was employed 




Scheme 2.17 Synthesis of Telaprevir through desymmetrization- IMCRs sequence 
 




Another very useful strategy that combines desymmetrization reaction with 
IMCRs was recently disclosed by Turner and Orru (Scheme 2.18). Optically pure 3,4-
disubstituted 1-pyrrolines 2.32 are generated from the corresponding meso-
pyrrolidines 2.31 by biocatalytic desymmetrization with an engineered MAO‐N 
(monoamine oxidase) enzyme. These compounds are then employed in both an Ugi-




Scheme 2.18 General MAO-MCR sequence 
 
According to this strategy, Ruijter et al. also developed a short and efficient 
synthesis of Telaprevir using a biotransformation and two multicomponent reactions 
as the key steps (Scheme 2.19)[38]. 
 
 








2.5 Integrating biocatalysis and MCRs with renewable sources 
 
As shown above, the combination of biocatalytic principles with MCRs 
strategies would represent a highly desirable approach towards the green 
stereoselective synthesis of chiral densely functionalized compounds. Nevertheless, to 
achieve a real green and sustainable strategy, this is not enough: not only the synthetic 
methods has to be green, but we need green starting materials as well. Therefore, the 
development of new green strategies, as the coupling of biocatalysis and MCRs, that 
can afford complex molecule starting from renewable feedstocks is the new objective 
for chemists.  
Within this context, the research project, I worked on, exploited the coupling 
of biocatalysis and Passerini multicomponent reaction starting from cyclic meso-diol 
2.19. This compound can be efficiently transformed into chiral compounds by 
desymmetrization reaction affording a useful intermediate for the multicomponent 
synthesis of complex molecules. In addition, it can be easily obtained from bio-based 
starting material and, thus, it can be considered a renewable compound. In fact, it is 
chemically derived from erythritol 2.42 or D-isoascorbic acid 2.43, both obtainable 
from biomass (Scheme 2.20). The use of these starting materials presents different 




Scheme 2.20 Retrosynthetic approach for diol 2.19  
 
Erythritol is a meso natural four-carbon polyol widely distributed in nature, 
that is considered a promising intermediate building block due to its easily conversion 
into polyfunctionalized chiral compounds. Erythritol occurs as a metabolite or storage 
compound in seaweeds and fungi and is also a component of a number of common 
fruits and fermented food. Its most famous application is undoubtedly as a “non-
caloric” sweetener. Osmophilic yeasts and some bacteria can produce it.  
The biosynthesis by yeast is a multi-step metabolic pathway, which proceeds 
mainly via the pentose phosphate pathway, while bacteria produce it as a by-product 
of NADPH regeneration for phosphoketolase pathway (Scheme 2.21). This was 
exploited for its large-scale production, which uses fermentative processes with pure 
glucose and sucrose from chemically and enzymatically hydrolysed wheat and corn 
starches[39]. 







Scheme 2.21 Biosynthesis of erythritol in yeasts and bacteria 
 
D-isoascorbic acid (also referred as erythorbic acid or D-araboascorbic acid) is 
an epimer at C5 of ascorbic acid, with similar physicochemical properties. As a 
vegetable-derived food additive, it can be considered natural. Because of its strong 
reducing properties, erythorbic acid has similar technologic applications to ascorbic 
acid as a water-soluble antioxidant[40] and is widely used as an additive in processed 
foods[41]. D-isoascorbic acid and its salts are considered GRAS (generally recognized 
as safe) by the US Food and Drug Administration and are approved as food ingredients 
E315 (free acid) and E316 (sodium salt) in Europe. It is synthesized by Penicillium 
from D-glucose, D-glucono- and β-lactone, D-gluconate, sucrose, maltose, and starch. 
Glucose and gluconolactones are more suitable substrates than others. The D 














2.5.1 Synthesis of meso-diol from renewable feedstocks 
 
The first part of my project was, therefore, focused on the synthesis of the 
building block diol 2.19. 
Initially, meso diol 2.19 was prepared from commercially available erythritol 
2.42, following a procedure reported in literature[42] and already used in the research 
group[33-34]. It involves a 3-step sequence, via selective protection of the primary 
hydroxy groups as pivaloyl esters, protection of the secondary hydroxy groups as 




Scheme 2.23 Synthesis of meso diol from erythritol 
 
This method presents some critical issues:  
- The yield of the first step is rather low (54%) since with the diacylate product 
2.44, other side-products are formed (mono- and tri-acylated compounds). 
- Once obtained compound 2.44, the subsequent protection as acetonide was 
performed and the crude was directly subjected to the basic hydrolysis. The 
reaction proceeds with good yield, but the diol is difficult to isolate because of its 
poor solubility in organic solvents and strong affinity toward water. Therefore, it 
is not possible to use an extractive work up. Another problem is its sensitivity to 
acidic environment, which, in some instances, may be responsible for the cleavage 
of the acetonide group. As a consequence, the control of pH is very important. 
Furthermore, we observed that the presence of pivalic acid formed during the 
reaction, if not properly removed, caused the deprotection of the acetonide group. 
The procedure reported by our group involved the use of solid NH4Cl; then the 
crude was filtered, washing with THF/MeOH 9:1 (v/v), and the residue was 
purified by chromatography. Under these conditions the product 2.19 was 
obtained with 72% yield. However, the chromatography resulted very 
troublesome owing to the physical state of the crude: it is a very thick oil difficult 
to transfer into the column. 
Two attempts of improving the work up conditions of the hydrolysis reaction 
and isolate the product has been accomplished. The first one involved the treatment of 
the reaction solution with a strongly acid cation exchange resin (Amberlite® IR 120 
hydrogen form) until pH 6/7 to neutralize KOH; the other one involved a liquid-liquid 
continuous extraction. The main disadvantage of the first procedure is that the use of 
the acid resin can cause the hydrolysis of acetonide and lead to the starting erythritol 




2.42. To overcome this problem, after treatment with the resin, K2CO3 was added (until 
pH = 10). Although the yield obtained with this method was quite satisfactory (71% 
yield), the purification of the product resulted troublesome since K2CO3 was difficult 
to remove, even by chromatography. Therefore, we tried to carry out a liquid-liquid 
continuous extraction of the crude. A similar yield (75%) was obtained but this 
procedure requires a specific equipment and several days -nine in our case- to have a 
quantitative extraction of the product.  
Due to the previous results, another strategy for the synthesis of diol 2.19 
starting from D-isoascorbic acid 2.43 was attempted (Scheme 2.24). As shown in the 
scheme, this second approach has the main disadvantage of starting from a chiral 
substrate, D-isoascorbic acid, to afford an achiral product, the diol, which will be used 
for the synthesis of chiral building blocks in a later step of the project. On the other 





Scheme 2.24 Synthesis of diol from D-isoascorbic acid 
 
The first two steps to obtain compound 2.46 were performed following a 
procedure reported in literature[43], that involved the oxidation of D-isoascorbic acid to 
lactone 2.45 in presence of hydrogen peroxide and the subsequent protection with 
acetonide. The reaction gave the product with a high yield (81%). For the reduction of 
the lactone 2.45 two different strategies have been compared. The first strategy, 
reported in literature[44], involves the reduction of the lactone with DIBAL-H to lactol 




Scheme 2.25 First strategy in two steps 
 
The second strategy (Scheme 2.26) was performed in only one step with 
LiAlH4.  
 






Scheme 2.26 Second strategy in one step 
 
The major advantage of this second procedure is the possibility to avoid the 
purification of the product, that can directly be used for the next step. Thus, only one 
purification with chromatography, after the protection as acetonide, is necessary. In 
addition, this procedure avoids acidic environment that could be responsible for the 
cleavage of the acetonide group and extractive work up. This is a crucial point since 
the intermediates and the final diol are slightly soluble in organic solvents and have a 
strong affinity toward water.  
  






The union of renewable feedstocks, biocatalysis and MCRs in a single 
integrated general strategy represents a powerful tool to achieve a sustainable 
synthesis. Enantioselective desymmetrization strategies for the synthesis of small 
chiral molecules create added-value building blocks from simple, easily accessible 
renewable starting materials. MCRs are surely one of the most convenient methods for 
producing polyfunctionalized complex structures in a highly convergent manner. 
Despite the great potential of this useful combination few examples have been 
described in literature whereas more examples of the combination of just two of them 
can be found. 
In this context, we provide an example of the use of this “powerful trio” for the 
stereoselective synthesis of functionalized complex molecules. Exploiting biocatalysis 
starting from meso diol 2.19, we afforded chiral precursors, which were conveniently 
used in a Passerini reaction, to direct the stereochemical outcome of the process. Once 
obtained in a diastereoselective way the Passerini products, they were submitted to 
further modification, to access diverse chiral heterocycle systems and to afford a 




Scheme 2.27 Research plan 
 
  




2.7 Experimental section 
 
2.7.1 General remarks  
 
NMR spectra were taken at room temperature in CDCl3 or in d6-DMSO at 300 
MHz (1H), and 75 MHz (13C), using, as internal standard, TMS (1H-NMR: 0.000 ppm) 
or the central peak of CDCl3 (
13C: 77.160 ppm). Chemical shifts are reported in ppm 
(δ scale). Coupling constants are reported in Hertz. Resonances are described as s 
(singlet), d (doublet), t (triplet), q (quartet), bs (broad singlet) and m (multiplet) or 
combinations thereof. Peak assignments were made with the aid of gCOSY and 
gHSQC experiments. In ABX system, the proton A is considered upfield and B 
downfield.  
TLC analyses were carried out on silica gel plates and viewed at UV (254 nm) 
and developed with Hanessian stain (dipping into a solution of (NH4)4MoO4·4H2O (21 
g) and Ce(SO4)2·4H2O (1 g) in H2SO4 (31 mL) and H2O (469 mL) and warming).  
Rf values were measured after an elution of 7-9 cm.  
Column chromatographies were done with the "flash" methodology using 220-
400 mesh silica.  
All reactions using dry solvents were carried out under a nitrogen atmosphere. 
 
2.7.2 Experimental procedures 
 
2.7.2.1 Synthesis of meso- diol from erythritol  
Compound 2.19 was prepared according to literature procedures, starting from 
erythritol [42].  
White solid, yield 54%. 
 
2.7.2.2 Synthesis of meso- diol from D-(-)-isoascorbic acid 
Compounds 2.45 and 2.46 were prepared according to literature procedures, 
starting from D-isoascorbic acid[43].   
 
((4S,5R)-2,2-dimethyl-1,3-dioxolane-4,5-diyl) dimethanol 2.19 
To a suspension of LiAlH4 (1.756 g, 23.14 mmol) in THF dry (45 mL) 
at 0°C under nitrogen atmosphere, a solution of 2.46 (3.659 g, 23.14 
mmol) in dry THF (32 mL) was added dropwise (40 min). The mixture 
was allowed to reach room temperature and stirred for 3h. Then it was cooled to 0 °C 
and carefully quenched with Fieser method: deionized water (1.7 mL), NaOH (15%, 
1.7 mL) and deionized water (5.1 mL) were sequentially added dropwise. The mixture 
was stirred until obtaining a white suspension and then filtered through a pad of celite.  
In order to fully recover the product, which in part remains adsorbed on the aluminates, 
celite was washed with 900 mL of boiling THF. The filtrate was concentrated, and the 
residue purified by trituration with Et2O and then heptane to afford 3.082 g (82% yield) 
of 2.19 as a white solid. The analytical data conform to those reported in literature[45]. 
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Application of biocatalysis and MCRs to the diversity-
oriented synthesis of polyfunctionalized oxygen heterocycles 
 
 
3.1 Diversity- oriented synthesis (DOS) 
 
The term diversity-oriented synthesis (DOS) first appeared in the chemical 
literature in 2000 by Stuart Schreiber[1]. DOS aims for the efficient generation of 
chemical libraries containing structurally diverse and complex molecules, that cover a 
wide range of the chemical space and have unknown properties. The retrosynthetic 
analysis does not suite DOS since the target is not known; therefore, the synthetic 
analysis must be carried out in the forward direction. Synthetic pathways are no longer 
linear and convergent as in target-oriented synthesis (TOS), but they are rather 
branched and divergent, and the direction has been switched from simple starting 
materials to complex and diverse final products. Hence, from a synthetic point of view, 





Figure 3.1 Diversity- oriented synthesis. 
Taken from Spandi et al.[3] 
 
An efficient DOS synthesis must reach the three principal components of 
structural diversity[4]: a. appendage or building blocks diversity that consists in the 
variation of structural moieties around a common scaffold or of the building blocks 
used; b. stereochemical diversity that is represented by variation in the orientation of 
functional groups and potential macromolecule-interacting elements; c. scaffold 
diversity that consists in the variation of ring structures and rigid elements resulting in 
molecules with distinct shapes and scaffolds. 
 






Scheme 3.1 The three fundamental levels of molecular diversity 
Taken from Ruijter et al[4]. 
 
For DOS to succeed, highly efficient versatile, and robust synthetic 
methodologies are needed. This requires new concepts and novel design approaches. 
A powerful strategy to address these challenges involves the use of multicomponent 
reactions, that allow the easily and rapidly generation of complex and diverse small 
molecules. 
One of the main limits of multicomponent reactions is represented by the 
narrow scaffold diversity that these reactions can achieve. Therefore, this problem can 
be overcome with two approaches. First, and most difficult, the discovery of novel 
MCRs. This is not just left to serendipity. On the contrary, in the past years, a rational 
design approach led to access to new multicomponent processes (this strategy will not 
be hereby deeper examined). The second approach, commonly referred to as the 
build/couple/pair strategy[5], involves the combination of already existent MCRs with 
post-condensation modification approach. The build phase involves the synthesis of 
the building blocks with appropriate chirality and functional groups that can be used 
for the coupling and subsequent pairing reactions. The second couple phase involves 
intermolecular reactions between the building blocks identified. MCRs play a 
significant role in this phase to construct the densely functionalized substrate for pair 
phase. Use of chiral building blocks allows to incorporate all possible stereochemical 
diversity in the substrate. Finally, in pair phase, intramolecular reactions are 
performed to obtain skeletal diversity. In particular, the most widely employed are 
cyclization reactions, which allow the obtainment of heterocyclic systems. Among 
MCRs, Passerini reaction, due to its efficiency and versatility, has been often used as 
coupling reaction. A wide variety of Passerini post-cyclization reactions is reported in 
literature[6] to access in only few steps different heterocycles, that could find useful 
applications in drug discovery as “privileged scaffold”. 
In this context, my research project was focused on the synthesis of chiral, bio-
based, oxygen heterocycles scaffolds, starting from meso diol 3.1, by coupling 
biocatalysis, diastereoselective Passerini reaction and post-condensation cyclizations. 
The general synthetic plan is depicted in Scheme 3.2. 






Scheme 3.2 Synthetic plan 
 
Diol 3.1 is a symmetrical molecule (meso compounds), therefore it is not 
optically active. To access enantiomerically pure building blocks, it was subjected to 
lipase-mediated desymmetrization. Then we investigated the manipulation of the 
enantiomerically pure building block 3.2 in order to introduce appropriate functional 
groups. With this functionalized molecule available, its use in the Passerini three-
component reaction as oxo-compound (with previous oxidation of alcohol 
functionality) was extensively studied. To achieve a better stereoinduction, a Lewis-
acid (ZnBr2) mediated process was performed.  As extensively described in Paragraph 
3.2.3, in fact, previous works demonstrated that the presence of ZnBr2 can enhance the 
diastereoselection of the Passerini reaction on α-chiral aldehydes[7]. Finally, to broaden 
the scaffold diversity of this methodology, we studied some cyclization pathways. 
Some interesting heterocyclic systems were obtained, with control of relative and 
absolute stereochemistry of the stereogenic centres. 
This strategy offers various benefits: the chiral aldehydes are accessible using 
low-cost and “green” catalysts; both enantiomers are accessible performing a 
complementary acylation or hydrolysis reaction, catalysed by the same enzyme; 
diversity can also be achieved by introducing, through functional group manipulations, 
a variety of alternative appendages that can be exploited for post-MCR cyclizations 
leading to a variety of non-aromatic heterocyclic scaffolds (exploration of scaffold 
diversity). These cyclizations may involve not only the CH2OCOR
2 or NHR3 groups, 
but also the double bond as well. 
Overall, this synthetic route leads to a fast and sustainable method to access a 
small library of chiral compounds with a high degree of diversity and complexity and 
with control of stereochemistry.  
  




3.2 Results and Discussion 
 
The results described in this chapter are organized in three main sections. 
Firstly, the synthesis of chiral starting material through an enzymatic approach will be 
discussed (Paragraph 3.2.1). Then, the introduction of suitable functional groups will 
be described (Paragraph 3.2.2) and the effect on the diastereoselection in the Passerini 
reaction will be presented (Paragraph 3.2.3). Finally, the transformation of the chiral 
Passerini adducts previously obtained into some different heterocyclic scaffolds will 
be shown (Paragraph 3.2.4). 
 
3.2.1 Enzymatic synthesis of chiral building block 3.2 
 
Diol 3.1 is a symmetric molecule, characterized by an internal mirror plane 
(Scheme 3.3). This prevents the molecule to be chiral. To access an enantiomerically 




Scheme 3.3 Diol 3.1: a meso compound 
 
Due to their chiral active site, lipases are able to discriminate between the two 
hydroxy groups on the substrate. Thus, only one of the two possible enantiomers can 
be in principle obtained, with theoretically 100% of both yield and enantiomeric excess 
(e.e.). The enzymatic reaction was not performed towards the “natural” direction that 
lipases follow (hydrolysis), but the opposite. Therefore, the reaction is an enzymatic 
acylation, which converts the diol 3.1 into its corresponding monoester 3.2 (Scheme 
3.4). This reaction was accomplished following an optimized protocol previously 




Scheme 3.4 Enzymatic desymmetrization of diol 
 
The enantiomeric excess was determined after benzoylation of the free alcohol, 
necessary to make the molecule visible to the UV detector, and HPLC analysis with a 
chiral column. 
 




3.2.2 Functional groups manipulation 
 
The optically active building block can be easily modified to introduce 
appropriate functional groups that can be used for further synthetic applications after 
the MCR. Specifically, we decided to introduce a double bond that can be exploited in 
ring closing metathesis reactions (RCM) or, if conjugated with an ester moiety, it can 
be used as a Michael acceptor[8]. 
The chiral alcohol was oxidized to the corresponding aldehyde under Swern 
conditions and the crude was directly subjected to the following olefination. During 
the olefination reaction an important factor has to be taken into account: preserving 
the enantiomeric purity obtained through the enzymatic desymmetrization. In fact, in 
aldehydes with a stereogenic centre in the α-position to the carbonyl function, the α-
hydrogen atom shows an enhanced acidity. This gives them the tendency to racemize 
(in this case epimerize, since the aldehyde has two stereogenic centres), thus leading 




Scheme 3.5 Oxidation and Wittig reaction 
 
Initially, we planned a simple Wittig reaction to introduce a terminal double 
bond (R = H). The reaction was performed in dry THF at room temperature. For the 
generation of methylenetriphenylphosphorane, starting from 
methyltriphenylposphonium bromide, two different bases were employed (LiHMDS 
and NaHDMS). Unfortunately, no product was obtained. Therefore, the reaction was 
performed with a stabilized ylide (R = COOEt). The yield of the reaction involving a 
stabilized ylide was quite good (73%) but the d.r. was not as satisfactory (41:59 E: Z). 
Moreover, a partial epimerization in the position α to the carbonyl occurred (about 2%, 
detected by GC-MS analysis). We also tried to perform the one-pot procedure 
involving the oxidation with the TEMPO/BAIB system, followed by addition of the 
Et3N (for quenching the acetic acid) and the stabilized ylide. In this case, a good yield 
(89%) and a moderate d.r. (70:30 E: Z, with desired E selectivity) were obtained but, 
again, a partial epimerization was found (about 6%).  
To solve these problems, we decided to perform the Horner-Wadsworth-
Emmons reaction (Scheme 3.6), using the DIPEA-LiCl system. The use of these 
reagents is shown to be highly effective for Horner− Wadsworth−Emmons (HWE) 
olefination of epimerizable aldehydes with phosphonoacetate, affording products with 
little or no epimerization[9]. 






Scheme 3.6 Swern oxidation and Horner-Wadsworth –Emmons reaction 
 
Treatment of the aldehyde with lithium chloride, diisopropylethylamine and 
triethyl phosphonoacetate furnished the desired product 3.9 with high yield and very 
good control over the configuration of the double bond (E: Z, 95:5, determined by 1H-
NMR analysis). The two diastereoisomers can be easily separated by chromatography. 
Moreover, as expected, no epimerization was observed.   
To perform the multicomponent reaction, the acetyl protecting group has to be 
removed and the chiral alcohol has to be converted into the corresponding aldehyde. 
The deprotection was carried out on the E diastereoisomer and both enzymatic and 
chemical methods were investigated (Tables 3.1).  
 
Table 3.1 Optimization of deprotection conditions of the Ac group 
 
 
Entry Reagent Solvent T Time Product Yield 
1b KOH 1M MeOH 0.46 M r.t. 3 h 3.12 79% 
2a  Et3N: H2O:EtOH 1:1:5 r.t 6 d 3.11 61% 





4c CAL-Bh buffere: THF 82:18, 0.15 M r.t. 7 d 3.10 54% 
5d CAL-Bh buffere: THF 82:18, 0.07 M r.t. 8 d 3.10 45% 
6d S-PPLi buffere: THF 82:18, 0.07 M r.t. 14 d -  
7c CAL-Bh buffere THF 82:18 0.07 M 60°C 14 d -  




buffere: iPr2O 85:15, 0.1 M 60°C 6 d 3.11 54% 
10d PPLg buffere: iPr2O 85:15, 0.1 M r.t. 11 d -  




a d.r. 74:26 anti: syn determined by GC-MS, b d.r. not determined, c Reaction performed with magnetic 
stirring or d with mechanic stirring, e Phosphate buffer at pH 7, f AMANO PS: Lipase from Pseudomonas 
cepacia, g PPL: Lipase from Porcine pancreas. h CAL-B: Lipase from Candida antarctica, I S-PPL: 
Lipase from Porcine pancreas immobilized on celite,  
 
Unfortunately, neither of them was successful. The desired product 3.10 was 
obtained in low yield (Entries 4 and 5) meanwhile, in most of the cases under the mild 
basic conditions, tetrahydrofuran 3.11 was always obtained. This is due to the fact that 
the hydrolysis of the acetate was immediately followed by a fast intramolecular 
Michael addition of the hydroxy group to the double bond. Moreover, in those 
examples where the hydrolysis was performed in MeOH as solvent, also a partial or 
complete transesterification occurred affording 3.12. The cyclization, even if not 
optimized, showed a moderate stereoselectivity (74:26). It is noteworthy that, also 
using lipase-catalysed hydrolysis which works under neutral conditions, in some cases, 
we isolated considerable amounts of 3.11 as well (Entry 9).  
Due to these results, we decided to change the acetyl protecting group with a 
silyl ether group (TBS: tert-butyldimethylsilyl ether). It can be removed under acidic 
conditions, which should disfavour the Michael reaction. This group can be introduced 




Scheme 3.7 Change of protecting group 
 
In this way, the oxidation reaction will be performed on the other CH2OH 
group but, however, the opposite enantiomer can be easily accessed by 
monohydrolysis of the corresponding diester. In detail, in a previous work conducted 
by us [7a], the best results were obtained performing the reaction on the dibutyrate with 
AMANO PS Lipase at 0°C.  
The chiral alcohol 3.12 was then submitted to the oxidation-olefination 
reaction sequence. To improve the yield of the Horner-Wadsworth-Emmons reaction, 
a different procedure was employed[10]. In particular, we switched to NaH as base and 
did not use LiCl (Schema 3.8). The reaction affords the α,β-unsaturated ester 3.14 in 
good yield and a high d.r. (E: Z, > 96: 4). Epimerization was not observed either. 
 






Scheme 3.8 Optimized Horner-Wadsworth-Emmons reaction 
 
Removal of the silyl ether group was not as simple as we expected. Classical 
deprotection conditions involve treatment with tetra-n-butylammonium fluoride but, 
again, most likely due to the slightly basic conditions, we obtained as expected the 
heterocycle derived from Michael addition. On the other hand, under acidic conditions, 
we observed the cleavage also of the acetonide group (as reported in Table 3.2 with 
HF 40%[7a] and H2SiF6[11]). Therefore, we tried different conditions
[12], requiring the 
use of HF·pyridinium complex in the presence of pyridine. The initial results were 
encouraging but we had to perform a careful optimization, in order to optimize the 
ratio of HF·Py complex vs. pyridine. In addition, we also studied the possibility to use 
a lower amount of reagent. In fact, based on the procedure reported in literature, a large 
excess of HF·Py complex was required (125 eq) (Entry 4, Table 3.2). We decided to 
keep unchanged the HF·Py complex: pyridine ratio and the concentration of HF and 
we tried to change the amount of HF·Py complex and the concentration of the 
substrate. Thus, the reaction was performed using 25 eq of complex and 0.02 M 
concentration. It proceeds with good yield, but it requires a longer time (Entry 5, Table 
3.2). 
 
Table 3.2 Optimization of deprotection conditions of the TBS group 
 
Entry Reagent Solvent T Time Yield 
1 HF 40% MeCN 0.023 M -10°C→r.t. 4 h - 
2 
H2SiF6 (0.042 eq) 
Et3N (0.17 eq) 
MeCN 0.1 M 0°C 3 h 30% 
3 HF·Py (125 eq) THF 0.04 M 0°C 4 h 71% 
4 
HF·Py (125 eq) 
Py (1.3 eqa) 
THF 
0.04 Mb, 5 Mc 
0°C 30 h Quantitative 
5 
HF·Py (25 eq) 
Py (1.3 eqa) 
THF 
0.2 Mb, 5 Mc 
0°C 4 d 93% 
6 
HF·Py (35 eq) 
Py (1.3 eqa) 
THF 
0.145 Mb, 5 Mc 
0°C 3 d Quantitative 
a Respect to HF, b concentration of the substrate, d concentration of HF 
 
An optimal compromise was found using 35 eq. of HF·Py complex with a 
concentration of the substrate of 0.145 M (Entry 6, Table 3.2). In these conditions, the 




desired product 3.14 was obtained in only three days with high yield, employing less 




Scheme 3.9 Deprotection of TBS group 
 
3.2.3 Oxidation and diastereoselective Passerini reaction 
 
Compound 3.3 is the precursor of an aldehyde that can be used as carbonyl 
input in a diastereoselective multicomponent reaction. 
Generally, chiral aldehydes with a stereogenic centre in the α-position have 
been rarely used in MCRs. However, during two projects[7], our group have gained 
some experience on the behaviour in Passerini reactions of some α-chiral aldehydes 
having two contiguous stereogenic centres (such as our aldehyde) derived from 
enzymatic desymmetrization of meso compounds. In this case, the Passerini reaction 
is highly conservative even with branched aldehydes with or without the presence of 
a heteroatom in α-position. Besides, these studies show that the presence of a Lewis 
acid can enhance the diastereoselection of the reaction.  
Initially, this fact was explained by the possibility of chelation realized by 
Lewis acid with the aldehyde oxygen and one of dioxolane oxygens that lead to a 6-
membered chelate 3.15. A contemporary activation of the carbonyl compound to the 
nucleophilic addition of the isocyanide and the formation of a more rigid transition 
state is realized. In this hypothesis the attack of the Si face of the carbonyl is sterically 




Scheme 3.10 Rigid transition state with Lewis acid coordination 
 
Recently, this hypothesis has been revised by the group, on the base of new 
experimental results[13] obtained on an aldehyde derived from hydroxymethyl furfural 
(HMF). Based on the initial hypothesis (chelation between zinc and aldehyde), the 




slow addition of the isocyanide to the premixed mixture of aldehyde and ZnBr2 should 
have led to an improvement in diastereoselection. Oppositely, a poor 
diastereoselection was observed, meanwhile good results were obtained by the slow 
addition of the aldehyde and carboxylic acid to the pre-mixed mixture of isocyanide 
and ZnBr2. This can be explained with the formation of a complex between the 
isocyanide and ZnBr2 3.16, that, through an exchange reaction with acetic acid, can 
lead to compound 3.17, the real reacting species. The chelated transition state I, 
initially hypothesized, would favour the syn product due to the steric encumbrance of 
the lower carbonyl face. Thus, it is more reasonable to assume the chelation of the 
aldehyde and complex 3.17 as shown in transition states II-IV. Then, the steric strain 
is expected to favour II, leading to the anti isomer. The same transition state is likely 
to be favoured under "normal" Passerini conditions, but the increased selectivity with 
the zinc modifications may be due to the more rigid transition states and the higher 




Scheme 3.11 Recent hypothesis for diastereoselection mechanism 
 
An optimization of oxidation and Passerini reaction on aldehydes derived from 
erythritol was performed by the group[7b]. The final conditions are reported in Scheme 
3.12 and gave product 3.21 in high yield and d.r.  
 






Scheme 3.12 One-pot oxidation-Passerini reaction 
 
Starting from these results we decided to employ our aldehyde derived from 
alcohol 3.3 to perform the multicomponent reaction. For our purpose, we had first to 
oxidize the alcohol to the aldehyde 3.22 and then we decided to study the Passerini 
reaction using acetic acid and t-BuNC. 
 














3 h tBuNC 1 h DCM 56% 71:29 
3 Swern 1 h tBuNC, AcOH 1.30 h DCM 92% 59:41 
4 Swern 1 h tBuNC, AcOH 31 h THF 97% 51:49 
5 Swern 1 h 
tBuNC, AcOH 
ZnBr2 
4 h THF 78% 77:23 
a Both procedures for oxidation were performed in dry DCM, b Passerini reaction was performed with 
1.1 eq of tBuNC and AcOH and 0.4 eq of ZnBr2 at 20°C under N2 atmosphere, c determined by 1H-
NMR analysis on the crude, d the reactions were performed adding 3Ǻ molecular sieves. 
 
The configuration of the newly formed stereogenic centre of the Passerini 
reaction products was determined at a later stage of the study, by 1H-NMR analysis on 
a cyclic derivative of them (Paragraph 3.2.4.2). 




We initially utilized the conditions previously optimized involving the one-pot 
procedure with the TEMPO/BAIB (bis-acetoxyiodosobenzene) system oxidation, 
followed by addition of the isocyanide[7b]. The TEMPO/BAIB protocol represents a 
good example of waste recycling in a tandem procedure; in fact, it allows the oxidation 
of primary alcohol to the corresponding aldehyde and develops acetic acid, which can 
be exploited as acidic component for the Passerini reaction. Therefore, during the 
oxidation step two out of three components of the Passerini reaction are produced (i.e. 
the aldehyde and the acid) and then only the isocyanide needs to be added. The 
oxidation, however, was not as straightforward as we expected (Entry 1, Table 3.3).  
The main problem we encountered was the overoxidation of the aldehyde to the 
corresponding carboxylic acid, which of course competed with acetic acid in the 
Passerini reaction, lowering the overall yield. The overoxidation is favoured by the 
formation of the hydrated form of the aldehyde (Scheme 3.13), likely stabilized by the 




Scheme 3.13 Hydrated form of aldehyde  
 
Therefore, we tried to suppress this unwanted reaction working under strictly 
anhydrous conditions (molecular sieves). As shown in Table 4, Entry 2 a shorter 
reaction time was observed and, even if the yield decreased, there was a slightly 
improvement on diastereoisomeric ratio. However, the result was not very satisfactory.  
To overcome this problem the Swern oxidation was employed. Even if Swern 
oxidation eliminates the one-pot procedure, this approach avoids overoxidation of 
aldehyde. Furthermore, this oxidation method allows to use any carboxylic acid as 
input in the Passerini reaction and, contrary to one-pot methodologies, allows to 
change solvent and other reaction conditions of the Passerini reaction. 
A brief optimization of the work up conditions for the Swern reaction was 
performed. In particular, the reaction was extracted with Et2O, (NH4)H2PO4 and 1 M 
HCl, making sure of the acidity of the aqueous phase (pH 4/5), to remove all the base 
before evaporation. Then the crude aldehyde was thoroughly dried by azeotropic water 
removal with toluene and kept under vacuum for one hour. As the aldehyde is not 
stable on silica, we decided to avoid the chromatographic purification; so, after the 
workup, the crude product was directly employed in the multicomponent step.   




Since the oxidation step was optimized, we decided to improve the 
diastereoisomeric ratio of the Passerini reaction; indeed, as reported in Entry 3, Table 
3.3, avoiding the use of a Lewis acid the diastereoselctivity is quite low. 
Due to the low solubility of ZnBr2 in DCM, we decide to use THF as solvent, 
which is able to completely dissolve the ZnBr2. Initially, we performed the reaction 
without the Lewis acid, obtaining comparable results in terms of yield and d.r. (Entry 
4, Table 3.3). However, the reaction requires more time (it was complete only after 31 
hours) and consequently, a low amount of epimerized aldehyde was observed by GC-
MS analysis. Then the reaction with ZnBr2 was performed. We observed that the 
presence of a catalytic amount of zinc bromide can improve the d.r. but at the same 
time it decreases the yield (Entry 5, Table 3.3).  
Another problem was the difficulty in determining the d.r. by 1H-NMR 
analysis, since the presence of the “so-called” truncated Passerini reaction products 
(compound 3.25, Scheme 3.14) interferes with the integration of the diagnostic peaks. 




Scheme 3.14 Truncated Passerini product 
 
Since the side-products are not separable by chromatography, we could 
acetylate the crude product in order to solve this problem. However, experimental data 
show that the formation of the truncated Passerini product occurs without 
stereoselection (d.r. about 1:1) indicating that they did not derive from a hydrolysis of 
3.23, but, instead, from an independent process. In particular, the formation of these 
side-products is promoted by ZnBr2
[14], through the generation of intermediate 3.27 
without incorporation of carboxylic acid, as shown in Scheme 3.15. Therefore, in this 




Scheme 3.15 Generation of truncated Passerini product in presence of Lewis acid 




This, of course, may affect the overall d.r., since a moderate stereoselectivity 
is observed for the normal Passerini products. Thus, it was important to suppress the 
undesired side-reaction.  
The difficulty in determine the d.r. was solved using a different carboxylic acid, 
benzoic acid (BzOH) (Scheme 3.16). In fact, the two Passerini products obtained could 
be separated by HPLC and by column chromatography. Therefore, the d.r. was 
determined by HPLC analysis and confirmed by 1H-NMR analysis. Moreover, using 




Scheme 3.16 Swern oxidation and Passerini reaction with BzOH 
 
For comparison, the product was first prepared using the standard Passerini 
conditions (reaction in THF at 20°C without any Lewis acid). Also, with benzoic acid, 
although the overall yield was good (97%), diastereoselectivity was only poor (d.r. 
45:55 anti: syn). To increase the diasteroselection, the reaction with ZnBr2 was 
performed. The product was obtained after 17 h with a lower yield (59%) but improved 
diastereoselection (74: 26 anti: syn). 
In the attempt of improving the stereocontrol in the Passerini reaction, further 
optimization was conducted. In particular, temperature effects and the use of zinc 
carboxylates were investigated (Table 3.4). A previous study conducted by our 
group[13] showed that, with aldehydes containing heteroatoms, the use of zinc 
carboxylates instead of ZnBr2 could be beneficial in term of d.r. and, at the same time, 
suppress the formation of truncated Passerini products. To obtain good results, the use 
of a stoichiometric amount of zinc carboxylates was observed to be necessary, 
probably because of their lower solubility and milder Lewis acid character. In fact, 
using a catalytic amount of Zn(OAc)2 and, therefore a stoichiometric amount of acetic 
acid, the reaction had resulted much faster but a lower d.r. had been detected, 












Table 3.4 Optimization of diastereoselectivity 
 
















16h THF 0°C. 54% 74:26 c 
aPasserini reaction was performed with 1.1 eq of tBuNC and BzOH, 0.4 eq of ZnBr2 and 1.1 eq of 
zinc carboxylate under N2 atmosphere, b determined by 1H-NMR analysis on the crude, 
c determined 
by HPLC analysis on the crude. 
 
The results obtained showed a negative influence of zinc carboxylates in terms 
of yield and d.r.. This is probably due to the fact that, since it is not possible to carry 
out an acidic work up because of the lability of the compound, part of the product 
remains chelated to the zinc carboxylates. In addition, the lower temperature did not 
significantly affect the diastereoselection of the process. 
Finally, exploiting the optimized conditions (20°C in dry THF with carboxylic 
acid (1.1 eq), isocyanide (1.1 eq) and ZnBr2 (0.4 eq)), a small library of Passerini 
adducts was synthesized. Different isocyanides, including aliphatic, aromatic, 
branched aliphatic and carboxylic acids, including aliphatic and aromatic ones, have 
been combined with the chiral aldehyde 3.22. The results obtained were mostly 
satisfying, as can be seen from Scheme 3.17 (the major diastereoisomers, anti, are 
shown). 
 






Scheme 3.17 Scope of Passerini reaction 
 
The diastereoselective ratio (determined by 1H-NMR analysis from compound 
3.23 to 3.32 and by HPLC from compound 3.33 to 3.36) was in all cases good, and 
even higher than for the first model compound, ranging from 77:23 to 96:4. The 
separation step of the isomers was not always easy to perform but, in every case, it 
was possible to isolate the major final product as a single isomer. The yields are 
calculated on two steps on both the diastereoisomers, anti and syn. For compounds 
3.30 and 3.32, also the presence of truncated Passerini products was detected (about 
50% by HPLC analysis on the crude). In order to remove the side-products, the 
acetylation of the crude product was performed with Ac2O, Et3N, and DMAP.  
 
3.2.4 Post-condensation modification 
 
The synthetic possibilities of IMCRs can be increased by all the procedures 
known as post-condensation transformations. Indeed, considering the high 
compatibility of MCRs with a variety of unprotected orthogonal functional groups, the 
scaffold diversity can be greatly enhanced employing suitable functionalized starting 
materials, which produce secondary modifications spontaneously, in a domino 
process, or upon treatment with further reagents.  
Considering this fact, the cyclization of the erythritol-derived Passerini 
products was studied quite extensively. Three diverse cyclizations were performed and 
two different chiral heterocyclic compounds were obtained. From these studies, it was 




also possible to assign the absolute stereochemistry of the stereogenic centre formed 
during the Passerini reaction (Paragraph 3.2.4.2). 
 
3.2.4.1 Intramolecular Michael addition 
 
Once we obtained the chiral Passerini adducts, we studied their conversion (as 
pure diastereomers) into tetrahydrofurans, exploiting an intramolecular Michael 
addition. To do this, we take advantage of the presence of an alcohol (obtained by 
hydrolysis) and the α-β, unsaturated ester moiety. The synthetic sequence was carried 
out separately on both diastereoisomers of Passerini adducts 3.23 and 3.29 and three 
different hydrolysis conditions were explored. 
 







Reagents Time T Solvent Yield 
d.ra 
(3.37a:3.37b) 
1 3.23 KOH 1M 2h r.t. EtOH 33% 91:9 
2 3.23 EtONab 0.1M 6h r.t. EtOH 58% 90:10 
3 3.29 EtONab 0.1M 5h r.t. EtOH 73% 92:8 
4 3.29 
EtOH: Et3N: H2O 
5:1:1 
36h r.t- 60°C EtOH 74% 82:18 
a Determined by 1H-NMR analysis on the crude. 
b Prepared in situ from Na and EtOH. 
  











Reagents Time T Solvent Yield 
d.ra 
(3.38a:3.38b) 
1 3.23 KOH 1M 2h r.t. EtOH 16% 84:16 
2 3.23 EtONab 0.1M 5h 20°C EtOH 73% 83:17 
3 3.29 EtONab 0.1M 22h 0°C EtOH 83% 89:11 
4 3.29 EtONab 0.1M 6h r.t. EtOH 65% 83:17 
 
The results reported in Table 3.5 and Table 3.6 show that the reaction proceeds 
on both diastereoisomers of Passerini products with good yields and d.r. In particular, 
the experimental data suggest that the configuration and d.r. of the newly formed 
stereocentre mostly depend on the configuration of the dimethyldioxolane ring and not 
on the configuration at Cα, preferably leading to the same stereocentre during the 
cyclization. After a little optimization, we found the best conditions in the use of 
EtONa as base in dry EtOH at room temperature  
We also tried to perform the cyclization with Swern and Passerini reactions 
without purification of intermediates. In this way, cyclization was performed on the 




Scheme 3.18 Swern oxidation, Passerini reaction and Michael addition 




The final product was obtained with 20% yield and a ratio between the two 
major diastereoisomers 3.37a:3.38a of 87:13.  
 
3.2.4.2 Determination of the relative configuration of Passerini products 
 
The stereochemistry of the Passerini products was established after conversion 
into tetrahydrofuran. These heterocycles are rather rigid compounds and, therefore, 
this allowed us to unambiguously assign the relative configuration to the stereogenic 
centre formed during the Passerini reaction and to the one obtained through the 
cyclization, by comparing the two 1H- NMR spectra. Since the OH group behaves as 
the nucleophile it is reasonable to assume that the configuration of the stereogenic 
centre (H-4 and H-4’) is retained during the cyclization. Consequently, by comparison 
between the most significant coupling constants, it is possible to determine the two 
possible diastereoisomers (3.23a or 3.23b). 
 
1) Product 3.37a: H-3 and H-4 couple, but their vicinal coupling constant is almost 
null (J= 0.66 Hz) because they describe a dihedral angle of about 90°. Therefore, 
in the 1H-NMR spectrum, H-4 should be a singlet and H-3 a doublet because of 
coupling with H-2.  
2) Product 3.38a: H-3’ and H- 4’ couple, with a dihedral angle of around 0°, with a 
detectable coupling constant (J= 4.16 Hz). Thus, in the 1H-NMR spectrum, H- 4’ 
should be a doublet due to the coupling with H-3’, and H-3’ a doublet of doublets 









Scheme 3.19 Stereochemical attribution of the stereogenic centres  




Part of the 1H-NMR spectrum of the two products obtained is reported. It can 
be easily seen the two patterns described above. From these analyses, we could 
unambiguously demonstrate the relative configuration of the stereocentre in product 
3.37a and 3.38a and, consequently, the configuration of 3.23a and 3.23b. Therefore, 
the configuration of the asymmetric carbon preferably produced in the Passerini 
reaction was elucidated (R). 
From 1H-NMR spectra was also possible to establish the configuration of the 
stereocentre generated during the cyclization. In both structures, 3.37a and 3.38a, H-
1 and H-2 couple and their vicinal coupling constant is J = 4 Hz. Therefore, in the 1H-
NMR spectrum H-2 is a doublet of doublets due to the coupling with H-1 and H-3, and 
H-1 is a complex multiplet because of coupling with H-2 and the AB part of ABX 
system (ABX = CH2CH).  So, we can demonstrate the relative configuration (S) of this 
stereocentre. 
 
3.2.4.3 Synthesis of bicyclic lactone 
 
Another heterocycle that can be accessed from tetrahydrofurans, is lactone 
3.40. In fact, the tetrahydrofuran would afford the desired bicyclic ring system upon 
acidic removal of the acetonide protecting group followed by spontaneous 
lactonisation. This synthetic sequence was performed only on the (S, R) product 
(3.37a). However, it should be easily applicable to all the other stereoisomers. Two 
different procedures were carried out and they both gave good results (Table 3.7). 
 
Table 3.7 Synthesis of bicyclic lactone 
 
 















a TFA: trifluoroacetic acid 
 
3.2.4.4 Ring closing metathesis (RCM) 
 
One of the most useful methods for generating partially saturated heterocycles 
with different ring sizes is ring closing metathesis (RCM). In order to perform the 




RCM, a precursor with two double bonds, one of them already present before the MCR 
and the other one introduced on either one of the reagents of the MCR (isocyanide or 
carboxylic acid), is required. Although the coupling of MCR with RCM has also been 
described by other groups, there were few examples in the literature of RCM that gives 
9 membered unsaturated lactones[16] and none of these, starting from substituted 
alkenes. In fact, while RCM usually involves two terminal double bonds, in our case 
a terminal alkene and a substituted alkene are implicated (the −unsaturated ester). 
However, some attempts to obtain the 9-membered rings were conducted, starting 
from the major diastereoisomer of Passerini product 3.35a, employing Grubbs’ 1st 
generation catalyst 3.42 and Grubbs’ 2nd generation catalyst 3.43 in refluxing dry DCM 
(Table 3.8). 
 
Table 3.8 Ring closing metathesis 
 
 
Entry Catalyst Solvent T Time Yield 
1 3.41 DCM (0.004M) reflux 3d - 
2 3.42 DCM (0.004M) reflux 4h - 
 
Unfortunately, in both reactions, the product was not obtained, and the starting 
material was recovered. 
Due to the previous results, we decided to reduce the ester group and to attempt 
the RCM on the corresponding protected allylic alcohol (Scheme 3.20). The use of 




Scheme 3.20 Synthesis of protected allyl alcohol  
 




The protected allyl alcohol was prepared from -unsaturated ester 3.14 in a 
3-step sequence. At first, the ester was reduced with DIBAL-H[17] to give the desired 
substrate, allylic alcohol 3.44. Then treatment of 3.43 under Mitsunobu conditions 
allowed to introduce the PMP protecting group and finally the TBS group was 
removed, using the previously optimized conditions. Compound 3.46 was then 





Scheme 3.21 Ring closing metathesis 
 
The reaction was performed with Grubbs’ 1st generation catalyst and Grubbs’ 
2nd generation catalyst in refluxing dry DCM but the cyclized product was not obtained 
and the only compound isolated was the product derived from intermolecular 
metathesis (yield 15%).  Probably, the higher steric requirements of the intramolecular 
reaction make the intermolecular reaction between two terminal olefins a competitive 





In summary, thanks to their generality, versatility and ease of combination with 
various transformations, MCRs can be considered a great approach in diversity-
oriented synthesis and exploration of chemical space.  
In the present work, we report the coupling of biocatalysis, Passerini three 
component reaction and cyclizations to access a variety of functionalized oxygen 
heterocycles with control over the stereochemical outcome.  In particular, we worked 
on a promising achiral building block, derived from renewable sources, with the aim 
of enhancing its value by increasing complexity and appendage and scaffold diversity. 
  




3.4 Experimental Section 
 
3.4.1 General remarks  
 
NMR spectra were taken at room temperature in CDCl3 or in d6-DMSO at 300 
MHz (1H), and 75 MHz (13C), using, as internal standard, TMS (1H-NMR: 0.000 ppm) 
or the central peak of CDCl3 (
13C: 77.160 ppm). Chemical shifts are reported in ppm 
(δ scale). Coupling constants are reported in Hertz. Resonances are described as s 
(singlet), d (doublet), t (triplet), q (quartet), bs (broad singlet) and m (multiplet) or 
combinations thereof. Peak assignments were made with the aid of gCOSY and 
gHSQC experiments. In ABX system, the proton A is considered upfield and B 
downfield.   
GC-MS were carried out using an HP-1 column (12 m long, 0.2 mm wide), 
electron impact at 70 eV, and a mass temperature of about 170 °C. Only m/z > 33 were 
detected. All analyses were performed (unless otherwise stated) with a constant He 
flow of 1.0 ml/min with initial temp. of 70 °C, init. time 2 min, rate 20 °C/min, final 
temp. 260 °C, inj. temp. 250 °C, det. temp. 280 °C.  
HPLC analyses for the determination of enantiomeric ratios were performed 
on a Daicel Chiral Pak AD 250x3.6 mm column, at 25–28 °C with a flow of 1 mL/min 
(UV detection at λ = 220 nm).  
HPLC-MS analyses were performed on Synergi Hydro RP 150x3 mm column, 
at 30 °C with a flow of 0.5 mL/min (where not otherwise stated). HRMS: samples, 
provided at 10mM in DMSO, were analysed on a UPLC Acquity system coupled to a 
Synapt G2 QToF mass spectrometer. MS signals were acquired from 50 to 1200 m/z 
both ESI positive and ESI negative ionization mode.   
IR spectra were recorded directly on solid, oil, or foamy samples with the ATR 
(attenuated total reflectance) technique, using a FT Perkin Elmer Spectrum 65 
spectrophotometer.  
Optical rotations were measured with a JASCO P-2000 digital polarimeter, 
using the sodium D line as the light source. The specific rotation [α]D was calculated 
as: [α]D = α *100/ c*l (α = observed rotation of solution; l = length of polarimeter tube 
in decimetres, c = concentration of the solution in g/100 mL in CHCl3).  
Melting points were determined with an electrothermal apparatus (Büchi B-
535).  
TLC analyses were carried out on silica gel plates and viewed at UV (254 nm) 
and developed with Hanessian stain (dipping into a solution of (NH4)4MoO4·4H2O (21 
g) and Ce(SO4)2·4H2O (1 g) in H2SO4 (31 mL) and H2O (469 mL) and warming).  
Rf values were measured after an elution of 7-9 cm.  
Column chromatographies were done with the "flash" methodology using 220-
400 mesh silica.  
 All reactions using dry solvents were carried out under a nitrogen or argon 
atmosphere. 




3.4.2 Experimental procedures 
 
3.4.2.1 Synthesis of chiral building blocks  
 
((4R,5S)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl) 
methyl acetate 3.2 
Prepared as previously reported by us[7a]. 
Colourless liquid, yield 96%, e.e. 96%, conversion: 51%. 





To a solution of DMSO (87 μL, 1.22 mmol) in dry CH2Cl2 (2.9 ml), 
at –78 °C under nitrogen atmosphere, a solution of oxalyl chloride 
in dry CH2Cl2 (1.43 M, 515 μL) was added. Upon completion of the addition, the 
mixture was stirred at -78 °C for 10 min. A solution of alcohol 3.3 (100 mg, 0.49 
mmol) in dry CH2Cl2 (2 ml) was added dropwise, and the solution was stirred for 10 
min at –78 °C. Then Et3N (320 μL, 2.30 mmol) was added and the solution was stirred 
for 1 h. The reaction was quenched by addition of 5% aq. (NH4)H2PO4 (10 mL + 1 N 
HCl solution) to have a final pH = 4 and extracted with Et2O (3 x 10 mL). The 
combined organic layers were washed with NaHCO3 5% solution (10 mL) and brine 
(10 mL), dried (Na2SO4) and concentrated to afford aldehyde 3.7 as a yellow oil, which 
was immediately used for the next reaction without further purification. 
Horner – Wadsworth - Emmons reaction 
To a suspension of LiCl (31 mg, 0.74 mmol) and 3Ǻ molecular sieves (10 mg/0.1 
mmol) in dry MeCN (5.4 mL) triethyl phosphonoacetate (165 μL, 0.73 mmol) 
diisopropylethylamine (84 μL, 0.49 mmol) and the crude aldehyde were added. The 
reaction was stirred at room temperature for 28 h. The reaction was filtered on celite 
and then extracted with NH4Cl solution (10 mL) and Et2O (3 x 10 mL). The combined 
organic layers were washed with brine (10 mL), dried over Na2SO4, and concentrated. 
The residue was purified by silica gel column chromatography (ETP: Et2O 7:3) to 
afford the α,β-unsaturated ester (108 mg, 81% yield in 2 steps) as a mixture of 
diastereoisomers (d.r. = 95:5 E: Z, calculated by 1H-NMR analysis on the crude 
product).  
 
3.9 E diastereoisomer: pale yiellow oil; Rf = 0.25 (ETP: Et2O 7:3), developed with 
Hanessian stain.  
 






Compound 3.9 (50 mg, 0.18 mmol) was solubilized in EtOH (1 mL). 
H2O (200 μL) and Et3N (200 μL) were added and the reaction was 
stirred for 6 days at room temperature. The reaction was quenched with 
10 mL of NH4Cl (sat) and extracted with Et2O (3 x 10 mL). The combined organic 
layers were washed with brine (10 mL), dried (Na2SO4) and concentrated. The residue 
was purified by flash column chromatography on silica gel (from ETP: Et2O 6:4 to 
Et2O + 1% EtOH) to give 26 mg (61% yield) of 3.11 as a colourless oil. Analysis of 
the crude product by GC-MS revealed a diastereomeric ratio of 74:26.  
Rf = 0.30 (ETP: Et2O 1:1), developed with Hanessian stain. 
 
Legend for NMR spectra: M= major diastereoisomer, m= minor diastereoisomer. 
1H NMR (300 MHz, CDCl3, 25 °C,TMS) mixture of the two diasteroisomers (M + m) 
not separable: δ = 4.85- 4.82 (m, 1H, CHCH2O, m), 4.79 (dd, J = 6.2, 3.5 Hz, 1H, 
CHCH2O, M), 4.71 (dd, J = 6.1, 3.6 Hz, 1H, CHCHO, M), 4.57 (dd, 6.3, 1.6 Hz, 1H, 
CHCHO, m), 4.46 (td, J = 7.2, 1.7 Hz, 1H, CHCHO, m) 4.24 – 4.11 (m, 4H, CH2CH3, 
M and m), 4.01 (d, J = 10.9 Hz, 1H, CHCH2O, M), 3.96 (d, J = 1.2 Hz, 1H, CHCH2O, 
m), 3.87 (dd, J = 6.5, 3.9 Hz, 1H, CHCHO, M), 3.85 – 3.83 (m, 1H. CHCH2O, m), 
3.49 (dd, J = 10.8, 3.6 Hz, 1H, CHCH2O, M), 2.81 and 2.78 (part AB of ABX syst., 
JAB = 14.47, JAX = 2.12, JBX = 2.41. Hz, 2 H, CHCH2C=O, M), 2.51 and 2.46 (part AB 
of ABX syst., JAB = 12.13, JAX = 1.07, JBX = 0.37 Hz, 2 H, CHCH2C=O, m), 1.52 (s, 
3H, CH3 of iPr, m), 1.48 (s, 3H, CH3 of iPr, M), 1.33 (s, 6H, CH3 of iPr (M and m))  
1.28 (t, J= 7.1 Hz, 3H, CH2CH3, M) 1.27 (t, J = 7.1, Hz, 3H, CH2CH3, m). 
13C NMR 
(75 MHz, CDCl3, 25 °C, TMS) mixture of the two diasteroisomers (M + m) not 
separable:  =  171.32 (C=O, M), 170.52 (C=O, m), 113.14 (C(CH3)2, m), 112.33 
(C(CH3)2, M), 84.64 (CHCHO m), 81.25 (CHCH2O, M), 81.21 (CHCH2O, m), 81.09 
(CHCHO, m), 80.93 (CHCHO, M), 78.48 (CHCHO, M), 72.80 (CHCH2O, M), 72.42 
(CHCH2O, m), 60.96 (CH2CH3, m), 60.79 (CH2CH3, M), 36.56 (CHCH2C=O, m), 
33.94 (CHCH2C=O, M), 26.75 (CH3 of iPr, m), 26.16 (CH3 of iPr, M), 25.17 (CH3 of 
iPr, m), 25.03 (CH3 of iPr, M), 15.42 (CH2CH3, M), 14.31 (CH2CH3, m). IR mixture 
of the two diasteroisomers (M + m) not separable   (cm-1) = 2983, 2937, 2863, 1732, 
1458, 1372, 1334, 1305, 1269, 1207, 1179, 1163, 1133, 1090, 1056, 1027, 1004, 993, 
975, 952, 916, 892, 860, 815, 722, 695. GC-MS (initial temp. 70 °C):  Rt1 = 6.29 min: 
m/z 216 (M+ -15, 10.8%), 216 (11), 215 (100), 186 (5,1), 185 (59), 172 (15), 155 (48), 
127 (48), 126 (6,6), 117 (5,7), 115 (5,6), 113 (15), 109 (11), 101 (15), 99 (18), 98 (5,3), 
97 (5,9), 89 (12), 88 (9,1), 86 (5,7), 85 (57), 84 (8,9), 83 (15), 82 (6,8), 81 (83), 71 
(37), 70 (7,0), 69 (10), 60 (7,9), 59 (42), 58 (7,9), 57 (11), 56 (7,0), 55 (17), 45 (5,3), 
43 (50), 42 (5,3), 41 (8,5); Rt2 = 6.46 min: m/z 216 (M+ -15, 7.5%), 216 (7,5), 215 
(84), 200 (17), 185 (13), 172 (7,6), 155 (17), 144 (5,8), 143 (69), 127 (54), 126 (7,8), 
113 (8,7), 109 (16), 101 (11), 99 (12), 98 (6,8), 97 (7,8), 89 (11), 88 (9,2), 86 (7,1), 85 




(70), 84 (8,0), 83 (7,7), 82 (8,1), 81 (100), 71 (31), 70 (8,6), 69 (7,9), 61 (5,0), 60 (8,2), 




Prepared as previously reported in literature[10]. 
Pale yellow oil, yield 91%. 
[α]23D= + 3.73 (c = 1.03, CHCl3). 





Aldehyde 3.13 was prepared employing the same procedure of 
3.7 from alcohol 3.12 (916 mg, 3.31 mmol).  
Horner – Wadsworth - Emmons reaction 
To a suspension of sodium hydride (60% in oil, 186 mg, 3.64 mmol) in dry THF (11.5 
mL) was added triethyl phosphonoacetate (986 μL, 3.97 mmol) at 0 °C under argon 
atmosphere. The mixture was stirred at the same temperature for 30 min. To the 
mixture, a solution of aldehyde 3.13 (3.31 mmol) in dry THF (8 mL) was added at -78 
°C. The mixture was stirred at the same temperature for 10 min, warmed to room 
temperature and stirred for 45 min.  The reaction was diluted with AcOEt (30 mL) and 
poured into saturated aqueous NH4Cl solution (30 mL). The aqueous phase was 
extracted with AcOEt (2 x 20). The combined organic layers were washed with brine 
(30 mL), dried over Na2SO4, and concentrated. The residue was purified by silica gel 
column chromatography (ETP: Et2O 95:5) to afford the α, β-unsaturated ester (1.071 
g, 94% yield in 2 steps) as a mixture of diastereoisomers (d.r. = 97:3 E: Z, calculated 
by 1H-NMR analysis on the crude product). The analytical data conform to those 
reported in literature[10]. 
 
3.14 E diastereoisomer: colourless oil; Rf = 0.88 (ETP: Et2O 1:1), developed with 
Hanessian stain. [α]24D= + 12.03 (c = 0.97, CHCl3). 
 
Ethyl (E)-3-((4R,5S)-5-(hydroxymethyl)-2,2-dimethyl-1,3-
dioxolan-4-yl) acrylate 3.3 
Compound 3.14 (803 mg, 2.33 mmol) was dissolved in 16 mL of 
dry THF and 8.6 mL of pyridine (106.10 mmol) under nitrogen 
atmosphere. Then HF˙pyridinium complex (70%, 2.1 mL, 81.59 
mmol) was added to the solution at 0°C and the reaction was stirred at the same 
temperature for 3 days. The reaction was quenched with 20 mL of NH4Cl (sat) and 
extracted with Et2O (3 x 20 mL). The combined organic layers were washed with water 
(4 x 25 mL) and brine (20 mL), dried (Na2SO4) and concentrated. The residue was 




purified by flash column chromatography on silica gel (ETP: Et2O 3:7) to give 532 mg 
(99% yield) of 3.3 as a colourless oil. The analytical data conform to those reported in 
literature[18]. 
Rf = 0.25 (PE/Et2O 3:7), developed with Hanessian stain.  
[α]24D= - 33.32 (c = 1.14, CHCl3).  
 




To a solution of DMSO (105 μL, 1.47 mmol) in dry CH2Cl2 (3.4 
ml), at –78 °C under nitrogen atmosphere, a solution of oxalyl 
chloride in dry CH2Cl2 (1.43 M, 949 μL) was added. Upon 
completion of the addition, the mixture was stirred at -78 °C for 10 min. A solution of 
alcohol 3.3 (125 mg, 0.54 mmol) in dry CH2Cl2 (2 ml) was added dropwise, and the 
solution was stirred for 10 min at –78 °C. Then Et3N (350 μL, 2.52 mmol) was added 
and the solution was stirred for 1 h. The reaction was quenched by addition of 5% aq. 
(NH4)H2PO4 (10 mL + 1 N HCl solution) to have a final pH = 4 and extracted with 
Et2O (3 x 10 mL). The combined organic layers were washed with NaHCO3 5% 
solution (10 mL) and brine (10 mL), dried (Na2SO4) and concentrated to afford 129 
mg of 3.22 as a yellow oil. The crude product was directly employed in the next 
Passerini reaction. 
 
General procedure A for Passerini reaction under classical conditions  
A solution of crude aldehyde in dry THF (1 M) was placed at 20°C under nitrogen 
atmosphere and was treated with the carboxylic acid (1.1 eq) and the isocyanide (1.1 
eq). The crude product was concentrated and purified by flash column chromatography 
on silica gel. 
 
General procedure B for Passerini reaction with ZnBr2  
A solution of ZnBr2 (0.4 eq) in dry THF (1 M) was placed at 20°C under nitrogen 
atmosphere. The crude aldehyde (1 eq), the carboxylic acid (1.1 eq) and the isocyanide 
(1.1 eq) were added. The resulting solution was stirred at 20°C for 16-25 h. The 
reaction was monitored by GC-MS, quenched with NH4Cl (sat) and extracted with 
ethyl acetate. The combined organic layers were washed with NaHCO3 5% solution, 
dried (Na2SO4) and concentrated. The residue was purified by flash column 




Firstly, prepared from crude aldehyde 3.22 (0.25 mmol), 
acetic acid (16 μL, 0.27 mmol) and tert-butylisocyanide (31 




μL, 0.27 mmol) according to procedure A. The crude was purified by column 
chromatography (ETP:DCM:Et2O 3:1:1) affording 3.23_anti and 3.23_syn (d.r. = 51 
: 49 calculated by 1H NMR analysis on the crude product) (90 mg, 97%) as a mixture 
of diastereoisomers.   
Then prepared from crude aldehyde 3.22 (0.52 mmol), acetic acid (33 μL, 0.57 mmol), 
tert-butylisocyanide (65 μL, 0.57 mmol) and ZnBr2 (47 mg, 0.21 mmol) according to 
procedure B. The crude product was purified by column chromatography 
(ETP:DCM:Et2O 3:1:1) affording 3.23_anti and 3.23_syn (d.r. = 73: 27 calculated by 
1H NMR analysis on the crude product) (151 mg, 78%) as a mixture of 
diastereoisomers.   
 
3.23_anti colourless oil; Rf = (0.68, ETP: Et2O 2:8) developed with Hanessian stain. 
[α]24D= - 50.26 (c = 0.815, CHCl3).  
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.88 (dd, J = 15.6, 5.4 Hz, 1H, 
CHCH=CH), 6.10 (dd, J = 15.6, 1.6 Hz, 1H, O=CCH=CH), 5.81 (broad s, 1H, NH), 
4.87 (ddd, J = 6.7, 5.4, 1.6 Hz, 1H, CHCHO), 4.84 (d, J = 7.9 Hz, 1H, CHOAc), 4.65 
(dd, J = 7.9, 6.5 Hz, 1H, CHCHOAc), 4.19 (q, J = 7.1 Hz, 2H, CH2CH3), 2.10 (s, 3H, 
CH3of OAc), 1.51 (s, 3H, iPr), 1.38 (s, 3H, iPr), 1.32 (s, 9H, 3 CH3 of tBu), 1.27 (t, J 
= 7.1 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 169.54 
(C=ONH), 166.11 (C=O), 165.95 (C=O), 141.46 (CHCH=CH), 122.59 
(O=CCH=CH), 109.78 (C(CH3)2), 76.55 (CHCHOAc), 76.24 (CHCHO), 71.41 
(CHOAc), 60.72 (CH2CH3), 51.82 (C(CH3)3), 28.69 (3 CH3 of tBu), 27.70 (CH3 of 
iPr), 25.14 (CH3 of iPr), 20.73 (CH3 of OAc), 14.37 (CH2CH3). IR  (cm
-1) = 3355, 
2981, 2938, 1751, 1719, 1682, 1525, 1456, 1368, 1303, 1253, 1210, 1179, 1161, 1122, 
1060, 1033, 982, 938, 883, 861, 795. GC-MS (initial temp. 70 °C): Rt 9.89 min: m/z 
357 (M+-15, 0.2%), 198 (5.1), 172 (6.8), 171 (8.6), 170 (12), 154 (7.3), 152 (8.6), 151 
(7.0), 143 (11), 131 (5.3), 130 (17), 129 (6.7), 126 (14), 125 (13), 113 (6.1), 112 (30), 
109 (7.9), 108 (5.5), 101 (8.1), 97 (24), 85 (15), 84 (43), 83 (5.6), 81 (10), 69 (6.0), 59 
(17), 58 (43), 57 (52), 56 (5.1), 55 (10), 43 (100), 42 (6.3), 41 (23), 39 (9.9). HRMS 
(ESI+): m/z calcd for C18H29NO7 [M+Na]
+: 393.1842; found: 393.1835. 
 
3.23_syn colourless oil; Rf = (0.79, ETP: Et2O 2:8) developed with Hanessian stain. 
[α]24D= - 62.52 (c = 0.90, CHCl3).  
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.74 (dd, J = 15.6, 5.6 Hz, 1H, 
CHCH=CH), 6.03 (dd, J = 15.6, 1.6 Hz, 1H, O=CCH=CH), 5.79 (broad s, 1H, NH), 
4.87 (d, J = 5.7 Hz, 1H, CHOAc), 4.82 (ddd, J = 7.1, 5.6, 1.6 Hz, 1H, CHCHO), 4.68 
(dd, J = 7.0, 5.7 Hz, 1H, CHCHOAc), 4.13 (q, J = 7.2 Hz, 1H, CH2CH3), 2.08 (s, 3H, 
CH3 of OAc), 1.46 (s, 3H, iPr), 1.32 (s, 3H, iPr), 1.25 (s, 9H, 3 CH3 of tBu), 1.22 (t, J 
= 7.1 Hz, 1H, CH2CH3). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 170.29 
(C=ONH), 166.31 (C=O), 165.75 (C=O), 141.97 (CHCH=CH), 123.59 
(O=CCH=CH), 109.82 (C(CH3)2), 76.84 (CHCHOAc), 75.99 (CHCHO), 72.94 
(CHOAc), 60.74 (CH2CH3), 51.71 (C(CH3)3), 28.60 (3 CH3 of tBu), 27.29 (CH3 of 




iPr), 25.29 (CH3 of iPr), 21.09 (CH3 of OAc), 14.35 (CH2CH3). IR  (cm
-1) = 3361, 
2981, 2937, 2875, 1751, 1719, 1682, 1525, 1456, 1368, 1303, 1254, 1210, 1178, 1161, 
1121, 1060, 1033, 983, 938, 883, 862, 795, 661. GC-MS (initial temp. 70 °C): Rt 9.79 
min: m/z 357 (M+-15, 0.8%), 198 (12), 172 (6.0), 171 (8.3), 170 (9.1), 154 (5.1), 152 
(9.9), 151 (5.2), 143 (8.6), 198 (12), 172 (6.0), 171 (8.3), 170 (9.1), 154 (5.1), 152 
(9.9), 151 (5.2), 143 (8.6), 131 (6.8), 130 (19), 129 (7.2), 126 (12), 125 (11), 113 (5.7), 
112 (27), 109 (6.0), 108 (5.3), 101 (8.5), 97 (22), 85 (15), 84 (36), 83 (5.4), 81 (9.0), 
69 (6.3), 59 (16), 58 (44), 57 (49), 55 (11), 43 (100), 42 (6.3), 41 (22), 39 (9.1). HRMS 
(ESI+): m/z calcd for C18H29NO7 [M+Na]




oxoethyl benzoate 3.29 
Firstly, prepared from crude aldehyde 3.22 (0.74 mmol), 
benzoic acid (100 mg, 0.82 mmol) and tert-
butylisocyanide (92 μL, 0.82 mmol), according to 
procedure A. The crude product was purified by column 
chromatography (ETP:DCM:Et2O 3:1:1) affording 3.29_anti and 3.29_syn (d.r. = 46 
: 54 calculated by HPLC analysis and confirmed by 1H-NMR analysis on the crude 
product) (314 mg, 97%) as a mixture of diastereoisomers.  
Then prepared from crude aldehyde (0.65 mmol), benzoic acid (87 mg, 0.71 mmol), 
tert-butylisocyanide (81 μL, 0.71 mmol) and ZnBr2 (59 mg, 0.26 mmol) according to 
procedure B. The crude product was purified by column chromatography 
(ETP:DCM:Et2O 3:1:1) affording 3.29_anti and 3.29_syn (d.r. = 76: 24 calculated by 
HPLC analysis and confirmed by 1H-NMR (73:27) analysis on the crude product) (167 
mg, 59%) as a mixture of diastereoisomers.   
 
3.29_anti white solid; Rf = (0.64, ETP: Et2O 4:6) developed with Hanessian stain. 
[α]24D= - 53.53 (c = 0.97, CHCl3). m.p. 103.5-107.1 °C (CH2Cl2). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 8.11 – 8.01 (m, 2H, 2 CH of Ph), 7.68 – 
7.55 (m, 1H, CH of Ph), 7.54 – 7.42 (m, 2H, 2 CH of Ph), 7.07 – 6.94 (m, 1H, 
CHCH=CH ), 6.15 (dd, J = 15.6, 1.0 Hz, 1H, O=CCH=CH), 5.90 (broad s, 1H, NH), 
5.56 – 5.47 (m, 1H, CHBz), 5.00 – 4.91 (m, 2H, CHCHO and CHCHBz), 4.10 (qd, J 
= 7.1, 1.8 Hz, 2H, CH2CH3), 1.39 (s, 6H 2 CH3 of iPr), 1.34 (s, 9H, 3 CH3 of tBu), 1.19 
(t, J = 7.1 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 166.09 
(C=ONH), 165.78 (C=O), 165.19 (C=O), 142.37 (CHCH=CH), 133.84 (CH of Ph), 
130.07 (2 CH of Ph), 128.92 (C quat. of Ph), 128.75 (2 CH of Ph), 123.17 
(O=CCH=CH), 109.64 (C(CH3)2), 76.13 (CHCHO and CHBz) 71.98 (CHCHBz), 
60.59 (CH2CH3), 51.86 (C(CH3)3), 28.60 (3 CH3 of tBu), 27.33 (CH3 of iPr), 24.94 
(CH3 of iPr), 14.28 (CH2CH3). IR  (cm
-1) = 3338, 3077, 2977, 1712, 1669, 1602, 
1535, 1453, 1368, 1294, 1253, 1238, 1218, 1179, 1161, 1114, 1068, 1047, 1029, 1001, 
989, 881, 819, 804, 787, 760, 709, 686, 671, 626. GC-MS (initial temp. 70 °C): Rt 




11.91 min: m/z 418 (M+-15, 2.2%), 130 (5.2), 112 (8.9), 106 (7.0), 105 (100), 84 (12), 
77 (16), 58 (6.7), 57 (16), 43 (7.8), 41 (7.1). HRMS (ESI+): m/z calcd for C23H31NO7 
[M+Na]+: 456.1999; found: 456.1995. 
3.29_syn white solid; Rf = (0.59, ETP: Et2O 4:6) developed with Hanessian stain. 
[α]24D= - 69.80 (c =1.00, CHCl3). m.p. 99.6 - 103.8 °C (CH2Cl2). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ =  8.16 – 8.03 (m, 2H, 2 CH of Ph), 7.66 
– 7.56 (m, 1H, CH of Ph), 7.54 – 7.41 (m, 2H, 2 CH of Ph), 6.83 (dd, J = 15.7, 4.9 Hz, 
1H, CHCH=CH), 6.06 (dd, J = 15.7, 1.4 Hz, 1H, O=CCH=CH), 5.96 (broad s, 1H, 
NH), 5.22 (d, J = 4.7 Hz, 1H, CHBz), 5.00 – 4.88 (m, 2H, CHCHO and CHCHBz), 
4.03 (q, J = 7.1 Hz, 2H, CH2CH3), 1.59 (s, 3H, CH3 of iPr), 1.42 (s, 3H, CH3 of iPr), 
1.31 (s, 9H, 3 CH3 of tBu), 1.14 (t, J = 7.1 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, 
CDCl3, 25 °C, TMS):  = 166.46 (C=ONH), 165.75 (C=O), 165.47 (C=O), 141.75 
(CHCH=CH), 133.82 (CH of Ph), 130.09 (2 CH of Ph), 129.12 (C quat. of Ph), 128.73 
(2 CH of Ph), 123.58 (O=CCH=CH), 109.72 (C(CH3)2), 77.09 (CHCHO), 75.93 
(CHCHBz), 73.42 (CHBz), 60.50 (CH2CH3), 51.71 (C(CH3)3), 28.62 (3 CH3 of tBu), 
27.30 (CH3 of iPr), 25.10 (CH3 of iPr), 14.16, (CH2CH3). IR  (cm
-1) = 3362, 2981, 
2965, 2937, 1730, 1713, 1688, 1603, 1586, 1543, 1495, 1454, 1381, 1364, 1317, 1296, 
1256, 1213, 1181, 1161, 1134, 1099, 1060, 1039, 987, 947, 914, 885, 851, 798, 765, 
716, 688, 676, 633, 610. GC-MS (initial temp. 70 °C): Rt 12.23 min: m/z 418 (M+-15, 
0.9%), 171 (9.4), 130 (5.9), 112 (8.8), 106 (8.8), 105 (100), 84 (12), 77 (15), 58 (6.6), 
57 (14), 43 (6.2), 41 (5.3). HRMS (ESI+): m/z calcd for C23H31NO7 [M+Na]
+: 




oxoethyl pent-4-enoate 3.35 
Firstly, prepared from crude aldehyde 3.22 (0.434 mmol), 
pentenoic acid (48 μL, 0.48 mmol) and tert-
butylisocyanide (54 μL, 0.48 mmol) according to 
procedure A. The crude product was purified by column 
chromatography ((ETP:DCM:Et2O 3:1:1) affording 3.35_anti and 3.35_syn (d.r. = 47 
: 53 calculated by HPLC analysis on the crude product) (117 mg, 66%) as a mixture 
of diastereoisomers.  
Then prepared from crude aldehyde 3.22 (0.650 mmol), pentenoic acid (72 μL, 0.71 
mmol), tert-butylisocyanide (81 μL, 0.71 mmol) and ZnBr2 (59 mg, 0.26 mmol) 
according to procedure B. The crude product was purified by column chromatography 
((ETP:DCM:Et2O 3:1:1) affording 3.35_anti and 3.35_syn (d.r. = 77 : 23 calculated 
by HPLC analysis on the crude product) (142 mg, 53%) as a mixture of 
diastereoisomers. 
   
3.35_anti colourless oil; Rf = (0.70, ETP: Et2O 4: 6) developed with Hanessian stain. 
[α]24D= - 22.22 (c = 0.99, CHCl3). 




1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.89 (dd, J = 15.7, 5.7 Hz, 1H, 
CHCH=CH), 6.10 (dd, J = 15.6, 1.6 Hz, 1H, O=CCH=CH), 5.91 – 5.73 (m, 2H, NH 
and CH2=CHCH2), 5.12 – 4.98 (m, 3H, CH2=CHCH2 and CHOC=O ), 4.87 (ddd, J = 
6.9, 5.7, 1.6 Hz, 1H, CHCHO), 4.72 (t, J = 6.8 Hz, 1H, CHCHOC=O), 4.19 (q, J = 7.1 
Hz, 2H, CH2CH3), 2.54 – 2.46 (m, 2H, CH2CH2C=O), 2.43 – 2.33 (m, 2H, 
CH2CH2C=O), 1.51 (s, 3H, CH3 of iPr), 1.38 (s, 3H, CH3 of iPr), 1.32 (s, 9H, 3 CH3 of 
tBu), 1.28 (t, J = 7.1 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 
171.53 (C=ONH), 166.06 (C=O), 165.92 (C=O), 141.99 (CHCH=CH), 136.42 
(CH2=CHCH2), 122.76 (O=CCH=CH), 115.97 (CH2=CHCH2), 109.64 (C(CH3)2), 
76.68 (CHCHOC=O), 76.17 (CHCHO), 71.40 (CHOC=O), 60.68 (CH2CH3), 51.80 
(C(CH3)3), 33.18 (CH2CH2C=O), 28.64 (3 CH3 of tBu), 28.49 (CH2CH2C=O), 27.60 
(CH3 of iPr), 25.03 (CH3 of iPr), 14.38 (CH2CH3). IR  (cm
-1) = 3385, 2987, 2966, 
2940, 1732, 1714, 1687, 1534, 1454, 1380, 1367, 1300, 1255, 1222, 1160, 1128, 1108, 
1070, 1043, 1003, 984, 957, 931, 914, 881, 810, 790, 762, 744, 691, 666, 631, 603. 
GC-MS (initial temp. 70 °C): Rt 10.75 min: m/z 396 (M+-15, 0.1%), 170 (7.4), 154 
(6.1), 152 (5.4), 151 (5.9), 130 (11), 129 (5.8), 126 (7.4), 125 (10), 112 (25), 97 (15), 
85 (7.9), 84 (40), 83 (58), 81 (8.8), 69 (5.3), 59 (13), 58 (33), 57 (51), 56 (8.9), 55 
(100), 54 (6.6), 53 (7.1), 43 (25), 42 (6.2), 41 (27), 39 (15). HRMS (ESI+): m/z calcd 
for C21H33NO7 [M+Na]
+: 433.2155; found: 433.2153. 
 
3.35_syn colourless oil; Rf = (0.67, ETP: Et2O 4: 6) developed with Hanessian stain. 
[α]20D= - 62.20 (c = 0.54, CHCl3). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.81 (dd, J = 15.6, 5.6 Hz, 1H, 
CHCH=CH), 6.09 (dd, J = 15.6, 1.6 Hz, 1H, O=CCH=CH), 5.91 – 5.75 (m, 2H, NH 
and CH2=CHCH2), 5.15 – 5.00 (m, 2H, CH2=CHCH2), 4.95 (d, J = 5.8 Hz, 1H, 
CHOC=O), 4.89 (ddd, J = 7.1, 5.6, 1.6 Hz, 1H, CHCHO), 4.75 (dd, J = 7.0, 5.8 Hz, 
1H, CHCHOC=O), 4.19 (q, J = 7.1 Hz, 2H, CH2CH3), 2.55 – 2.48 (m, 2H, 
CH2CH2C=O), 2.45 – 2.35 (m, 2H, CH2CH2C=O ), 1.52 (s, 3H, CH3 of iPr), 1.38 (s, 
3H, CH3 of iPr), 1.30 (s, 9H, 3 CH3 of tBu), 1.27 (t, J = 7.1 Hz, 3H, CH2CH3). 
13C 
NMR (75 MHz, CDCl3, 25 °C, TMS):  = 172.32 (C=ONH), 166.36 (C=O), 165.72 
(C=O), 142.00 (CHCH=CH), 136.33 (CH2=CHCH2), 123.60 (O=CCH=CH), 116.12 
(CH2=CHCH2), 109.78 (C(CH3)2), 76.88 (CHCHOC=O), 76.04 (CHCHO), 72.92 
(CHOC=O), 60.72 (CH2CH3), 51.70 (C(CH3)3), 33.50 (CH2CH2C=O), 28.63 (3 CH3 
of tBu and CH2CH2C=O), 27.31 (CH3 of iPr), 25.29 (CH3 of iPr), 14.37 (CH2CH3). IR 
 (cm-1) = 3376, 2980, 2936, 1752, 1720, 1684, 1524, 1455, 1367, 1303, 1254, 1215, 
1160, 1116, 1060, 1033, 984, 916, 883, 862, 796. GC-MS (initial temp. 70 °C): Rt 
10.66 min: m/z 396 (M+-15, 0.8%), 311 (5.7), 254 (5.2), 198 (9.3), 197 (6.4), 181 
(5.5), 172 (6.8), 171 (9.1), 170 (11), 154 (8.9), 153 (5.1), 152 (9.7), 151 (7.5), 143 
(5.5), 131 (9.7), 130 (21), 129 (12), 126 (11), 125 (15), 113 (6.1), 112 (29), 108 (6.0), 
101 (7.0), 97 (18), 85 (8.6), 84 (41), 83 (81), 82 (5.4), 81 (11), 69 (6.0), 59 (14), 58 
(36), 57 (54), 56 (9.6), 55 (100), 54 (6.8), 53 (6.0), 43 (26), 42 (6.3), 41 (26), 39 (13). 
HRMS (ESI+): m/z calcd for C21H33NO7 [M+Na]
+: 433.2155; found: 433.2150. 







Prepared from crude aldehyde 3.22 (0.534 mmol), acetic 
acid (34 μL, 0.59 mmol), dimethylphenyl isocyanide (77 
mg, 0.59 mmol) and ZnBr2 (48 mg, 0.21 mmol) according to procedure B. At the end, 
the crude mixture was acetylated with Ac2O (47 μL, 0.493 mmol, 1.2 eq.), Et3N (114 
μL, 0.82 mmol, 2 eq.) and 4-dimethylaminopyridine (10 mg, 0.08 mmol, 0.2 eq.).  
Analysis of the crude product by 1H NMR revealed a d.r. of 91:9. The crude product 
was purified by column chromatography (ETP:DCM:Et2O 3:1:1) affording 
diastereomerically pure  3.30_anti (104 mg, 46%).  On the basis of the determined d.r. 
we calculated an overall yield of 3.30_anti + 3.30_syn of 51%. 
 
3.30_anti white solid; Rf = (0.37, ETP:DCM:Et2O 3:2:2) developed with Hanessian 
stain. [α]20D= - 48.78 (c = 0.98, CHCl3). m.p. 123.8 – 127.1 °C (CH2Cl2). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 7.29 (broad s, 1H, NH), 7.13 – 7.01 (m, 
3H, 3 CH Ar), 6.93 (dd, J = 15.6, 5.0 Hz, 1H, CHCH=CH), 6.18 (dd, J = 15.6, 1.7 Hz, 
1H, O=CCH=CH), 4.96 (ddd, J = 6.5, 5.0, 1.7 Hz, 1H, CHCHO), 4.86 (d, J = 9.6 Hz, 
1H, CHOAc), 4.70 (dd, J = 9.5, 6.2 Hz, 1H, CHCHOC=O), 4.20 (q, J = 7.1 Hz, 2H, 
CH2CH3), 2.20 (s, 6H, 2 CH3 of 2.6-dimethylphenyl), 2.12 (s, 3H, CH3 of OAc), 1.58 
(s, 3H, CH3 of iPr), 1.42 (s, 3H, CH3 of iPr), 1.29 (t, J = 7.1 Hz, 3H, CH2CH3) 
13C NMR 
(75 MHz, CDCl3, 25 °C, TMS):  = 169.70 (C=ONH), 165.87 (C=O), 165.65 (C=O), 
140.98 (CHCH=CH), 135.58 (2 C quat. Ar), 133.15 (C quat. Ar), 128.28 (2 CH Ar), 
127.57 (CH Ar), 122.59 (O=CCH=CH), 110.27 (C(CH3)2), 76.37 (CHCHOAc), 76.08 
(CHCHO), 71.38 (CHOAc), 60.77 (CH2CH3), 27.91 (CH3 of iPr), 25.26 (CH3 of iPr), 
20.42 (CH3 of OAc), 18.45 (2 CH3 of 2.6-dimethylphenyl), 14.33 (CH2CH3). IR  (cm
-
1) = 3239, 2985, 2928, 2855, 1747, 1717, 1660, 1540, 1472, 1371, 1304, 1259, 1227, 
1161, 1120, 1069, 1041, 982, 928, 880, 800, 766, 708, 685. GC-MS (initial temp. 70 
°C): Rt 12.64 min: m/z 419 (M+-15, 8.7%), 419 (8.7), 404 (8.3), 361 (11), 219 (30), 
199 (5.8), 190 (6.3), 179 (6.7), 178 (15), 177 (100), 176 (33), 172 (5.7), 160 (7.7), 148 
(47), 147 (12), 143 (6.1), 126 (15), 125 (6.0), 122 (6.7), 121 (27), 120 (13), 112 (12), 
109 (6.2), 106 (5.8), 105 (11), 101 (6.7), 97 (18), 91 (5.0), 85 (9.1), 84 (20), 81 (5.0), 
77 (6.6), 59 (8.2), 55 (6.6), 43 (66), 39 (5.6). HRMS (ESI+): m/z calcd for C22H29NO7 




dioxolan-4-yl) acrylate 3.31 
Prepared from crude aldehyde 3.22 (0.61 mmol), 2-
methoxyacetic acid (51 μL, 0.67 mmol), cyclohexyl 
isocyanide (83 μL, 0.67 mmol) and ZnBr2 (55 mg, 0.24 
mmol) according to procedure B. The crude product was purified by column 




chromatography (ETP:DCM:Et2O 3:2:2) affording 3.31_anti and 3.31_syn (d.r. = 84 
: 18 calculated by 1H NMR analysis on the crude product) (149 mg, 57%) as a mixture 
of diastereoisomers.   
 
3.31_anti white solid; Rf = (0.20, ETP:DCM:Et2O 3:2:2) developed with Hanessian 
stain. [α]20D= - 43.13 (c = 1.03, CHCl3). m.p. 146.2 – 148.7 °C (CH2Cl2). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.86 (dd, J = 15.6, 5.4 Hz, 1H, 
CHCH=CH), 6.12 (dd, J = 15.6, 1.6 Hz, 1H, CHCH=CH), 5.91 (d, J = 8.4 Hz, 1H, 
NH), 4.98 (d, J = 8.0 Hz, 1H, CHC=O), 4.88 (ddd, J = 6.9, 5.4, 1.6 Hz, 1H, CHCHO), 
4.69 (dd, J = 8.0, 6.4 Hz, 1H, CHCHOC=O), 4.18 (q, J = 7.1 Hz, 2H, CH2CH3), 4.09 
(d, J = 7.1 Hz, 2H, OCH2C=O), 3.84 – 3.67 (m, 1H, CH of Cy), 3.44 (s, 3H, OCH3), 
1.93 – 1.80 (m, 2H, CH2 of Cy), 1.75 – 1.53 (m, 4H, CH2CH3), 1.52 (s, 3H, CH3 of 
iPr), 1.39 (s, 3H, CH3 of iPr), 1.42 – 1.03 (m, 4H, CH2 of Cy), 1.28 (t, J = 7.1 Hz, 3H, 
CH2CH3) . 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 169.02 (C=ONH), 165.81 
(C=O), 165.55 (C=O), 141.12 (CHCH=CH), 122.70 (O=CCH=CH), 109.88 (C(CH3)2) 
, 76.27 (CHCHOC=O), 76.13 (CHCHO), 71.17 (CHOC=O), 69.40 (OCH2C=O), 
60.71 (CH2CH3), 59.50 (OCH3), 48.42 (CH of Cy), 32.81 (CH2 of Cy), 32.67 (CH2 of 
Cy), 27.66 (CH3 of iPr), 25.51 (CH2 of Cy), 25.08 (CH3 of iPr), 24.66 (2 CH2 of Cy), 
14.26 (CH2CH3). IR  (cm
-1) = 3314, 2989, 2938, 2856, 1758, 1716, 1661, 1550, 1452, 
1420, 1384, 1356, 1303, 1259, 1245, 1225, 1183, 1161, 1122, 1096, 1077, 1031, 978, 
929, 889, 879, 853, 804, 760, 734, 720, 694, 665, 645.  GC-MS (initial temp. 70 °C): 
Rt 12.39 min: m/z 412 (M+-15, 0.4 %), 170 (5.9), 168 (5.4), 154 (6.6), 152 (7.5), 130 
(5.1), 125 (5.5), 112 (27), 109 (5.1), 98 (15), 97 (14), 85 (6.4), 84 (30), 83 (16), 81 
(8.1), 59 (11), 56 (7.9), 55 (27), 45 (100), 43 (21), 41 (14), 39 (6.3). HRMS (ESI+): 
m/z calcd for C21H33NO8 [M+Na]




dioxolan-4-yl)-2-oxoethyl benzoate 3.33 
Prepared from crude aldehyde 3.22 (0.65 mmol), benzoic 
acid (88 mg, 0.72 mmol) dimethylphenyl isocyanide (94 
mg, 0.72 mmol) and ZnBr2 (59 mg, 0.26 mmol) according 
to procedure B. Analysis of the crude product by HPLC 
revealed a d.r. of 89:11. The crude product was purified by column chromatography 
(ETP:DCM:Et2O 3:1:1) affording diastereomerically pure 3.33_anti (160 mg, 51%). 
On the basis of the determined d.r. we calculated an overall yield of 3.33_anti + 
3.33_syn of 57%. 
 
3.33_anti white solid; Rf = (0.31, ETP: Et2O 4:6) developed with Hanessian stain. 
[α]20D= + 25.16 (c = 1.03, CHCl3). m.p. 152.7 – 153.2 °C (CH2Cl2). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 8.08 – 8.02 (m, 2H, 2 CH Ar.), 7.64 – 
7.57 (m, 1H, 1 CH Ar.), 7.49 – 7.42 (m, 2H, 2 CH Ar.), 7.37 (s, 1H, NH), 7.13 – 7.03 




(m, 3H, 3 CH Ar.), 6.96 (dd, J = 15.6, 5.4 Hz, 1H, CHCH=CH), 6.16 (dd, J = 15.6, 1.6 
Hz, 1H,  O=CCH=CH), 5.36 (d, J = 8.5 Hz, 1H, CHBz), 5.06 – 5.00 (m, 1H, CHCHO), 
4.94 (dd, J = 8.5, 6.4 Hz, 1H, CHCHOC=O), 3.97 (m, 2H, CH2CH3), 2.23 (s, 6H, 2 
CH3 of 2.6-dimethylphenyl), 1.58 (s, 3H, CH3 of iPr), 1.46 (s, 3H, CH3 of iPr), 1.08 (t, 
J = 7.1 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 165.51 (2 
C=O), 165.44 (C=O), 141.30 (CHCH=CH), 135.57 (2 C quat. Ar), 133.88 (CH Ar.), 
133.10 (2 C quat. Ar), 130.09 (CH Ar.), 128.69 (2 CH Ar.), 128.34 (2 CH Ar.), 127.64 
(2 CH Ar.), 123.42 (O=CCH=CH), 110.30 (C(CH3)2), 76.49 (CHCHOC=O and 
CHCHO), 71.84 (CHOC=O), 60.58 (CH2CH3), 27.89 (CH3 of iPr), 25.33 (CH3 of iPr), 
18.56 (2 CH3 of 2.6-dimethylphenyl), 14.10 (CH2CH3). IR  (cm
-1) = 3247, 2987, 
2935, 1726, 1671, 1602, 1515, 1475, 1452, 1371, 1263, 1223, 1176, 1161, 1110, 1071, 




oxoethyl 2-methylbenzoate 3.34 
Prepared from crude aldehyde 3.22 (0.56 mmol), o-toluic 
acid (85 mg, 0.62 mmol), benzyl isocyanide (76 μL, 0.62 
mmol) and ZnBr2 (51 mg, 0.23 mmol) according to 
procedure B. Analysis of the crude product by 1H NMR 
revealed a d.r. of 88:12. The crude product was purified by column chromatography 
(ETP:DCM:Et2O 3:1:1) affording diastereomerically pure  3.34_anti (134 mg, 49%).  
On the basis of the determined d.r. we calculated an overall yield of 3.34_anti + 
3.34_syn of 56%. 
 
3.34_anti white solid; Rf = (0.69, ETP : Et2O 4 : 6) developed with Hanessian stain. 
[α]20D= - 33.33 (c = 1.01, CHCl3). m.p. 83.8 – 85.9 °C (CH2Cl2). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 7.95 (dd, J = 8.2, 1.4 Hz, 1H, CH Ar), 
7.43 (td, J = 7.7, 1.4 Hz, 1H, CH Ar), 7.35 – 7.21 (m, 7H, 7 CH Ar), 6.93 (dd, J = 15.6, 
5.4 Hz, 1H, CHCH=CH), 6.46 (bt, J = 4.5 Hz, 1H, NH), 6.12 (dd, J = 15.6, 1.4 Hz, 
1H, O=CCH=CH), 5.37 (d, J = 7.0 Hz, 1H, CHOC=O), 4.98 – 4.85 (m, 2H, CHCHO 
and CHCHOC=O), 4.61 and 4.33 (part AB of ABX syst., JAB = 15.0, JAX = 6.61, JBX = 
5.09 Hz, 2 H, CH2NH), 4.03 (qd, J = 7.1, 2.9 Hz, 2H, CH2CH3), 2.57 (s, 3H, CH3C), 
1.46 (s, 3H, CH3 of iPr), 1.41 (s, 3H, CH3 of iPr), 1.13 (t, J = 7.1 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 167.31 (C=ONH), 165.55 (C=O), 165.52 
(C=O), 141.61 (CHCH=CH), 141.40 (C quat. Ar), 137.62 (C quat Ar), 132.86 (1 CH 
Ar), 131.92 (1 CH Ar), 130.91 (1 CH Ar), 128.71 (2 CH Ar), 127.74 (C quat. Ar), 
127.64 (2 CH Ar), 127.59 (1 CH Ar), 125.95 (1 CH Ar), 123.33 (O=CCH=CH), 110.01 
(C(CH3)2), 76.79 (CHCHOC=O), 76.29 (CHCHO), 71.40 (CHC=O), 60.54 (CH2CH3), 
43.52 (CH2NH), 27.42 (CH3 of iPr), 25.03 (CH3 of iPr), 21.82 (CH3), 14.12 (CH2CH3). 




IR  (cm-1) = 3331, 2984, 2931, 1723, 1664, 1601, 1551, 1494, 1455, 1434, 1387, 
1367, 1307, 1235, 1208, 1173, 1157, 1141, 1071, 1029, 972, 922, 880, 858, 802, 737, 






Prepared from crude aldehyde 3.22 (0.61 mmol), 
benzoic acid (82 mg, 0.67 mmol), 1-(benzyloxy)-
4-(2-isocyanoethyl)benzene (159 mg, 0.67 
mmol) and ZnBr2 (55 mg, 0.24 mmol) according to procedure B. Analysis of the crude 
product by 1H NMR revealed a d.r. of 84:16.  
The crude product was purified by column chromatography (ETP:DCM:Et2O 3:1:1) 
affording diastereomerically pure  3.36_anti (190 mg, 53%).  On the basis of the 
determined d.r. we calculated an overall yield of 3.36_anti + 3.36_syn of 63%. 
 
3.36_anti pale yellow solid; Rf = (0.25, ETP: Et2O 4: 6) developed with Hanessian 
stain. [α]20D= - 43.85 (c = 1.00, CHCl3). m.p. 119.5 – 122.3 °C (CH2Cl2). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 8.02 (d, J = 8.4 Hz, 2H, 2 CH Ar ortho 
of OBn), 7.60 (t, J = 7.4 Hz, 1H, CH Ar para of OBn), 7.46 (t, J = 7.7 Hz, 2H, CH Ar 
meta of OBn), 7.41 – 7.29 (m, 5H, 5 CH Ar of Bz), 7.04 (d, J = 8.4 Hz, 2H, 2 CH Ar 
ortho to OBn), 6.95 (dd, J = 15.2, 4.4 Hz, 1H, CHCH=CH), 6.76 (d, J = 8.3 Hz, 2H, 2 
CH Ar meta to OBn), 6.19 – 6.15 (m, 1H, NH), 6.12 (d, J = 15.6 Hz, 1H, O=CCH=CH), 
5.49 (d, J = 5.1 Hz, 1H, CHBz), 4.99 – 4.87 (m, 4H, CHCHO, CHCHBz and OCH2Ph), 
4.03 (qq, J = 6.4, 3.6 Hz, 2H, CH2CH3), 3.47 (ddp, J = 19.9, 13.1, 6.7 Hz, 2H, CH2NH), 
2.72 (t, J = 6.9 Hz, 2H, CH2CH2NH), 1.37 (s, 6H, 2 CH3 of iPr), 1.13 (t, J = 6.9 Hz, 
3H, CH2CH3). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 166.88 (C=ONH), 165.64 
(C=O), 165.02 (C=O), 157.56 (C quat. Ar), 142.02 (CHCH=CH), 137.10 (C quat. Ar), 
133.80 (CH Ar para of OBn), 130.74 (C quat. of Bz), 130.06 (2 CH Ar ortho of OBn) 
, 129.74 (2 CH Ar ortho to OBn), 128.76 (C quat. Ar), 128.68 (2 CH Ar meta of OBn), 
128.65 (2 CH Ar of Bz), 128.02 (CH Ar of Bz), 127.47 (2 CH Ar of Bz), 123.17 
(O=CCH=CH), 115.05 (2 CH Ar meta to OBn) , 109.85 (C(CH3)2), 76.95 
(CHCHOC=O), 76.18 (CHCHO), 71.65 (CHBz), 69.99 (OCH2Ph), 60.55 (CH2CH3), 
40.67 (CH2NH), 34.47 (CH2CH2NH), 27.29 (CH3 of iPr), 24.97 (CH3 of iPr), 14.17 
(CH2CH3). IR  (cm
-1) = 3409, 2983, 2937, 1714, 1683, 1611, 1583, 1530, 1511, 1453, 
1379, 1241, 1177, 1162, 1111, 1070, 1026, 991, 878, 858, 806, 736, 711, 695. HRMS 
(ESI+): m/z calcd for C34H37NO8 [M+Na]
+: 610.2417; found: 610.2427. 
 







Prepared from crude aldehyde 3.22 (0.53 mmol), acetic 
acid (34 μL, 0.59 mmol), diethyl 2-allyl-2-
isocyanomalonate 3.48 (132 mg, 0.59 mmol) and ZnBr2 
(48 mg, 0.21 mmol) according to procedure B. At the end, the crude mixture was 
acetylated with Ac2O (41 μL, 0.42 mmol, 1.2 eq.), Et3N (97 μL, 0.71 mmol, 2 eq.) and 
4-dimethylaminopyridine (9 mg, 0.07 mmol, 0.2 eq.).  Analysis of the crude product 
by 1H NMR and HPLC revealed a d.r. of 96:3. The crude product was purified by 
column chromatography (ETP:DCM:Et2O 3:1:1) affording diastereomerically pure 
3.32_anti (167 mg, 61%).  On the basis of the determined d.r. we calculated an overall 
yield of 3.32_anti + 3.32_syn of 64%. 
 
3.32_anti pale yellow oil; Rf = (0.45, ETP:DCM:Et2O 3:1:1) developed with 
Hanessian stain. [α]20D= - 39.19 (c = 1.04, CHCl3).  
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 7.44 (broad s, 1H, NH), 6.89 (dd, J = 
15.6, 4.9 Hz, 1H, CHCH=CH), 6.15 (dd, J = 15.6, 1.3 Hz, 1H, O=CCH=CH), 5.68 – 
5.49 (m, 1H, CH=CH2), 5.15 – 5.06 (m, 2H, CH=CH2) 4.92 – 4.88 (m, 1H, CHCHO 
), 4.86 (d, J = 9.2 Hz, 1H, CHOAc), 4.55 (dd, J = 9.2, 6.1 Hz, 1H, CHCHOC=O), 4.30 
– 4.15 (m, 6H, 3 CH2CH3), 3.05 (dt, J = 10.5, 5.1 Hz, 2H, CH2CH=CH2), 2.09 (s, 3H, 
CH3 of OAc), 1.60 (s, 3H, CH3 of iPr), 1.41 (s, 3H, CH3 of iPr), 1.31 – 1.21 (m, 9H, 3 
CH2CH3). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 169.03 (C=ONH), 167.27 
(C=O), 167.22 (C=O), 165.95 (C=O), 165.87 (C=O), 140.63 (CHCH=CH), 131.15 
(CH=CH2), 122.38 (O=CCH=CH), 120.04 (CH=CH2), 110.27 (C(CH3)2), 76.39 
(CHCHOAc), 75.98 (CHCHO), 70.28 (CHOAc), 66.31 (C(COOEt)2), 62.71 (2 
CH2CH3), 60.70 (CH2CH3), 36.92 (CH2CH=CH2), 27.87 (CH3 of iPr), 25.39 (CH3 of 
iPr), 20.40 (CH3 of OAc), 14.30 (CH2CH3), 14.09 (CH2CH3), 14.06 (CH2CH3). IR 
 (m-1) = 3410, 2984, 2925, 2855, 1740, 1720, 1695, 1505, 1466, 1370, 1305, 1259, 
1213, 1178, 1160, 1096, 1060, 1014, 987, 928, 882, 857, 795, 756, 665. GC-MS (initial 
temp. 70 °C): Rt 12.29 min: m/z 498 (M+-15, 11%), 498 (11), 455 (9.6), 440 (11), 410 
(5.8), 396 (5.9), 383 (6.7), 382 (35), 344 (15), 313 (7.5), 272 (5.5), 271 (19), 241 (10), 
239 (8.9), 229 (7.7), 216 (7.5), 214 (10), 213 (6.3), 199 (34), 198 (13), 181 (12), 174 
(13), 172 (6.0), 171 (25), 170 (27), 168 (7.1), 153 (12), 143 (20), 142 (51), 141 (9.1), 
126 (7.3), 125 (17), 124 (10), 114 (5.4), 113 (8.5), 112 (58), 111 (6.0), 109 (6.6), 101 
(14), 97 (37), 96 (16), 87 (6.7), 85 (17), 84 (41), 83 (7.1), 81 (7.5), 73 (5.2), 71 (5.8), 
69 (11), 68 (26), 59 (12), 55 (9.4), 44 (8.6), 43 (100), 41 (14), 39 (6.9).  
 
Diethyl 2-allyl-2-isocyanomalonate 3.49  
A solution of diethyl 2-allyl-2-formamidomalonate (300 mg, 1.23 mmol) 
in dry CH2Cl2 (6 ml) was cooled to -30°C under argon atmosphere and 
treated with Et3N (857 μL, 6.16 mmol), POCl3 (169 μL, 1.85 mmol). After 1 h the 




reaction was quenched with NaHCO3 (40 ml). The mixture was allowed to warm to 
room temperature and then extracted with Et2O. The crude product was purified by 
chromatography (ETP: AcOEt 8:2) to afford the product as a colourless oil (236 mg, 
85%). The analytical data conform to those reported in literature[16b]. 
 





Compound 3.23_anti (100 mg, 0.23 mmol) was dissolved in dry 
ethanol (2.3 ml) under nitrogen atmosphere and sodium 
ethoxide (1.6 mL, 0.1 M, prepared in situ from Na and EtOH) was added. After 5 h 
the reaction mixture was poured into NH4Cl (10 mL) and extracted with 
dichloromethane (3 x 10 ml). The organic phase was then washed with brine, dried 
(Na2SO4), and concentrated. Analysis of the crude product by 
1H NMR revealed a d.r. 
of 90:10. The residue was purified by chromatography (ETP: Et2O 1:1) affording 
diastereomerically pure 3.37a (50 mg, 66%).  On the basis of the determined d.r. we 
calculated an overall yield of 3.37a + 3.37b of 73%.  
Compounds 3.37a and 3.37b were also obtained under the same conditions starting 
from 3.29_anti. Yield: 58%, d.r. 90:10 (calculated by 1H NMR analysis on the crude 
product).  
 
3.37a pale yellow solid; Rf = (0.48, ETP: Et2O 1:1) developed with Hanessian stain. 
[α]21D= - 2.94 (c = 1.00, CHCl3). m.p. 61.1 – 62.4 °C (CH2Cl2). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.70 (s, 1H, NH), 5.17 (dd, J = 6.0, 0.7 
Hz, 1H, CHCHC=O), 4.62 (dd, J = 6.0, 3.6 Hz, 1H, CHCHCH2), 4.30 (s, 1H, CHC=O), 
4.18 (qd, J = 7.1, 4.2 Hz, 2H, CH2CH3), 4.12 – 4.02 (m, 1H, CHCHCH2), 2.81 and 
2.70 (part AB of ABX syst., JAB = 17.3, JAX = 9.31, JBX = 3.65 Hz, 2 H, CHCH2C=O) 
1.46 (s, 3H, CH3 of iPr), 1.36 (s, 9H, 3 CH3 of tBu), 1.31 (s, 3H, CH3 of iPr), 1.28 (t, 
J = 7.1 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  =  171.24 
(C=ONH), 168.05 (C=O), 112.85 (C(CH3)2), 84.05 (CHC=O) , 83.77 (CHCHC=O), 
80.89 (CHCHCH2), 77.74 (CHCHCH2), 60.98 (CH2CH3), 51.18 (C(CH3)3), 33.95 
(CHCH2C=O), 28.81 (3 CH3 of tBu), 26.27 (CH3 of iPr), 25.14 (CH3 of iPr), 14.35 
(CH2CH3). IR  (cm
-1) =  3389, 2988, 2964, 2936, 1729, 1683, 1524, 1480, 1457, 1403, 
1395, 1375, 1364, 1308, 1280, 1268, 1251, 1237, 1205, 1179, 1159, 1106, 1072, 1057, 
1038, 1024, 992, 973, 927, 897, 866, 839, 825, 809, 763, 698, 648, 616. GC-MS (initial 
temp. 70 °C): Rt 9.14 min: m/z 314 (M+-15, 0.8%), 226 (14), 186 (18), 185 (12), 184 
(100), 172 (17), 171 (30), 170 (16), 155 (20), 154 (5.4), 143 (8.5), 129 (9.3), 128 (26), 
127 (14), 126 (27), 125 (11), 109 (5.1), 101 (27), 100 (6.3), 99 (11), 98 (14), 97 (18), 
88 (18), 87 (30), 85 (41), 84 (17), 83 (7.8), 82 (7.0), 81 (37), 74 (7.0), 73 (7.7), 71 (11), 
70 (8.2), 69 (8.6), 59 (18), 58 (33), 57 (79), 56 (7.1), 55 (15), 43 (39), 42 (9.0), 41 (32), 




39 (7.0). HRMS (ESI+): m/z calcd for C16H27NO6 [M+Na]
+: 352.1736; found: 
352.1728. 
 
3.37b colourless oil; Rf = (0.36, ETP: Et2O 1:1) developed with Hanessian stain. 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.57 (s, 1H, NH), 4.94 (dd, J = 6.4, 2.8 
Hz, 1H, CHCHC=O), 4.51 (dd, J = 6.3, 3.8 Hz, 1H, CHCHCH2), 4.42 (dd, J = 7.9, 4.1 
Hz, 1H, CHCHCH2), 4.36 (d, J = 2.8 Hz, 1H, CHC=O), 4.18 (q, J = 7.2 Hz, 2H, 
CH2CH3), 2.66 and 2.54 (part AB of ABX syst., JAB = 15.4, JAX = 4.58, JBX = 7.99. Hz, 
2 H, CHCH2C=O), 1.54 (s, 3H, CH3 of iPr), 1.36 (d, J = 2.3 Hz, 9H, 3 CH3 of tBu), 
1.33 (s, 3H, CH3 of iPr), 1.28 (t, J = 7.1 Hz, 3H, CH2CH3).
13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 170.33 (C=ONH), 169.22 (C=O), 114.27 (C(CH3)2), 84.63 
(CHC=O), 83.98 (CHCHC=O), 83.57 (CHCHCH2), 82.42 (CHCHCH2), 61.10 
(CH2CH3), 51.28 (C(CH3)3), 38.14 (CHCH2C=O), 28.77 (3 CH3 of tBu), 27.31 (CH3 
of iPr), 25.47 (CH3 of iPr), 14.36 (CH2CH3). GC-MS (initial temp. 70 °C): Rt 9.40 min: 
m/z 314 (M+-15, 0.7%), 271 (16), 254 (6.3), 229 (17), 215 (32), 198 (7.7), 184 (16), 
173 (5.2), 172 (46), 171 (21), 170 (9.3), 155 (11), 152 (13), 143 (11), 135 (5.4), 129 
(7.2), 128 (6.4), 127 (14), 126 (19), 125 (14), 109 (9.9), 101 (18), 100 (6.0), 99 (8.8), 
98 (10), 97 (32), 88 (33), 86 (6.7), 85 (100), 84 (17), 83 (7.7), 81 (18), 74 (6.5), 73 
(7.8), 71 (12), 70 (9.9), 69 (10), 61 (6.8), 60 (6.2), 59 (24), 58 (35), 57 (82), 56 (8.3), 





Prepared using the same procedure described for 3.37, starting 
from 3.23_syn (63 mg, 0.17 mmol). Analysis of the crude 
product by 1H NMR revealed a diastereomeric ratio of 84:16. Column chromatography 
on silica gel (ETP/Et2O 3:7) gave 3.38a and 3.38b as an inseparable diastereomeric 
mixture (as a pale yellow oil) in 73% yield. Compounds 3.38a and 3.38b were also 
obtained under the same conditions starting from 3.29_syn. Yield: 65%, d.r. 83:17 
(calculated by 1H NMR analysis on the crude product).  
 
3.38a/3.38 b: Rf = (0.34, ETP: Et2O 1:1, single TLC spot) developed with Hanessian 
stain. 
Legend for NMR spectra: M= major diastereoisomer, m= minor diastereoisomer  
1H NMR (300 MHz, CDCl3, 25 °C,TMS) mixture of the two diasteroisomers (M + m) 
not separable: δ = 6.35 (s, 1H, NH, m), 6.23 (s, 1H, NH, M), 5.02 (dd, J = 5.5, 4.4 Hz, 
1H, CHCHC=O, m), 4.97 (dd, J = 6.0, 4.2 Hz, 1H, CHCHC=O, M), 4.72 (dd, J = 6.0, 
3.6 Hz, 1H, CHCHCH2, M), 4.66 – 4.57 (m, 2H, CHCHCH2 and CHCHCH2, m), 4.28 
(d, J = 4.3 Hz, 1H, CHC=O, m), 4.24 – 4.13 (m, 4H, CH2CH3, M and m), 4.04 (dd, J = 
6.7, 3.6 Hz, 1H, CHCHCH2, M), 4.01 (d, J = 4.2 Hz, 1H, CHC=O, M), 2.83 and 2.78 
(part AB of ABX syst., JAB = 15.22, JAX = 3.46, JBX = 3.83. Hz, 2 H, CHCH2C=O, M), 




2.50 and 2.45 (part AB of ABX syst., JAB = 14.37, JAX = 5.14, JBX = 4.19 Hz, 2 H, 
CHCH2C=O, m), 1.46 (s, 3H, CH3 of iPr, m), 1.43 (s, 3H, CH3 of iPr, M), 1.37 (s, 
18H, CH3 of tBu, M and m), 1.31 – 1.26 (m, 12H, CH3 of iPr (M and m) and CH2CH3 
(M and m)). 13C NMR (75 MHz, CDCl3, 25 °C, TMS) mixture of the two 
diasteroisomers (M + m) not separable:  =  170.82 (C=ONH, M), 170.19 (C=ONH, 
m), 166.72 (OC=O, m) 166.48 (OC=O, M), 113.02 (C(CH3)2, m), 112.72 (C(CH3)2, 
M), 84.09 (CHCHCH2, m), 81.93 (CHC=O, M), 81.71 (CHCHC=O, M and m), 81.33 
(CHCHCH2 and CHC=O, m), 80.45 (CHCHCH2, M), 77.83 (CHCHCH2, M), 60.94 
(CH2CH3, M), 60.54 (CH2CH3, m), 51.28 (C(CH3)3, M and m), 36.40 (CHCH2C=O, 
m), 33.89(CHCH2C=O, M), 28.96 (3 CH3 of tBu, M and m), 26.34 (CH3 of iPr, m), 
25.99 (CH3 of iPr, M), 24.65 (CH3 of iPr, M), 24.58 (CH3 of iPr, m), 14.31(CH2CH3, 
M and m). IR mixture of the two diasteroisomers (M + m) not separable   (cm-1) = 
3417, 2976, 2936, 2908, 2876, 1734, 1681, 1525, 1456, 1366, 1332, 1288, 1266, 1229, 
1209, 1181, 1163, 1101, 1045, 1028, 983, 951, 921, 895, 861, 800, 723. GC-MS (initial 
temp. 70 °C):  Rt1 = 9.33 min: m/z 314 (M+ -15, 21.0%), 314 (21), 284 (15), 229 (6.1), 
228 (5.5), 184 (9.3), 173 (8.4), 172 (100), 171 (14), 170 (9.3), 155 (16), 154 (11), 152 
(10), 143 (6.8), 128 (10), 127 (11), 126 (55), 125 (7.8), 101 (15), 100 (6.0), 99 (11), 
98 (22), 97 (11), 88 (12), 87 (22), 85 (26), 84 (13), 83 (6.4), 82 (5.7), 81 (29), 71 (7.2), 
70 (5.2), 59 (12), 58 (22), 57 (30), 55 (7.8), 43 (18), 41 (14); Rt2 = 9.42 min: m/z 314 
(M+ -15, 7.1%), 314 (7.1), 284 (5.2), 242 (5.8), 229 (15), 215 (16), 212 (8.0), 186 
(6.6), 184 (14), 173 (5.7), 172 (47), 171 (69), 170 (18), 155 (15), 154 (16), 146 (8.0), 
143 (11), 129 (6.1), 128 (8.1), 127 (11), 126 (29), 125 (29), 115 (5.8), 101 (17), 100 
(6.1), 99 (11), 98 (16), 97 (31), 89 (6.7), 88 (47), 87 (5.2), 86 (7.2), 85 (100), 84 (28), 
83 (8.2), 82 (6.6), 81 (34), 73 (8.2), 72 (6.0), 71 (14), 70 (13), 69 (11), 61 (7.6), 60 
(6.3), 59 (31), 58 (41), 57 (63), 56 (8.4), 55 (15), 44 (5.3), 43 (47), 42 (13), 41 (35), 39 
(7.7). HRMS (ESI+): m/z calcd for C16H27NO6 [M+Na]




Compound 3.40 was synthetized using two different procedures. 
Procedure 1[7a] 
Compound 3.37a (25 mg, 0.08 mmol) was dissolved in THF (759 
μL) and water (379 μL) and treated with CF3COOH (379 μL). The reaction was stirred 
at r.t. for 48 h and then at reflux for 6 days. The crude product was evaporated and 
chromatographed (AcOEt) to afford the pure product (17 mg, 92%) as a white solid.  
Procedure 2[15] 
Compound 3.37a (25 mg, 0.08 mmol) was dissolved in MeOH (173 μL) and water 
(108 μL) and treated with CF3COOH (108 μL). The reaction was stirred at reflux for 
3 days. The crude product was evaporated and chromatographed (AcOEt) to afford the 
pure product (16 mg, 87%) as a white solid. 
 






Prepared as previously reported in literature[17]. 




Compound 3.44 (116 mg, 0.38 mmol), p-methoxyphenol (143 mg, 
1.15 mmol), and triphenylphosphine (155 mg, 0.57 mmol) were 
dissolved in 3.8 mL of DCM dry under nitrogen atmosphere. Then diethyl 
azodicarboxylate (73 µL, 0.57 mmol) was added slowly at 0°C. The reaction mixture 
was then stirred for 4 d at room temperature. The reaction solvent was removed by 
evaporation under reduced pressure and the residue was purified by column 
chromatography on silica gel (ETP: Et2O, 8:2) to afford product 3.45 (138 mg, 88%). 
 
3.45 colourless oil Rf = (0.89, ETP: AcOEt 6:4) developed with Hanessian stain. 
[α]23D= + 2.46 (c = 0.95, CHCl3).  
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.83 (s, 4H, 4 CH Ar), 6.01 (dt, J = 15.6, 
4.9 Hz, 1H, CHCH=CH), 5.90 (dd, J = 15.6, 6.5 Hz, 1H, O=CCH=CH), 4.69 (t, J = 
6.5 Hz, 1H, CHCHO), 4.49 (d, J = 4.9 Hz, 2H, CH2OPMP), 4.20 (q, J = 6.1 Hz, 1H, 
CHCHOC=O), 3.76 (s, 3H, CH3 of PMP), 3.60 (d, J = 6.0 Hz, 2H, CH2OTBS), 1.47 
(s, 3H, CH3 of iPr), 1.37 (s, 3H, CH3 of iPr), 0.88 (s, 9H, 3 CH3 of tBu), 0.05 (s, 3H, 
CH3 of TBS), 0.04 (s, 3H, CH3 of TBS). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  
= 154.03 (C quat Ar), 152.87 (C quat Ar), 128.99 (CHCH=CH), 128.47 
(O=CCH=CH), 115.79 (2CH Ar), 114.75 (2 CH Ar), 108.70 (C(CH3)2), 78.67 
(CHCHOC=O), 77.84 (CHCHO), 68.50 (CH2OPMP), 62.34 (CH2OTBS), 55.84 (CH3 
of PMP), 27.96 (CH3 of iPr), 26.00 (3 CH3 of tBu), 25.49 (CH3 of iPr) , 18.38 
(C(CH3)3), -5.28 (2 CH3 of TBS). IR  (cm
-1) = 2930, 2857, 1507, 1463, 1379, 1228, 
1212, 1168, 1096, 1040, 972, 939, 834, 824, 775, 745, 714, 666. GC-MS (initial temp. 
70 °C): Rt 11.58 min: m/z 408 (M+, 2.7%), 293 (20), 285 (6.0), 227 (5.4), 211 (12), 
201 (11), 181 (19), 169 (17), 165 (9.6), 131 (9.3), 125 (16), 124 (37), 123 (37), 117 
(8.4), 116 (9.9), 115 (11), 112 (8.0), 111 (100), 109 (8.0), 101 (7.2), 95 (25), 93 (6.0), 
89 (29), 83 (5.9), 81 (6.0), 77 (8.8), 75 (39), 74 (8.7), 73 (90), 69 (52), 67 (8.6), 59 




Compounds 3.46 was synthetized using the same procedure 
described for 3.3, starting from 3.44 (203 mg, 0.49 mmol). After 24 
h the reaction was quenched and the residue was chromatographed (ETP: Et2O 3:7) 
affording the product as a colourless oil (133 mg, 92%).   
3.46 colourless oil Rf = (0.03, ETP: Et2O 7:3) developed with Hanessian stain. 




[α]23D= -33.74 (c = 0.74, CHCl3).  
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.83 (s, 4H, 4 CH Ar of PMP), 6.04 (dt, 
J = 15.6, 5.1 Hz, 1H, CHCH=CH), 5.86 (dd, J = 15.6, 7.2 Hz, 1H, O=CCH=CH), 4.70 
(t, J = 7.0 Hz, 1H, CHCHO), 4.51 (d, J = 5.0 Hz, 2H, CH2OPMP), 4.26 (q, J = 5.7 Hz, 
1H, CHCHOC=O), 3.76 (s, 3H, CH3 of PMP)  3.55 (t, J = 5.6 Hz, 2H, CH2OH), 1.86 
(s, 1H, OH), 1.51 (s, 3H, CH3 of iPr), 1.39 (s, 3H, CH3 of iPr). 
13C NMR (75 MHz, 
CDCl3, 25 °C, TMS):  = 154.16 (C quat. Ar), 152.62 (C quat. Ar), 130.24 
(CHCH=CH), 127.77 (O=CCH=CH), 115.92 (2 CH Ar), 114.79 (2 CH Ar), 109.02 
(C(CH3)2), 78.42 (CHCHOC=O), 77.39 (CHCHO), 68.28 (CH2OPMP), 62.14 
(CH2OH), 55.86 (CH3 of PMP), 27.91 (CH3 of iPr), 25.34 (CH3 of iPr). IR  (cm
-1) = 
3544, 3496, 2983, 2927, 2872, 1592, 1504, 1463, 1408, 1385, 1339, 1309, 1292, 1235, 
1211, 1184, 1162, 1136, 1109, 1075, 1061, 1028, 1014, 977, 945, 897, 870, 851, 828, 
800, 744, 649. GC-MS (initial temp. 70 °C): Rt 11.15 min: m/z 294 (M+, 2.6%), 125 
(9.1), 124 (100), 123 (15), 111 (5.3), 109 (14), 95 (5.7), 81 (8.4), 69 (6.6), 59 (21), 57 
(5.7), 55 (6.6), 53 (8.8), 44 (7.2), 43 (21), 41 (9.9). HRMS (ESI+): m/z calcd for 
C16H22O5 [M+Na]




yl)-2-oxoethyl pent-4-enoate 3.48 
Swern oxidation 
Aldehyde 3.47 was synthetized using the same procedure 
described for 3.22, starting from 0.34 mmol of alcohol 3.46. 
Passerini reaction 
Firstly, prepared from crude aldehyde 3.47 (0.34 mmol), pentenoic acid (38 μL, 0.37 
mmol) and tert-butylisocyanide (42 μL, 0.37 mmol) according to procedure A. 
Analysis of the crude product by HPLC revealed a d.r. of 62:38. The residue was 
purified by column chromatography ((ETP:DCM:Et2O 3:1:1) affording 
diastereomerically pure 3.48_anti (66 mg, 41%).  On the basis of the determined d.r. 
we calculated an overall yield of 3.48_anti + 3.48_syn of 64%.  
Then, prepared from crude aldehyde 3.46 (0.34 mmol), pentenoic acid (38 μL, 0.37 
mmol), tert-butylisocyanide (42 μL, 0.37 mmol) and ZnBr2 (31 mg, 0.14 mmol) 
according to procedure B. Analysis of the crude product by HPLC revealed a d.r. of 
77:23. The residue was purified by column chromatography ((ETP:DCM:Et2O 3:1:1) 
affording diastereomerically pure 3.48_anti (56 mg, 35%). On the basis of the 
determined d.r. we calculated an overall yield of 3.48_anti + 3.48_syn of 45%. 
 
3.48_anti; colourless oil Rf = (0.03, ETP: Et2O 7:3) developed with Hanessian stain. 
[α]20D= -22.70 (c = 0.45, CHCl3). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = = 6.82 (s, 4H, 4 CH Ar of PMP), 6.02 
(dt, J = 15.5, 4.8 Hz, 1H, CHCH=CH), 5.93 –5.82 (m, 2H, NH and O=CCH=CH), 5.82 
– 5.70 (m, 1H, CH2=CHCH2) 5.08 – 4.93 (m, 3H, CH2=CHCH2 and CHOC=O), 4.77 




(t, J = 6.3 Hz, 1H, CHCHO), 4.56 (dd, J = 7.6, 6.4 Hz, 1H, CHCHOC=O), 4.45 (d, J 
= 4.7 Hz, 2H, CH2OPMP), 3.76 (s, 3H, CH3 of PMP) 2.57 – 2.41 (m, 2H, 
CH2CH2C=O), 2.41 – 2.30 (m, 2H, CH2CH2C=O) 1.50 (s, 3H, CH3 of iPr), 1.38 (s, 
3H, CH3 of iPr), 1.33 (s, 9H, 3 CH3 of tBu). 13C NMR (75 MHz, CDCl3, 25 °C, TMS): 
 = 171.63 (C=ONH), 166.38 (C=O), 154.13 (C quat. Ar), 152.72, (C quat. Ar) 136.49 
(CH2=CHCH2), 129.46 (CHCH=CH), 127.11 (O=CCH=CH), 115.90 (CH2=CHCH2), 
115.63 (2 CH Ar), 114.82 (2 CH Ar), 109.25 (C(CH3)2), 77.68 (CHCHOC=O), 76.50 
(CHCHO), 71.65 (CHOC=O), 68.12 (CH2OPMP), 55.86 (CH3 of PMP), 51.70 
(C(CH3)3), 33.29 (CH2CH2C=O), 28.77 (3 CH3 of tBu), 28.57 (CH2CH2C=O), 
27.77(CH3 of iPr), 25.20 (CH3 of iPr). IR  (cm
-1) = 3391, 2977, 2935, 1745, 1689, 
1507, 1455, 1367, 1216, 1163, 1107, 1063, 1035, 973, 916, 877, 824, 798, 744, 711. 
GC-MS (initial temp. 70 °C): Rt 13.03 min: m/z 475 (M+, 5.1%), 475 (5.1), 353 (21), 
352 (100), 270 (13), 252 (11), 238 (5.8), 214 (14), 196 (9.2), 165 (5.1), 156 (7.9), 144 
(8.8), 138 (14), 125 (8.1), 124 (54), 123 (20), 113 (5.5), 111 (33), 109 (11), 95 (13), 
88 (11), 83 (31), 81 (7.1), 69 (8.9), 59 (7.9), 58 (17), 57 (32), 55 (54), 53 (13), 43 (13), 
41 (15). HRMS (ESI+): m/z calcd for C26H37NO7 [M+Na]
+: 498.2468; found: 
498.2473. 
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Application of biocatalysis and MCRs to the target-oriented 
synthesis of Bengamides 
 
 
4.1 Target-oriented synthesis (TOS) 
 
Target-oriented synthesis (TOS) is primarily used to access well-defined 
compounds, often complex natural products known for specific biological properties. 




Figure 4.1 Target-oriented synthesis. 
Taken from Spandi et al.[1] 
 
Synthetic pathways in TOS are linear and convergent, and they are planned by 
using retrosynthetic analysis (Scheme 4.1). E.J. Corey, who received the Nobel Prize 
in 1990 for this approach, defined retrosynthesis as the approach in which “target 
structure is subjected to a deconstruction process which corresponds to the reverse of 
a synthetic reaction, so as to convert that target structure to simpler precursor 
structures, without any assumptions with regard to starting materials. Each of the 
precursors so generated is then examined in the same way, and the process is repeated 










By saving synthetic operations while maximizing the build-up of structural and 
functional complexity, multicomponent reactions are particularly appealing in the 
context of target-oriented synthesis. Thanks to their numerous advantages (extensively 
described in Chapter 2), MCRs allow the synthesis of structurally complex substances 
more quickly and efficiently than the classical linear approach. However, although the 
use of multicomponent approach in total synthesis can be potentially very useful, its 
application, and in particular of IMCRs, in this field remained a quite unexplored area 
and "classic" approach based on the linear syntheses is still preferred. Some examples, 
reported in literature, of application of Passerini reaction (P-3CR) for the synthesis of 
bioactive compounds and natural products are described below. 
Passerini reaction was used by Schmidt and collaborators[3] for the elaboration 
of a key fragment for the synthesis of the serine protease prolyl endopeptidase (PEP) 
inhibitor Eurystatin A 4.5 (Scheme 4.2). The reaction of methyl (S)-2-isocyano-4-
methylpentanoate 4.1, protected (S)- alanine 4.2 and benzoic acid 4.3, under classical 




Scheme 4.2 Synthesis of Eurystatin A using Passerini reaction 
 
In 2001 an improved synthesis of Eurystatin A was reported by Semple et al.[4]. 
who developed a highly efficient and atom-economic Passerini reaction/ 
deprotection/acyl migration (PADAM) strategy[5] for the rapid construction of the key 










Another example of the application of Passerini reaction in target-oriented 
synthesis was reported by Domling and co-workers[6] (Scheme 4.4). They have 
developed a three-component Lewis acid-catalysed Passerini-type reaction for the 
synthesis of a precursor of Tubulysins 4.14, a class of compounds that show promising 




Scheme 4.4 Synthesis of Tubulysins by Lewis acid-catalysed Passerini-type reaction 
 
As illustrated by the examples above, Passerini reaction, and in general MCRs, 
represent an important tool for the synthesis of natural products, since they can afford 
the formation of several bonds in just one step with control of stereochemistry. Thus, 
comparing with linear synthesis, they can lead to complex molecules, such as natural 
products, though a convergent and shorter synthetic pathway. 
In this context, my research project was based on the possibility of synthesizing 
Bengamide E, one of the members of a new class of antitumor natural products of marine 
origin, through a methodology that combines biocatalysis and Passerini reaction, 




Scheme 4.5 Synthesis of Bengamide E starting from meso diol 4.15 using 
biocatalysis and multicomponent reaction. 
 
Bengamides are a wide family of natural products of marine origin isolated by 
Crews and coworkers[7] between 1986 and 1989 from an undescribed specimen of an 
orange sponge belonging to the Jaspidae family. Until now 23 compounds of this 








Scheme 4.6 Structure of Bengamides derived from Jaspis cf. Coriacea sponge 
 
Several hypotheses on biosynthetic origin of Bengamides has been proposed; 
according to the most accepted[8] the C-10 backbone structure derives from the 
connection between a diketide and the L-leucine amino acid, on which subsequently 




Scheme 4.7 Hypothesis for biosynthetic origin of Bengamides 
 
Bengamides present a complex structure characterized by a chain with 10 
carbon atoms with 4 contiguous stereocentres, a double bond with E configuration and 
a secondary amide which binds an aminocaprolactamic unit. Since they possess a 
promising biological profile as antibiotic, anthelmintic and antitumoral (as inhibitors 
of methionine aminopeptidases enzymes  MetAP1 and MetAP2[9]), an intense research 
activity in the chemical and biological fields, including total syntheses and synthesis 
of analogues for biological evaluation has been carried out[10]. Some strategies for the 








Scheme 4.8 Total synthesis of Bengamides and analogues in the period 1991-2010 
Modified from García-Ruiz and Sarabia[10] 
 
Through a retrosynthetic analysis, we developed a novel strategy for the total 
synthesis of Bengamides, and in particular of Bengamide E. Our idea is based on the 
possibility to synthesize the general structure of these compounds through the 
combination of three different fragments: the central skeleton derived from bio-based 
meso diol through biocatalysis, on which the olefinic residue is introduced through the 
formation of a new C-C bond, and on the other side the aminocaprolactamic unit is 
introduced thanks to a diastereoselective Passerini multicomponent reaction with a 









The main advantages of this strategy are the possibility to use a renewable 
source as starting material and the flexibility and convergence of the approach. In fact, 
Bengamide analogues can be easily obtained modifying caprolactamic unit and the 
olefinic residue by suitable use of different reagents. In addition, it also possible alter 
the different stereocentres of the molecule exploiting complementary enzymatic 
procedures to obtain the two meso diol derived enantiomers and performing the 
addition of acetylide and Passerini reaction with opposite diastereoselection. The 
possibility of achieving these modifications are of particular interest to the obtainment 
of more potent Bengamide derivatives.  
 
 
4.2 Results and Discussion 
 
This work was initiated before my doctoral research by master and bachelor 
students, whose work, after a thorough evaluation of different pathways, lead to the 
development of a synthetic strategy in 13 steps, (Scheme 4.10 shows the key steps), 




Scheme 4.10 Synthetic strategy 
 
The general strategy consists of four key steps: 
1) Enantioselective generation of monoester 4.18 via biocatalysis.  
2) Diastereoselective 1,2-additon of an acetylide, precursor of the alkenyl moiety. To 
obtain the desired diastereoisomer the reaction has to occur with an anti-selectivity. 
3) Diastereoselective Passerini reaction using a chiral isocyanide to introduce the 
caprolactam moiety. The anti-selectivity is necessary as well. 





As shown in the scheme, to obtain Bengamide E 4.17 it would be necessary to 
add further synthetic steps to change the stereochemistry of one of the stereocentres 
(C4) of the polyhydroxylated chain. For this reason, initially, we planned to synthesize 
4-epi-Bengamide E, which already presents the stereocentres obtained by the Passerini 
reaction. 
Due to presence of four contiguous stereocentres in the final product 4.22, one 
of the main objectives of this synthetic sequence was the optimization of all the steps 
in order to obtain optically pure products and avoid the formation of complex mixture 
of diastereoisomers. With this aim, attention was devoted to the stereochemical issues 
of the addition of acetylide and of the Passerini reaction. In addition, the optical purity 
of the compounds was checked along the synthetic pathways. In fact, the presence of 
synthetic racemizing steps, mainly during the preparation of the building blocks for 
the Passerini reaction, could lead to the formation of products with low optical purity, 
causing waste of starting materials and time. 
In the following paragraphs, some of the work previously done will be 
described and the results obtained during my research will be extensively discussed. 
In detail, after a brief optimization of some reaction conditions to obtain compound 
4.20 from compound 4.18, my work was mainly focused on the study of the last steps 
(from Passerini reaction to final product) of this strategy.  
 
4.2.1 Enzymatic synthesis of chiral building blocks  
 
As described in Chapter 4, diol 4.15 is a symmetrical achiral molecule. To 
afford the enantiomerically pure building block, we planned to apply a 
chemoenzymatic approach, involving an AMANO PS Lipase for the monoacylation 
of compounds 4.15 (Scheme 4.11). In a previous optimization, the use of vinyl butyrate 
had been preferred to vinyl acetate, due to the instability of the latter in the subsequent 
Mitsunobu reaction. In fact, a low e.e. (from 96% to 76%) had been observed due to 
the migration of the acetyl group and subsequent racemization. On the contrary, the 
use of butyrate group, probably due to the major steric hindrance, can avoid the 
migration process. The enzymatic reaction was performed following the procedure 
reported in literature[11], and, stopped at 56% conversion, allowing us to isolate the 
monoacylated compound 4.18 in good yield (96%). The enantiomeric excess (95%) 
was determined, in a later step, by HPLC analysis with a chiral column on product 
4.23 that presents a chromophore necessary to make the molecule visible to the UV 
detector. Once obtain compound 4.18 the synthetic strategy involves the Mitsunobu 
and deacylation reactions to introduce the p-methoxyphenyl (PMP) group (Scheme 
4.11). The change of functional group is necessary to obtain the desired monomer, that 
could also conveniently obtain by hydrolysis of the corresponding diester[11], but 
mainly because of the instability of the acyl group in the subsequent reactions, as a 





protecting group since it has orthogonally cleavage conditions (reaction with 
ammonium cerium (IV) nitrate) respect to the other protecting groups present on the 
molecule (acetonide and TBS group are removed under acidic conditions). In fact, it 
has to be removed in a previous step of the synthesis, as shown in Scheme 4.10 and 




Scheme 4.11 Enzymatic desymmetrization and change of protecting group 
 
Mitsunobu reaction was performed at room temperature in presence of p-
methoxy phenol (PMP-OH), triphenylphosphine and di-tert-butyl azodicarboxylate 
(TBAD). The crude was directly subjected to the next reaction with KOH in MeOH to 
remove the acyl group. With these conditions product 4.23 was obtained in high yield 
(89%) also on a large scale (about 5 grams). 
 
4.2.2 Diastereoselective addition of acetylide 
 
In earlier work, some attempts to directly introduce the olefinic residue had 
been tried, using organolithium and Grignard reagents, but they didn’t lead to good 
results. Therefore, we tried to perform the nucleophilic addition of acetylide to 
carbonyl compounds. This strategy leads to the formation of propargyl alcohol[12] 
which can be selectively reduced to double bond with the E configuration using 
aluminium hydrides. This method presents two advantages: acetylides can be easily 
obtained from corresponding terminal alkyne through a metalation reaction (lithium-
hydrogen exchange) and many alkynes are commercially available  
Alcohol 4.23 was oxidized under Swern conditions and the corresponding 










Among the different strategy to oxidize alcohols to aldehydes, Swern oxidation 
presents some important features that makes it particularly interesting: the reaction is 
generally fast (on this type of substrate it occurs in about an hour), the product is 
usually obtained in high yields and purification is not necessary since the by-products 
are all volatile. This last point represents a fundamental advantage in the presence of 
unstable aldehyde, as in our case. In fact, aldehyde 4.24 is unstable on silica and 
decomposes rapidly once it is dried. For this reason, it is important to carefully 
evaporate the solvent on the rotavapor without completely drying the crude product 
and to use it immediately after the work up without chromatographic purification. In 
addition, this aldehyde tends to remain in the hydrated form and, therefore, the 
presence of water within the reaction environment affects the success of the subsequent 
reaction. 
Due to these problems, a thorough optimization of the work up conditions was 
accomplished to make the subsequent acetylide attack efficient and reproducible. 
Different precautions were taken to make the aldehydes as dry as possible. 
Swern reaction was carried out under classical conditions; after work up the crude 
product was filtered through a sintered funnel filled with celite, dry Na2SO4 (dried in 
an oven), and celite layers in order to remove the water. Concerning the addition of 
acetylide, THF dried on molecular sieves, argon atmosphere and 4Å molecular sieves 
were employed during the reaction. Moreover, 2,2-bipyridyl was employed to control 
the efficiency of the nBuLi, alkyne and THF system. In this way, product 4.19 was 
obtained with a high yield (88%) but low diastereoselectivity (d.r. 57:43 anti:syn).  
The absolute stereochemistry of propargyl alcohols has been determined, at an 
earlier stage of the research, by the formation of the corresponding lactones, after 
cleavage of the protecting group, and analysis of the J constant coupling by 1H-NMR 










Since only the anti diastereoisomer has the same configuration of the 
stereocentre adjacent to the triple bond of the 4-epi-Bengamide E, it is important to 
have a good diastereoselection to obtain a major quantity of the desired 
diastereoisomer. Consequently, in order to improve the d.r. of compound 4.19, the 
diastereoisomeric mixture was oxidized to ketone with Dess Martin periodinane and 
the stereoselective reduction of the ketone was studied. Different reagents were used 
in a previous optimization (Table 4.1).  
 
Table 4.1 Optimization of diastereoselective reduction 
 
 
Entry Reagent Solvent T (°C) Time d.r. (anti/syn)a 
1 Red-Al THF -78 1 h 49:51 
2 L-selectride THF -78 1 h 63:37 
3 NaBH4 MeOH -78 1 h 24:76 












- 40 to rt 2 h 58:42 
a Determined by HPLC 
 
In all cases the reactions were performed until completion (conversion 100 % 
determined by HPLC) and the d.r. were determined by HPLC analysis. As shown in 
the table, using Red-Al, L-selectride and DIBAL-H in presence of MgBr2·Et2O as 
additive, a poor diastereoselection was observed (Entries 1, 2, 5 and 6); meanwhile, 
NaBH4 afforded syn diastereoisomer. Best results were obtained with K- selectride 
(Entry 4, yield 72%, d.r.76:24, anti: syn). 
 
4.2.3 Manipulation of functional groups 
 
To obtain alcohol 4.20, the substrate of Passerini reaction, it is necessary to 
reduce the triple to double bond and to introduce the TBS protecting group. The 
description of these steps follows in this paragraph.  
Propargyl alcohols can conveniently be reduced to alkenes with sodium bis(2- 





obtained were not satisfactory; in fact, the major problems were the difficulty for the 
reaction to go to completion and the difficulty to separate the unreacted starting 
material from the product, ending up in an only moderate yield (67% after 17h). To 
solve this problem the reaction was performed at reflux rather than at room 




Scheme 4.14 Reduction of the triple bond 
 
The reaction was initially carried out on the mixture of the two 
diastereoisomers of 4.19 to verify if they were more easily separable at the level of the 
double bond. Unfortunately, the chromatographic separation of the two 
diastereoisomers was difficult both on the products with the triple bond and on those 
with the double. In Figure 4.2 the TLC of the reduction was reported: it is possible to 
see that the four compounds have similar Rf and their spots are very close on TLC 




Figure 4.2 TLC of the reduction on both diastereoisomers 
 
Therefore, we decided to perform the reaction after separation, on the major 
diastereoisomer of the substrate 4.19 (anti). With the optimized condition the reaction 
went to completion, leading to the product 4.29 with 81% yield. 
We also tried to carry out the oxidation/reduction sequence on the two 
diastereoisomers of product 4.29 in order to verify if a higher stereoselectivity could 
be obtained (Scheme 4.15). The same conditions previously optimized were used for 
the reduction step (K-selectride) but it was less stereoselective than on substrate 4.19 













Diastereoisomers with triple bond 







Scheme 4.15 Oxidation to ketone and diastereoselective reduction  
 
Once we obtained compound 4.29, we planned to protect the primary hydroxy 
group as TBS and to remove the PMP protecting group in order to later perform 
Passerini reaction. As previously said, the choice of these two protecting groups was 
due to their orthogonally behaviour.  
The protection reaction with TBS was conducted under the conditions 





Scheme 4.16 Protection with TBS group and cleavage of PMP group 
 
The subsequent cleavage of PMP group was accomplished using the reagent 
ammonium cerium (IV) nitrate (CAN) in CH3CN: H2O 3:1. This step is particularly 
delicate because the acidic environment of the reaction can also promote the release of 
the silyl group. In particular, the formation of compound 4.32 has been observed. For 
this reason, the reaction must take place in a very short time, about 10-15 minutes, and 
it is extremely important to block it promptly. In the previous work, the excess of 
oxidant had been removed by NaHCO3 / AcOEt or 10% Na2S2O5. However, the 
formation of several by-products, that could not be removed during the 
chromatography, had been observed. The problem was solved changing the work up 
conditions; it was carried out with NaHCO3: 10% Na2S2O5 in a 1: 1 mixture. In this 
way, the excess of oxidant is destroyed and benzoquinone resulted is reduced to 





water. Thus, the clean product 4.20, first building blocks for the subsequent Passerini 
reaction, was obtained with a 94% yield. 
 
4.2.4 Synthesis of isocyanide  
 
In the previous paragraphs the synthesis of the first building block, alcohol 
4.20, necessary for the Passerini reaction has been described. In this paragraph the 
synthesis of the second building block, isocyanide 4.35, is reported. 
Isocyanide 4.35 was synthesized following a previously optimized procedure, 
starting from commercially available L-(-)-α-amino-ε-caprolactam 4.33 via two steps 
sequence (Scheme 4.17). The first step involves the formation of the corresponding 
formamide through the coupling reaction with formic acid, in presence of DCC and 
Et3N. The product can be isolated by filtration, avoiding an aqueous work up; this is a 
great advantage in our case since formamide 4.34 has a high affinity towards water 
and, therefore, the extraction would be troublesome. Then, the dehydration reaction 
was carried out to obtain the final product. After an optimization conducted in the 
previous work, POCl3 was selected as dehydrating agent for the reaction. Even if an 
extractive work up is necessary to recover the product 4.35, making the procedure 
longer due to the poor solubility of the product in organic solvent, the use of POCl3 




Scheme 4.17 Synthesis of isocyanide 
 
As stated at the beginning of this chapter, particular attention was dedicated to 
the control of the preservation of optical purity of the products. Thus, the optical purity 
of isocyanide 4.35 was checked as well. In fact, it is well known that chiral isocyanides 
bearing an amide or ester group in α position tend to racemize during their preparation. 
HPLC studies, conducted by the group before my research, demonstrated that the 
stereochemical information was maintained during the synthetic steps.  
 
4.2.5 Oxidation and diastereoselective Passerini reaction 
 
The synthesized building blocks alcohol 4.20 and isocyanide 4.35 were 
subsequently used with AcOH, to accomplish, after oxidation to aldehyde, the 
diastereoselective Passerini multicomponent reaction. Based on researches conducted 
by the group[14], oxidation reaction had been initially performed, in a previous work, 





pot TEMPO/BAIB procedure. These studies had demonstrated that best results in 
terms of yield and d.r. could be obtained exploiting Swern condition followed by 
Passerini reaction. In addition, as also observed in the first project (Chapter 3), Swern 
procedure avoided the overoxidation of the aldehyde to carboxylic acid.  
Before describing the results obtained during my work, two other aspects, 
previously investigated, have to be considered: 
a. The maintenance of stereochemical information of the building blocks, isocyanide 
and alcohol, was verified also during the multicomponent reaction by HPLC 
analysis. The racemization of the products was not observed, confirming the 
stability of these compounds in the reaction conditions. 
b. The configuration of the newly formed stereogenic centre of the Passerini reaction 
products was established by analogy with the meso diol derived Passerini products 
obtained in previous works[14a, 14b]. 
Alcohol 4.20 was oxidized to the corresponding aldehyde 4.36 under Swern 





Scheme 4.18 Swern oxidation and Passerini reaction 
 
Swern oxidation was carried out under classical conditions. As for aldehyde 
4.24, we found further drying procedures and the direct use without chromatography 
to be beneficial. Passerini reaction was initially studied using acetic acid and 
isocyanide 4.35 as reagents in dry CH2Cl2 without any additives. However, following 
this procedure, we envisioned some problems, described below. 
In previous experiments, it had been observed that isocyanide 4.35 is not very 
reactive (Passerini reaction was slow and difficult to go to completion) and tends to 
hydrate to the corresponding formamide 4.34 in the reaction environment. To solve 
these problems, we tried to slowly add the isocyanide, through a syringe pump, to a 








Figure 4.3 Addition of isocyanide through syringe pump  
 
With this method, the presence of the formamide was not observed in the 
reaction (checked by TLC), indicating that the slow addition was functional. 
Nevertheless, the product was obtained with a low yield (41% yield in two steps). 
The first attempt to perform the diastereoselective Passerini reaction had 
shown high diastereoselection (87:13 anti: syn) but a small amount of truncated 
Passerini products (Scheme 4.19) was detected. It doesn’t constitute a big problem 
because the next step consists in a deacetylation reaction. However, by HPLC analysis 
we observed that the deacetylation mainly occurs on the syn diastereosimer of the 
Passerini products and, therefore, considering only the two acetylated Passerini 
products a false value of d.r. is obtained. Consequently, the initially d.r. of 87:13 could 





Scheme 4.19 Truncated Passerini product 
 
Another problem is that the two Passerini products cannot be easily separated 
by column chromatography. So only a small amount of the desired diastereoisomer 
(anti) can be obtained. 
To solve the two last problems, the formation of truncated products and the 
difficult separation of the two diastereoisomers, we decided to perform Swern 
oxidation, Passerini reaction and deacetylation in a tandem process in order to avoid 
the chromatography of the Passerini products and to directly determine the d.r. on the 








Scheme 4.20 Swern oxidation, Passerini reaction and deacetylation reaction 
 
Swern oxidation was performed under classical conditions to obtain the 
aldehyde which was subsequently used in Passerini reaction with isocyanide (2 eq) 
and acetic acid (2 eq). CH2Cl2 was chosen as solvent and all the reagents were added 
at the same time (not slowly addition) in the reaction environment. The reaction was 
stirred for 25 hours at room temperature. Once we obtained the Passerini products 
4.37, the crude product was filtered on silica and then directly subjected to 
deacetylation reaction with MeOH: Et3N: H2O (5:1::1). The reaction was monitored 
by HPLC analysis (starting material 4.37 and product 4.21 have the same Rf in TLC) 
and it afforded the desired product as a mixture of diastereoisomers with 52% yield on 




Figure 4.4 HPLC chromatogram of deacetylated products 4.21 
 
Further optimization was conducted on the reaction in order to investigate 
solvent effects on diastereoselectivity and yield. Based on some results of previous 





solvent. As shown in Table 4.2, in both cases the reaction requires more time. 
However, improved results in terms of yield were obtained using iPr2O as solvent. 
Moreover, it was clear that the solvent did not affect the diastereoselection (in all 
reactions the d.r. was about 8:2 anti: syn). 
 
Table 4.2 Solvent optimization for Passerini reaction 
 








21 h r.t. iPr2O dry 74% 80:20 
a Reactions were performed with 2 eq of isocyanide and AcOH, b solvents were dried on molecular 
sieves 4Ǻ, c on three steps: Swern oxidation, Passerini reaction and deacetylation, d determined by 
HPLC analysis on the crude product of deacetylation reaction, e partial solubility of isocyanide. 
 
To improve the diastereoisomeric ratio we decided to investigate the possible 
beneficial effect of a Lewis acid additive. Structurally similar chiral aldehydes derived 
from erythritol have been shown to benefit of the presence of a catalytic amount of 
ZnBr2
[14a] (as diffusely discussed in Paragraph 3.2.3). Due to the insolubility of ZnBr2 
in CH2Cl2, the reaction was only performed in THF and iPr2O.  
 
Table 4.3 Passerini reaction with ZnBr2 
 












20 h r.t. iPr2O dry 14% 80:20 
a Reactions were performed with 2 eq of isocyanide and AcOH and 0.4 eq of ZnBr2, b solvents were 
dried on molecular sieves 4Ǻ, c on three steps: Swern oxidation, Passerini reaction and deacetylation, d 
determined by HPLC analysis on the crude product of deacetylation reaction, e partial solubility of 
isocyanide and ZnBr2. 
 
We can see (Table 4.3) that in all cases, the addition of ZnBr2 decreased the 
yield, as expected, but unlike in the case of other aldehydes deriving from the erythritol 
it did not lead to a significant improvement on the observed diastereoselectivity. 
Our final attempt to improve the diastereoselection of the process was to slowly 





hoped to be able to slow down the reaction rate, thus increasing the possibility of 
diastereofacial differentiation. We decided to slowly add (in 2 hours) a mixture of 
aldehyde and acid to the isocyanide and ZnBr2. However, once again the products were 
obtained with poor yield (19%) and no benefit to the diastereoselection was observed 
(d.r. 82:18 anti:syn). 
 
4.2.6 Synthesis of 4-epi-Bengamide E  
 
To obtain 4-epi-Bengamide E, methylation reaction and cleavage of the 
protecting groups (silyl ether and isopropylidene) should be performed on the 
diastereoisomer anti of the product 4.21. 
Concerning methylation reaction, first results had been obtained before my 
research using MeI and NaH at 0°C. In this condition, product 4.38 had been obtained 
with other two products, the N-methylated compound 4.39 and the bis-methylated 4.40 
(Scheme 4.21). In fact, if we consider compounds 4.21, three sites for the attack of 
methylating agent are possible: the secondary hydroxy group, the amide group 




Scheme 4.21. Methylation reaction 
 
The formation of the side-products was checked by HPLC-MS analysis on the 
crude product (Figure 4.6) and the structures were confirmed by NMR spectra (1H, 
13C, HSQC). By HPLC-MS analysis, it is possible to distinguish the peaks of 
compound 4.21 (tr = 13.8 min, m/z = 499.2), 4.39 (tr = 16.6 min, m/z = 513.2) and 4.40 








Figure 4.5 Chromatogram of methylation reaction 
 
To improve the formation of the desired product 4.38 and limit the formation 
of the two side-products, a very slight excess of the base NaH has to be added. In this 
way, only the desired hydroxy group should be deprotonated lead preferentially to the 
O-methylated product. Nevertheless, NaH is commercially available as 60% 
suspension in silicon oil that is very difficult to weight, especially in small quantity. 
Therefore, an addition of a precise quantity of NaH to the reaction mixture is 
troublesome. To solve this problem, we decided to perform the reaction with different 
systems. 
Firstly, we tried the reaction using the Meerwein’s reagent (CH3)3OBF4 (1.2 
eq) in presence of proton sponge (2 eq), 3Ǻ MS in dry CH2Cl2 (0.05 M) at -10°C. 
Trimethyloxonium tetrafluoroborate is a strong methylating agent; therefore, it can be 
used with weaker base and, consequently, it could decrease the formation of side-
products. Unfortunately, only N-methylated derivative 4.39 was obtained (checked by 
HPLC analysis).  
Other two attempts (Table 4.4) were performed using MeI and lithium or 
sodium hexamethyldisilazane. These reactions were carried out on the syn 
diastereoisomer of the product, since we had a small quantity of the anti-product. 
Obviously, once obtained good results, the reaction should have been performed on 
the anti diastereoisomer. The reaction with LiHMDS afforded product 4.39 as well, 
meanwhile the use of NaHMDS did not gave any product, probably due to the bad 






Table 4.4 Optimization of methylation reaction on syn diatereoisomer 
 
Entry Reagents Base Temperature Solvent Products 
1 MeI LiHMDSa 0°C→r.t. THF 4.39 
2 MeI NaHMDS 0°C→r.t. THF - 
a Prepared in situ from HMDS and nBuLi 
 
In all the three reactions above the presence of the bis methylated compound 
was not observed.  
From these results, we decided to use the initial conditions (NaH and MeI). To 
prevent the formation of the bis methylated product, only a small excess of NaH (1.2 
eq) was used and the reaction was performed at -10°C instead of 0°C in THF dry (0.2 
M). We also tried to add the base in small aliquots (0.6 + 0.6 eq) to the reaction to 
avoid the presence of an excess of the base in the reaction environment. The reaction 
is difficult to checked since starting material 4.21 and product 4.38 have the same Rf 
in TLC. Unfortunately, the reaction was slow and after 24 h did not go to completion 
(starting material: product ratio of 45:55). Therefore, we attempted to increase the 
conversion of the reaction using dry DMF as solvent. Thus, we performed again the 
reaction on the crude product of the previous one, with 1 eq of NaH in dry DMF. We 
observed an improvement in the conversion (the reaction was stopped with a starting 
material: product ratio of 5:95, determined by HPLC analysis on the crude product), 
but at the same time a major quantity of bis methylated product 4.40 and the formation 
of N-methylated product 4.39. The increased formation of the side-products (20% 
yield of 4.40 and 3% of 4.39) can be explained by the use of an excess of NaH respect 
to the starting material, that was added to lead the reaction to completion. In addition, 
probably DMF solvent makes the methylating agent too reactive and consequently less 
selectivity for O-methylation. Other experiments should be performed in THF to limit 
the formation of side-products, monitoring the reaction with HPLC analysis to be sure 
to stop the reaction after completion. 
The last step of the synthesis involves the cleavage of the protecting groups 
(silyl ether and isopropylidene groups). Both these functionalities can be removed 
under acidic conditions, therefore, theoretically the final cleavage could be performed 
in only one step. 
Some preliminary studies had been done before my research. In particular, two 








Scheme 4.22 Previous results of final cleavage 
 
The first one involved a one-step procedure with TFA in H2O/THF. In the 
second attempt a two steps sequence, as reported by Sarabia[15], was performed. It 
involves the cleavage of TBS group with TBAF in THF and the subsequent reaction 
with AcOH 70% (aqueous solution) in MeOH to remove the acetonide group. In both 
cases the product 4.22 was obtained with low yields and two other side-products 4.41 
and 4.42 were observed (Scheme 4.22). The formation of these products is probably 
due to the intramolecular attack of OH to the carbonyl group of the amide. The possible 
mechanism involves the initial cleavage of t-butyldimethylsilyl ether which is easily 
hydrolysed in the acidic environment. The spatial proximity between the hydroxy 
group and the amide group favours the intramolecular attack of OH to the carbonyl 
group of the amide to form the corresponding lactone 4.41 and expelling the amino-
caprolactam 4.33. Once the lactone is formed, the acidic environment promotes the 










Taking into account the previous results, we decided to perform a different 
strategy for the cleavage of the protecting groups using HCl 1M in THF (Scheme 
4.24)[16]. In these conditions, the product 4.22 was obtained with a higher yield (35%) 
and only a small quantity of cyclized products was obtained. We also observed the 
presence of the product without the TBS group but still with the acetonide group. 














In summary, the total synthesis of 4-epi-Bengamide E, a stereoisomer of 
Bengamide E never synthesized before, was successfully completed applying a new 
synthetic route. 
This new strategy demonstrates the efficiency of coupling biocatalysis and 
MCRs starting from bio-based products to access a densely functionalized and 
stereochemically complex compound. The four contiguous stereocentres are generated 
with high stereocontrol: the enzymatic desymmetrization delivers 95% e.e. (in favour 
of the desired enantiomer), whereas the diastereoselective reduction of ketone and the 
Passerini reaction provide the required diastereoisomer with good selectivity. In 
addition, using the same approach different analogues of Bengamides could be 
synthesized by variation of the reagents. 
Studies on the optimization of the final steps (methylation and final cleavage) 
are in progress. The last results obtained showed an increase in the yields for both the 
reactions. Performing the methylation with NaH (1.5 eq) and MeI (2 eq) in THF dry 
for 2 days at -10°C the reaction went to completion (monitored by HPLC analysis) and 
the product was obtained with 63% yield. Concerning the final cleavage, it was carried 
on with a higher concentration of HCl (2 M) affording the final product with 43% 
yield. 
The extension of this synthetic strategy to the natural Bengamide E will require 
some modifications in order to selective epimerized the 4-OH. Some further 






4.4 Experimental Section 
 
4.4.1 General remarks  
 
NMR spectra were taken at room temperature in CDCl3 or in d6-DMSO at 300 
MHz (1H), and 75 MHz (13C), using, as internal standard, TMS (1H-NMR: 0.000 ppm) 
or the central peak of CDCl3 (
13C: 77.160 ppm). Chemical shifts are reported in ppm 
(δ scale). Coupling constants are reported in Hertz. Resonances are described as s 
(singlet), d (doublet), t (triplet), q (quartet), bs (broad singlet) and m (multiplet) or 
combinations thereof. Peak assignments were made with the aid of gCOSY and 
gHSQC experiments. In ABX system, the proton A is considered upfield and B 
downfield.   
GC-MS were carried out using an HP-1 column (12 m long, 0.2 mm wide), 
electron impact at 70 eV, and a mass temperature of about 170 °C. Only m/z > 33 were 
detected. All analyses were performed (unless otherwise stated) with a constant He 
flow of 1.0 ml/min with initial temp. of 70 °C, init. time 2 min, rate 20 °C/min, final 
temp. 260 °C, inj. temp. 250 °C, det. temp. 280 °C.  
HPLC analyses for the determination of enantiomeric ratios were performed 
on a Daicel Chiral Pak AD 250x4.6 mm column, at 25–28 °C with a flow of 1 mL/min 
(UV detection at λ = 220 nm).  
HPLC-MS analyses were performed on Synergi Hydro RP 150x3 mm column, 
at 30 °C with a flow of 0.5 mL/min (where not otherwise stated). HRMS: samples, 
provided at 10mM in DMSO, were analysed on a UPLC Acquity system coupled to a 
Synapt G2 QToF mass spectrometer. MS signals were acquired from 50 to 1200 m/z 
both ESI positive and ESI negative ionization mode.   
IR spectra were recorded directly on solid, oil, or foamy samples with the ATR 
(attenuated total reflectance) technique, using a FT Perkin Elmer Spectrum 65 
spectrophotometer.  
Optical rotations were measured with a JASCO P-2000 digital polarimeter, 
using the sodium D line as the light source. The specific rotation [α]D was calculated 
as: [α]D = α *100/ c*l (α = observed rotation of solution; l = length of polarimeter tube 
in decimetres, c = concentration of the solution in g/100 mL in CHCl3).  
Melting points were determined with an electrothermal apparatus (Büchi B-
535).  
TLC analyses were carried out on silica gel plates and viewed at UV (254 nm) 
and developed with Hanessian stain (dipping into a solution of (NH4)4MoO4·4H2O (21 
g) and Ce(SO4)2·4H2O (1 g) in H2SO4 (31 mL) and H2O (469 mL) and warming).  
Rf values were measured after an elution of 7-9 cm.  
Column chromatographies were done with the "flash" methodology using 220-
400 mesh silica.  







4.4.2 Experimental procedures 
 
4.4.2.1 Synthesis of chiral building blocks  
 
((4R,5S)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)methyl butyrate 4.18 
Diol 4.15 (3.592 g, 22.15 mmol) was dissolved in THF dry (55.4 
mL) under nitrogen atmosphere. Molecular sieves 3Å (1.107 g, 
50mg/mol), vinyl butyrate (14 mL, 110.74 mmol) and Amano PS 
lipase (1.796 g) were added and the reaction was stirred at 20 °C for 32 h. Then it was 
filtered on celite washing with DCM and concentrated. The residue was purified by 
column chromatography on silica gel (ETP/AcOEt 6:4), to give alcohol 4.18 as a 
colourless oil (4.629 g, 96% yield, conversion: 56%). The analytical data conform to 
those reported in literature[17]. 
 
4.15, colourless oil, Rf = 0.0.38 (ETP:AcOEt 3:2), developed with Hanessian stain.  
[α]20D= + 13.70 (c = 1.04, CHCl3)  
HRMS (ESI+): m/z calcd for C11H20O5 [M+Na]





A solution of alcohol 4.18 (4.629 g, 21.21 mmol) in dry CH2Cl2 
(212 mL) was treated with triphenylphosphine (8.345 g, 31.81 mmol) and p-
methoxyphenol (7.899 g, 63.63 mmol), under nitrogen atmosphere. Then tert-butyl 
azodicarboxylate (7.326 g, 31.81 mmol) was added slowly at 0°C. The reaction 
mixture was then stirred for 26 h at room temperature. The solvent was removed by 
evaporation under reduced pressure and the residue was filtered on silica gel (ETP: 
DCM: Et2O 1:1:1) and directly used for the next reaction.  
Rf = 0.9 (ETP:AcOEt 6:4), developed with Hanessian stain. 
Butyrate cleavage 
To a solution of crude compound (21.55 mmol) in MeOH (76 mL), KOH (1M, 1.815 
g, 32.35 mmol solubilized in 32 mL of MeOH) was added. The reaction was stirred at 
room temperature for 6 h and then it was quenched with 100 mL of NH4Cl (sat) and 
extracted with Et2O. The organic phase was washed with brine, dried (Na2SO4), and 
concentrated. In order to remove the precipitate (p-methoxyphenol and hydrazine 
carboxylate), the residue was diluted and filtered on celite and purified by flash column 
chromatography on silica gel (ETP: AcOEt 2:1 and ETP: AcOEt 1:1) to give 4.16 g 
(89% yield in 2 steps) of a pale yellow solid. e.e. 95% 
 
4.23, pale yellow solid, Rf = 0.27 (ETP:AcOEt 2:1), developed with Hanessian stain. 





1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 6.95 – 6.77 (m, 4H, CH Ar.), 4.54 (q, J 
= 6.3 Hz, 1H, CHCH2OPMP), 4.39 (q, J = 6.0 Hz, 1H, CHCH2OH), 4.04 (d, J = 6.2 
Hz, 2H. CH2OPMP), 3.88 – 3.73 (m, 2H, CH2OH), 3.77 (s, 3H, OCH3), 2.28 (s, 1H, 
OH), 1.50 (s, 3H, CH3 of iPr), 1.41 (s, 3H, CH3 of iPr). 
13C NMR (75 MHz, CDCl3, 25 
°C, TMS):  = 154.48 (C quat. Ar), 152.33 (C quat. Ar), 115.72 (2 CH Ar), 114.84 (2 
CH Ar), 109.02 (C(CH3)2), 77.39 (CHCH2OH), 75.05 (CHCH2OPMP) 67.29 
(CH2OPMP), 61.14 (CH2OH), 55.86 (OCH3), 27.88 (CH3 of iPr), 25.29 (CH3 of iPr). 
IR  (cm-1) = 3519; 3058; 2988; 2938; 2887; 2836; 1509; 1460; 1374; 1335; 1289; 
1216; 1182; 1164; 1111; 1089; 1050; 1035; 996; 907; 845; 830; 818; 803; 751; 715; 
650. HRMS (ESI+): m/z calcd for C14H20O5 [M+Na]
+: 291.1209; found: 291.1106. 
 





To a solution of DMSO (1.1 mL, 15.08 mmol) in dry CH2Cl2 
(36 ml), at –78 °C under nitrogen atmosphere, a solution of oxalyl chloride in dry 
CH2Cl2 (1.43 M, 9.8 mL) was added. Upon completion of the addition, the mixture 
was stirred at -78 °C for 10 min. A solution of alcohol 4.23 (1.499 g, 5.59 mmol) in 
dry CH2Cl2 (20 ml) was added dropwise, and the solution was stirred for 10 min at –
78 °C. Then Et3N (4.3 mL, 30.73 mmol) was added and the solution was stirred for 2 
h (the reaction was monitored by TLC and 1H-NMR). The reaction was quenched by 
addition of 5% aq. (NH4)H2PO4 (130 mL + 1 N HCl solution) to have a final pH = 4 
and extracted with Et2O (3 x 60 mL). The combined organic layers were washed with 
brine (60 mL) and dried (Na2SO4, dried in an oven at 100°C for one night and cooled 
under vacuum). In order to remove water, the organic phase was filtered on celite and 
Na2SO4 and concentrated to afford aldehyde 4.24 as a yellow oil, which was 
immediately used for the next reaction without any further purification. 
Rf = 0.54 (ETP:AcOEt 6:4), developed with Hanessian stain. 
Addition of acetylide 
In a 3-necks flask 2,2-bipyridyl and dry THF (30 mL, dried over molecular sieves 4 
A°) were added under argon atmosphere. Then the mixture was cooled to -50°C and 
nBuLi (11 mL, 1.6 M in hexane) and 3-methyl-1-butyne (2 mL, 19.55 mmol) were 
added. The reaction was stirred for 30 min (until the red colour disappeared) and a 
solution of crude aldehyde (5.59 mmol) in 20 mL dry THF was added dropwise (15 
min). The reaction mixture was stirred 1 h at -50°C and then it was allowed to reach 
room temperature and stirred overnight. The reaction was quenched with 100 mL of 
NH4Cl (sat) and extracted with AcOEt (3 x 60 mL). The combined organic layers were 
dried (Na2SO4) and concentrated. The residue was purified by flash column 





steps) as a mixture of diastereoisomers (d.r. = 57: 43 anti: syn, calculated by HPLC 
analysis on the crude product). 
 
4.19_anti pale yellow foam; Rf = 0.73 (ETP:AcOEt 6:4), developed with Hanessian 
stain. [α]24D= -13.01 (c = 1.00, CHCl3) 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.93 –6.79 (m, 4H, CH Ar.), 4.63 – 4.56 
(m, 2H, CHCH2 e CHOH), 4.36 (dd, J= 10.1, 5.1 Hz, 1H, CH2OPMP), 4.31 (dd, J= 
6.5, 5.0 Hz, 1H, CHCHOH), 4.20 (dd, J= 10.1, 6.3 Hz, 1H, CH2OPMP), 3.76 (s, 3H, 
OCH3), 2.79 (d, J= 5.7 Hz, 1H, OH), 2.56 (heptd, J= 6.9, 1.8 Hz, 1H, CH(CH3)2), 1.55 
(s, 3H, CH3 of iPr), 1.42 (s, 3H, CH3 of iPr), 1.13 (d, J= 6.9 Hz, 6H, 2 CH3 of 
CH(CH3)2). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 154.07 (C quat. Ar), 152.40 
(C quat. Ar), 115.58 (2 CH Ar), 114.53 (2 CH Ar), 109.08 (C(CH3)2), 92.55 
(C≡CCHOH and C≡CCHOH), 79.29 (CHCHOH), 75.45 (CHCH2OPMP) 67.32 
(CH2OPMP), 61.65 (CHOH), 55.57 (OCH3), 27.29 (CH3 of iPr), 25.15 (CH3 of iPr), 
22.62 (2 CH3 of CH(CH3)2), 20.42 (CH(CH3)2). HRMS (ESI+): m/z calcd for C19H26O5 
[M+Na]+: 357.1678; found: 357.1670. 
 
4.19_syn pale yellow oil; Rf = 0.65 (ETP:AcOEt 6:4), developed with Hanessian stain 
[α]20D= -76.29 (c = 1.03, CHCl3) 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 6.94 – 6.74 (m, 4H, CH Ar.), 4.63 – 
4.47 (m, 2H, CHCH2OPMP and CHOH), 4.39 – 4.23 (m, 2H, CHCHOH and 
CH2OPMP), 4.18 – 3.92 (m, 1H, CH2OPMP), 3.77 (s, 3H, OCH3), 2.76 – 2.31 (m, 1H, 
CH(CH3)2), 1.54 (s, 3H, CH3 of iPr), 1.43 (s, 3H, CH3 of iPr), 1.13 (dd, J = 6.9, 2.0 Hz, 
6H, 2 CH3 of CH(CH3)2). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 154.21 (C 
quat. Ar), 152.70 C (quat. Ar), 115.65 (CH Ar.), 114.68 (CH Ar.), 109.62 (C(CH3)2), 
93.05 (C≡CCHOH and C≡CCHOH), 79.84 (CHCHOH), 75.57 (CHCH2OPMP), 67.18 
(CH2OPMP), 61.32 (CHOH), 55.83 (OCH3), 27.80 (CH3 of iPr), 25.46 (CH3 of iPr), 
22.81 (2 CH3 of CH(CH3)2), 20.59 (CH(CH3)2). IR  (cm
-1) = 3455; 3222; 2970; 2934; 
2835; 1507; 1458; 1381; 1319; 1289; 1228; 1214; 1167; 1125; 1106; 1082; 1038; 884; 
856; 824; 727; 639. HRMS (ESI+): m/z calcd for C19H26O5 [M+Na]





Compound 4.19 (both diastereoisomers) (1.476 mg, 4.41 
mmol) was dissolved in 44 mL of dry CH2Cl2 under nitrogen 
atmosphere. Then Dess Martin periodinane (2.00 g, 4.85 mmol) was added to the 
solution at 0°C and the reaction was stirred at room temperature for 3 h and 30 minutes. 
The reaction was quenched with 140 mL of a solution 1:1 NaHCO3: Na2S2O3 and 
extracted with CH2Cl2 (3 x 60 mL). The combined organic layers were dried (Na2SO4) 
and concentrated. The residue was purified by flash column chromatography on silica 
gel (ETP: AcOEt 5:1) to afford 4.28 as a pale yellow foam (1.036 g, 71% yield). 
 





[α]23D= + 16.59 (c = 1.07, CHCl3) 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 6.90 – 6.73 (m, 4H, CH Ar.), 4.76 (ddd, 
J = 7.6, 5.8, 4.0 Hz, 1H, CHCH2OPMP), 4.67 (d, J = 7.6 Hz, 1H, CHC=O), 4.12 (dd, 
J = 10.2, 4.0 Hz, 1H, CH2OPMP), 4.00 (d, J = 5.8 Hz, 1H, CH2OPMP), 3.75 (s, 3H, 
OCH3), 2.71 (hept, J = 6.9 Hz, 1H, CH(CH3)2), 1.67 (s, 3H, CH3 of iPr), 1.44 (s, 3H, 
CH3 of iPr), 1.20 (dd, J = 6.9, 1.7 Hz, 6H, 2 CH3 of CH(CH3)2). 
13C NMR (75 MHz, 
CDCl3, 25 °C, TMS):  = 185.51 (C quat. C=O), 154.27 (C quat. Ar), 152.36 (C quat. 
Ar), 115.59 (2 CH. Ar), 114.58 (2 C quat. Ar), 111.43 (CHC≡C), 103.64 (C(CH3)2), 
81.76 (CHCH2OPMP), 79.29 (CHC≡C), 76.91 (CHC=O), 66.47 (CH2OPMP), 55.74 
(OCH3), 27.04 (CH3 of iPr), 25.39 (CH3 of iPr), 21.77 (2 CH3 of CH(CH3)2), 20.99 
(CH(CH3)2). IR  (cm
-1) = 2976; 2935; 2835; 2205; 1667; 1593; 1507; 1456; 1381; 
1317; 1289; 1212; 1163; 1093; 1066; 1036; 985; 909; 890; 857; 823; 798; 743; 709; 
663; 636. HRMS (ESI+): m/z calcd for C19H24O5 [M+Na]





A solution of 4.28 (1.036 g, 3.12 mmol) in dry THF (31 mL) 
was placed at -78°C under nitrogen atmosphere and K-
Selectride (1 M in THF, 31 mL) was added. The reaction was stirred at room 
temperature for 5 h and then it was quenched with 40 mL NH4Cl (sat) and extracted 
with AcOEt (3 x 40 mL). The organic phase was washed with brine (40 mL), dried 
(Na2SO4), and concentrated. The residue was purified by flash column 
chromatography on silica gel (ETP: AcOEt 3:1) to afford 4.19 (844 mg, 81% yield) as 
a mixture of diastereoisomers (d.r. = 74:26 anti: syn, calculated by HPLC analysis on 
the crude product). 
 




Compound 4.19 (556 mg, 1.66 mmol) was dissolved in 17 mL 
of dry THF under argon atmosphere. Then Red-Al (3.5 M in 
toluene, 1.2 mL) was added dropwise to the solution at 0°C and 
the reaction was stirred under reflux for 4 h. Then it was cooled to 0 °C and carefully 
quenched with 50 mL of 30% Rochelle salt solution and NH4Cl (sat.) 1:1. The mixture 
was stirred for 1 h and then extracted with AcOEt. The organic phase was then washed 
with brine, dried (Na2SO4), and concentrated. The residue was purified by flash 
column chromatography on silica gel (ETP: Et2O 3:1) to afford 4.29 (451 mg, 81% 
yield) as a white solid. 
 
4.29, white solid, Rf = 0.55 (ETP:AcOEt 4:1), developed with Hanessian stain.  





1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.92 – 6.80 (m, 4H, CH Ar.), 5.79 (ddd, 
J= 15.6, 6.5, 1.2 Hz, 1H, CH=CHCHOH), 5.57 (ddd, J= 15.6, 5.7, 1.2 Hz, 1H, 
CH=CHCHOH), 4.62 – 4.47 (m, 1H, CHCH2), 4.33 – 4.25 (m, 1H, CHOH), 4.19 (dd, 
J= 9.7, 6.8 Hz, 1H, CH2OPMP), 4.13 (dd, J= 7.8, 5.7 Hz, 1H, CHCHOH), 4.0 (dd, J= 
9.7, 5.5 Hz, 1H, CH2OPMP), 3.77 (s, 3H, OCH3), 2.72 (d, J= 3.6 Hz, 1H, OH), 2.45 – 
2.22 (m, 1H, CH(CH3)2), 1.47 (s, 3H, CH3 of iPr), 1.39 (s, 3H, CH3 of iPr), 1.02 (d, J= 
6.8 Hz, 3H, CH3 of CH(CH3)2), 1.01 (d, J= 6.8 Hz, 3H, CH3 of CH(CH3)2).
13C NMR 
(75 MHz, CDCl3, 25 °C, TMS):  = 154.54 (C quat. Ar), 152.22 (C quat. Ar), 140.59 
(CH=CHCHOH), 125.90 (CH=CHCHOH), 115.79 (2 CH Ar), 114.84 (2 CH Ar), 
109.02 (C(CH3)2), 80.24 (CHCHOH), 75.71 (CHCH2), 70.38 (CHOH) 67.78 
(CH2OPMP), 55.87 (OCH3), 30.98 (CH(CH3)2), 28.09 (CH3 of iPr), 25.55 (CH3 of iPr), 
22.41 (CH3 of CH(CH3)2), 22.30 (CH3 of CH(CH3)2). IR  (cm
-1) = 3487; 2990; 2957; 
2939; 2883; 2867; 2837; 1858; 1670; 1624; 1591; 1506; 1458; 1441; 1412; 1379; 
1367; 1329; 1302; 1290; 1250; 1220; 1183; 1167; 1137; 1113; 1081; 1039; 1013; 971; 
958; 936; 923; 906; 861; 822; 799; 778; 721; 669; 659; 642; 605. HRMS (ESI+): m/z 
calcd for C19H28O5 [M+Na]





Compound 4.29 (381 mg, 1.13 mmol) was dissolved in 5.7 mL 
of dry CH2CH2 under nitrogen atmosphere and 2,6-lutidine (527 
μL, 4.53 mmol) was added. Then TBS-OTf (624 μL, 2.72 mmol) was added dropwise 
to the solution at 0°C and the reaction was stirred at room temperature for 3 h. The 
reaction was quenched with 10 mL of NH4Cl (sat.) and extracted with CH2CH2 (3 x 
10 mL). The combined organic layers were dried (Na2SO4) and concentrated. The 
residue was purified by flash column chromatography on silica gel (ETP: Et2O 8:1) to 
give 4.31 (470 mg, 92%) as a colourless oil. 
 
4.31, colourless oil, Rf = 0.81 (ETP:AcOEt 4:1), developed with Hanessian stain. 
[α]25D = -26.25 (c=1.03, CHCl3). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 6.89 – 6.78 (m, 4H, CH Ar), 5.66 (ddd, 
J = 15.5, 6.6, 1.1 Hz, 1H, CH=CHCHOH), 5.38 (ddd, J = 15.5, 7.0, 1.3 Hz, 1H, 
CH=CHCHOH), 4.48 (ddd, J = 8.8, 6.4, 2.8 Hz, 1H, CHCH2), 4.39 (ddd, J = 6.6, 5.5, 
1.0 Hz, 1H, CHOTBS), 4.22 (dd, J = 10.2, 2.8 Hz, 1H, CH2OPMP), 4.11 (dd, J = 6.3, 
5.4 Hz, 1H, CHCHOH), 4.06 (dd, J = 10.2, 1.8 Hz, 1H, CH2OPMP), 3.77 (s, 3H, 
OCH3), 2.38 – 2.23 (m, 1H, CH(CH3)2), 1.47 (s, 3H, CH3 of iPr), 1.38 (s, 3H, CH3 of 
iPr), 0.99 (d, J = 6.7 Hz, 6H, 2 CH3 of CH(CH3)2), 0.90 (s, 9H, CH3 of tBu), 0.09 (s, 
3H, CH3 of TBS), 0.05 (s, 3H, CH3 of TBS). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS): 
 = 153.8 (C quat. Ar), 153.2 (C quat. Ar), 140.9 (CH=CHCHOH), 126.5 
(CH=CHCHOH), 115.6 (2 CH Ar), 114.5 (2 CH Ar), 108.5 (C(CH3)2), 79.7 





30.8 (CH(CH3)2), 27.9 (CH3 of iPr), 26.0 (3 CH3 of tBut), 25.5 (CH3 of iPr), 22.1 (CH3 
of CH(CH3)2), 22.0 (CH3 of CH(CH3)2), 18.2 (C quat of tBu), -3.6 (CH3 of TBS), -4.4 
(CH3 of TBS). IR  (cm
-1) = 2956; 2931; 2858; 1669; 1592; 1508; 1463; 1375; 1288; 
1222; 1179; 1141; 1080; 1043; 1005; 976; 939; 880; 824; 775; 736; 670. HRMS 
(ESI+): m/z calcd for C25H42O5Si [M+Na]
+: 473.2700; found: 473.2731. 
 
((4S,5S)-5-((R,E)-1-((tert-butyldimethylsilyl)oxy)-4-methyl 
pent-2-en-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)methanol  4.20 
Compound 4.31 (75 mg, 0.17 mmol) was dissolved in CH3CN (3 
mL) and a solution of CAN (1 mL, 0.4M in deionized water) was 
added dropwise at -15°C. The reaction was stirred for 15 minutes 
at -15° C. The reaction was quenched with 20 mL of a solution 1:1 NaHCO3: Na2S2O3 
and extracted with CH2CH2 (3 x 15 mL). The combined organic layers were dried 
(Na2SO4) and concentrated. The residue was purified by flash column chromatography 
on silica gel (ETP: DCM: Et2O 4:1:0.5) to afford 4.20 as a pale yellow oil (54 mg, 
94% yield). 
 
4.20, pale yellow oil, Rf = 0.18 (ETP: DCM: Et2O 4:1:0.5), developed with Hanessian 
stain. [α]24D= -17.83 (c = 1.24, CH3Cl). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 5.65 (dd, J = 15.4, 6.6 Hz, 1H, 
CH=CHCHOTBS), 5.38 (dd, J = 15.5, 7.2 Hz, 1H, CH=CHCHOTBS), 4.43 (t, J= 6.3 
Hz, 1H, CHOTBS), 4.18 (q, J = 5.7 Hz, 1H, CHCH2), 4.01 (t, J = 5.6 Hz, 1H, 
CHCHOTBS), 3.91 – 3.71 (m, 2H, CH2OH), 2.95 (t, J= 6.9 Hz, 1H, OH), 2.31 (heptd, 
J= 6.6, 1.1 Hz, 1H, CH(CH3)2), 1.44 (s, 3H, CH3 of iPr), 1.34 (s, 3H, CH3 of iPr), 0.99 
(dd, J = 6.7, 1.6 Hz, 6H, 2 CH3 of CH(CH3)2), 0.89 (s, 9H, 3 CH3 of tBu), 0.11 (s, 1H, 
CH3 of TBS), 0.07 (s, 1H, CH3 of TBS). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  
= 141.43 (CH=CHCHOH), 126.17 (CH=CHCHOH), 108.05 (C(CH3)2), 79.76 
(CHCHOTBS), 77.80 (CHCH2), 72.92 (CHOTBS), 61.71 (CH2OH), 30.87 
(CH(CH3)2), 27.93 (CH3 of iPr), 25.97 (3 CH3 of tBut), 25.78 (CH3 of iPr), 22.23 (CH3 
of CH(CH3)2), 22.04 (CH3 of CH(CH3)2), 18.31 (C quat of tBu), -3.73 (CH3 of TBS), 






Colourless oil, Rf = 0.32 (ETP: Et2O 1:2), developed with 
Hanessian stain. [α]22D= + 23.83 (c = 1.19, CH3Cl) 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 5.77 (dd, J = 15.6, 
6.5 Hz, 1H, CH=CHCHOTBS), 5.54 (ddd, J = 15.6, 6.2, 1.0 Hz, 1H, 
CH=CHCHOTBS), 4.37 – 4.23 (m, 2H, CHOTBS and CHCH2), 4.04 (dd, J = 8.0, 5.8 
Hz, 1H, CHCHOTBS), 3.92 – 3.71 (m, 2H, CH2OH), 3.18 (broad s, 1H, OH), 2.99 





iPr), 1.36 (s, 3H, CH3 of iPr), 1.02 (d, J = 6.7 Hz, 6H, 2 CH3 of CH(CH3)2). 
13C NMR 
(75 MHz, CDCl3, 25 °C, TMS);  = 141.19 (CH=CHCHOH), 126.17 
(CH=CHCHOH), 108.50 (C(CH3)2), 79.81 (CHCHOH), 77.54 (CHCH2), 70.81 
(CHOH), 61.01 (CH2OH), 30.95 (CH(CH3)2), 27.91 (CH3 of iPr), 25.50 (CH3 of iPr), 
22.35 (CH3 of CH(CH3)2), 22.25 (CH3 of CH(CH3)2). ). IR  (cm
-1) = 3345; 2959; 
2935; 2871; 1460; 1376; 1245; 1218; 1167; 1132; 1070; 1038; 971; 920; 886; 854; 
794. HRMS (ESI+): m/z calcd for C11H12O4 [M+Na]
+: 253.1416; found: 253.1398. 
 
4.4.2.4 Synthesis of isocyanide 
 
(S)-N-(2-oxoazepan-3-yl)formamide 4.34 
To a solution of L -(−)-α-amino-ε-caprolactam hydrochloride 4.33 (500 
mg, 3.04 mmol) in dry CH2Cl2 (15.2 mL) under nitrogen atmosphere, 
Et3N (591 µL, 4.25 mmol) was added. Then, formic acid (183 μL, 4.86 
mmol) and DCC (277 mg, 4.25 mmol) were added e to the solution at 0°C and the 
reaction was stirred at room temperature for 19 h. The mixture was filtered through a 
pad of celite, washing with CH2Cl2 and the solvent was removed under reduced 
pressure. The residue was purified by flash column chromatography on silica gel 
(AcOEt + 2% MeOH and AcOEt + 10% MeOH) to afford 4.34 as a white amorphous 
solid (428 mg, 90% yield). 
 
4.34, white amorphous solid, Rf = 0.42 (DCM: MeOH 9:1), developed with Hanessian 
stain. [α]22D= - 8.48 (c = 1.01, CH3Cl). 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 8.20 (s, 1H, CHO), 7.14 (s, 1H, NH), 
6.50 (s, 1H, NH), 4.61 (dd, J= 11.1, 6.2 Hz, 1H, CHNH), 3.33 –3.24 (m, 2H, CH2NH), 
2.19 –2970 (m, 2H, CH2 of caprolactam), 1.94 –1.75 (m, 2H, CH2 of caprolactam), 
1.61–1.32 (m, 2H, CH2 of caprolactam). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS);  
= 175.1 (C=O), 160.2 (CHO), 51.0 (CHNH), 42.1 (CH2NH), 31.5 (CH2 of 
caprolactam), 28.8 (CH2 of caprolactam), 27.9 (CH2 of caprolactam). IR  (cm
-1) = 
3268; 3089; 2972; 2912; 2866; 2850; 1695; 1628; 1517; 1482; 1437; 1381; 1370; 
1361; 1335; 1316; 1292; 1278; 1222; 1212; 1122; 1092; 1057; 1043; 978; 946; 910; 
851; 835; 804; 759; 726; 660. HRMS (ESI+): m/z calcd for C7H12N2O2 [M+Na]
+: 
179.9797: found: 179.9856. 
 
(S)-3-isocyanoazepan-2-one 4.35 
Compound 4.34 (250 mg, 1.60 mmol) was dissolved in dry CH2Cl2 (8 mL) 
under nitrogen atmosphere. Et3N (1.05 mL, 7.52 mmol) and POCl3 (228 
µL, 2.40 mmol) were added dropwise at -30°C. The reaction was stirred 
for 1.30 h at -30° C. Then it was quenched with 40 mL of NaHCO3 (sat.) extracted 
with AcOEt (3 x 30 mL). The combined organic layers were dried (Na2SO4) and 
concentrated. The residue was purified by flash column chromatography on silica gel 





4.35, white amorphous solid, Rf = 0.63 (DCM: MeOH 9:1), developed with Hanessian 
stain. [α]24D= -11.2 (c = 1.03, CH3Cl) 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = (s, 1H, NH), 4.49 (d, J= 9.6 Hz, 1H, 
CHNC), 3.47 –3.31 (m,1H, CH2NH), 3.12 (ddd, J= 15.5, 10.1, 5.7Hz, 1H, CH2NH), 
2.21 –1.96 (m, 3H, H of caprolactam), 1.85 –1.68 (m, 2H, H of caprolactam), 1.66 –
1.48 (m, 1H, H of caprolactam). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 170.0 
(C=O), 159.4 (NC), 57.7 (CHNC), 41.5 (CH2NH), 31.2 (CH2 of caprolactam), 28.4 
(CH2 of caprolactam), 26.7 (CH2 of caprolactam). IR  (cm
-1) = 3328; 3223; 3099; 
2992; 2948; 2925; 2858; 2148; 1670; 1478; 1466; 1436; 1428; 1359; 1331; 1323; 
1291; 1274; 1248; 1111; 1092; 1075; 1038; 1015; 964; 944; 885; 823; 789; 776; 687. 
HRMS (ESI+): m/z calcd for C7H10N2O2 [M+Na]
+: 161.0691; found: 161.0634. 
 





ethyl acetate 4.37 
Swern oxidation 
Aldehyde 4.36 was prepared employing the same procedure of 4.19 from alcohol 4.20 
(65 mg, 0.19 mmol). Rf = 0.81 (ETP: Et2O 3:1), developed with Hanessian stain. 
Passerini reaction 
To a solution of crude aldehyde 4.36 (0.19 mmol) in iPr2O (500 μL, dried over 
molecular sieves 4Ǻ) under nitrogen atmosphere, acetic acid (22 μL, 0.39 mmol) and 
isocyanide 4.32 (53 mg, 0.39 mmol) were added. The reaction was stirred at room 
temperature for 21 h. The reaction solvent was removed by evaporation under reduced 
pressure and the residue was filtered on silica gel (ETP: AcOEt 3:4) and directly used 
for the next reaction.  
 
4.37_anti pale yellow solid; Rf = 0.57 (ETP: AcOEt 1:5), developed with Hanessian 
stain. [α]19D= -22.9 (c = 0.98, CHCl3). 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 7.33 (d, J = 5.6 Hz, 1H, NHCH), 6.07 
(t, J = 6.1 Hz, 1H, NHCH2), 5.67 (dd, J = 15.6, 6.0 Hz, 1H, CH=CHCHOTBS), 5.54 
(ddd, J = 15.6, 7.9, 1.0 Hz, 1H, CH=CHCHOTBS), 5.23 (d, J = 7.4 Hz, 1H, CHOAc), 
4.64 (dd, J = 7.8, 4.5 Hz, 1H, CHOTBS), 4.59 – 4.46 (m, 1H, CHNH), 4.40 (dd, J = 
7.3, 6.1 Hz, 1H, CHCHOAc), 4.09 (dd, J = 5.9, 4.5 Hz, 1H, CHCHOTBS), 3.36 – 3.12 
(m, 2H, CH2NH), 2.40 – 2.20 (m, 1H, CH(CH3)2), 2.12 (s, 3H, CH3 of OAc), 2.04 – 
1.56 (m, 6H, 3 CH2 of caprolactam), 1.43 (d, J = 1.0 Hz, 3H, CH3 of iPr), 1.32 (s, 3H, 
CH3 of iPr), 1.01 (dd, J = 6.7, 1.0 Hz, 6H, 2 CH3 of CH(CH3)2), 0.87 (s, 9H, 3 CH3 of 
tBu), 0.11 (s, 3H, CH3 of TBS), 0.05 (s, 3H, CH3 of TBS). 
13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 175.16 (C=ONH), 169.36 (C=ONH), 167.43 (OC=O), 141.55 
(CH=CHCHOTBS), 126.82 (CH=CHCHOTBS), 108.68 (C(CH3)2), 80.73 
(CHCHOTBS), 76.16 (CHCHOAc), 73.34 (CHOTBS), 72.83 (CHOAc), 52.30 





of caprolactam), 28.00 (CH2 of caprolactam), 27.45 (CH3 of iPr), 26.08 (3 CH3 of tBu), 
25.34 (CH3 of iPr), 22.27 (CH3 of CH(CH3)2), 22.01 (CH3 of CH(CH3)2), 21.01 (CH3 
of OAc), 18.46 (C quat of tBu), - 3.69 (CH3 of TBS), - 4.31 (CH3 of TBS). HRMS 
(ESI+): m/z calcd for C27H48N2O7Si [M+Na]
+: 563.3129; found: 563.3138. 
 
4.37_syn pale yellow oil; Rf = 0.60 (ETP: AcOEt 1:5), developed with Hanessian stain 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 7.36 (d, J = 7.0 Hz, 1H, NHCH), 5.93 
– 5.77 (m, 1H, NHCH2), 5.59 (dd, J = 15.5, 5.9 Hz, 1H, CH=CHCHOTBS), 5.43 (d, J 
= 1.2 Hz, 1H, CHOAc), 5.34 (ddd, J = 15.3, 8.2, 1.6 Hz, 1H, CH=CHCHOTBS), 4.62 
(dd, J = 6.4, 1.2 Hz, 1H,  CHCHOAc), 4.54 – 4.40 (m, 1H, CHNH), 4.11 (dd, J = 9.2, 
6.2 Hz, 1H, CHCHOTBS), 4.02 – 3.88 (m, 1H, CHOTBS), 3.34 – 3.08 (m, 2H, 
CH2NH), 2.43 – 2.24 (m, 1H, CH(CH3)2), 2.24 (s, 3H, CH3 of OAc), 2.19 – 1.75 (m, 
6H, 3 CH2 of caprolactam), 1.32 (s, 3H, CH3 of iPr), 1.25 (s, 3H, CH3 of iPr), 1.02 (dd, 
J = 6.8, 4.2 Hz, 6H, 2 CH3 of CH(CH3)2), 0.89 (s, 9H, 3 CH3 of tBu) 0.09 (s, 3H, CH3 
of TBS), 0.03 (s, 3H, CH3 of TBS). HRMS (ESI+): m/z calcd for C27H48N2O7Si 






Triethylamine (200 μL) and H2O (200 μL) were added to a stirred solution of 4.37 
crude (0.19 mmol) in MeOH (1 mL). The mixture was stirred at room temperature for 
2 d. When the reaction was completed (monitored by HPLC analysis), the solvent was 
removed by evaporation under reduced pressure and the residue was purified by flash 
column chromatography on silica gel (Et2O: ETP 20:1) to afford 4.21_anti and 
4.21_syn as a mixture of diastereoisomers (d.r. = 80: 20 calculated by HPLC analysis 
on the crude product) (70 mg, 74% yield in three steps). 
 
4.21_anti, pale yellow oil, Rf = 0.35 ((Et2O: ETP 20:1) developed with Hanessian 
stain. [α]20D= +16.96 (c = 0.95, CH3Cl). 
1H NMR (300 MHz, CDCl3, 25 °C,TMS): δ = 7.78 (d, J = 6.5 Hz, 1H, NHCH), 6.18 
(broad s, 1H, NHCH2), 5.62 (dd, J = 15.5, 6.6 Hz, 1H, CH=CHCHOTBS), 5.46 (dd, J 
= 15.5, 7.8 Hz, 1H, CH=CHCHOTBS), 4.63 – 4.51 (m, 3H, CHNH, OH and 
CHOTBS), 4.29 – 4.16 (m, 2H, CHCHOH and CHCHOH), 4.05 (t, J = 4.5 Hz, 1H, 
CHCHOTBS), 3.33 – 3.13 (m, 2H, CH2NH), 2.41 – 2.18 (m, 1H, CH(CH3)2), 2.18 – 
1.71 (m, 5H, H of caprolactam), 1.50 (s, 3H, CH3 of iPr), 1.48 – 1.32 (m, 1H, H of 
caprolactam), 1.32 (s, 3H, CH3 of iPr), 0.98 (dd, J = 6.8, 1.1 Hz, 6H, 2 CH3 of 
CH(CH3)2), 0.89 (s, 9H, 3 CH3 of tBu), 0.12 (s, 3H, CH3 of TBS), 0.09 (s, 3H, CH3 of 
TBS). 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 175.49 (C=ONH), 170.58 
(C=ONH), 142.02 (CH=CHCHOTBS), 125.92 (CH=CHCHOTBS), 108.47 
(C(CH3)2), 80.83 (CHCHOTBS), 77.93 (CHCHOH), 73.61 (CHOTBS), 70.17 
(CHCHOH), 52.15 (CHNH), 42.05 (CH2NH), 31.43 (CH2 of caprolactam), 30.85 





iPr), 25.92 (3 CH3 of tBu), 25.62 (CH3 of iPr), 22.09 (CH3 of CH(CH3)2), 21.93 (CH3 
of CH(CH3)2), 18.26 (C quat of tBu), - 3.92 (CH3 of TBS), - 4.35 (CH3 of TBS). IR 
 (cm-1) = 3462; 3346; 2956; 2931; 2858; 1685; 1598; 1525; 1463; 1375; 1254; 1215; 
1168; 1069; 1045; 974; 834; 800; 777; 667. HRMS (ESI+): m/z calcd for C25H46N2O6Si 
[M+Na]+:521.3023; found: 521.3018. 
 
4.21_syn, pale yellow foam Rf = 0.25 ((Et2O: ETP 20:1) developed with Hanessian 
stain. [α]22D= -33.85 (c = 1.20, CH3Cl). 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 7.98 (d, J = 7.0 Hz, 1H, NHCH), 6.16 
(broad s, 1H, NHCH2), 5.72 (dd, J = 15.6, 6.9 Hz, 1H, CH=CHCHOTBS), 5.38 (dd, J 
= 15.5, 6.1 Hz, 1H, CH=CHCHOTBS), 4.68 (t, J = 4.9 Hz, 1H, CHOTBS), 4.63 – 4.48 
(m, 3H, CHNH, OH and CHCHOH), 4.29 (d, J = 2.2 Hz, 1H, CHCHOH), 4.17 (dd, J 
= 6.5, 4.4 Hz, 1H, CHCHOTBS), 3.40 – 3.13 (m, 2H, CH2NH), 2.41 – 2.27 (m, 1H, 
CH(CH3)2), 2.16 – 1.65 (m, 5H, H of caprolactam), 1.61 – 1.51 (m, 1H, H of 
caprolactam) 1.49 (s, 3H, CH3 of iPr), 1.32 (s, 3H, CH3 of iPr) 0.99 (d, J = 6.7 Hz, 6H, 
2 CH3 of CH(CH3)2), 0.92 (s, 9H, 3 CH3 of tBu), 0.14 (s, 3H, CH3 of TBS), 0.11 (s, 
3H, CH3 of TBS). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 175.65 (C=ONH), 
170.79 (C=ONH), 141.25 (CH=CHCHOTBS), 124.63 (CH=CHCHOTBS), 108.35 
(C(CH3)2), 79.24 (CHCHOTBS), 77.77 (CHCHOH), 72.45 (CHOTBS), 71.50 
(CHCHOH), 51.92 (CHNH), 42.28 (CH2NH), 31.94 (CH2 of caprolactam), 30.99 
(CH(CH3)2), 29.18 (CH2 of caprolactam), 28.17 (CH2 of caprolactam), 26.35 (CH3 of 
iPr), 25.96 (3 CH3 of tBu), 25.49 (CH3 of iPr), 22.25 (CH3 of CH(CH3)2), 22.22 (CH3 
of CH(CH3)2), 18.56 (C quat of tBu), -4.22 (CH3 of TBS), -4.73 (CH3 of TBS). HRMS 
(ESI+): m/z calcd for C25H46N2O6Si [M+Na]
+:521.3023; found: 521.3018. 
 






A solution of 4.21_anti (95 mg, 0.19 mmol) in dry THF (1 mL) under Ar atmosphere 
was cooled at -10°C. NaH (60% in silicon oil, 4.5 mg, 0.09 mmol) was added and the 
mixture was stirred for 30 minutes. Then MeI (18 µL, 0.19 mmol) was added and the 
reaction was stirred at -10°C. After 6 h other 0.6 eq of NaH were added and the reaction 
mixture was stirred for 18 h at -10°C. The reaction was quenched with 5 mL of NH4Cl 
(sat) and extracted with DCM (3 x 5 mL). The combined organic layers were washed 
with LiCl (4 x 5 mL), dried (Na2SO4) and concentrated. From HPLC analysis, a 
starting material; product ratio of 45:55 was observed and no formation of side-
products. Therefore, the reaction has been set up again using dry DMF as solvent (1 
mL), NaH (8 mg, 0.19 mmol) and MeI (18 µL, 0.19 mmol). After 21 h the reaction 





HPLC analysis, resulting in 5:95. The residue was purified by flash column 
chromatography on silica gel (ETP: Et2O 1:20) to give 4.38 (58 mg, 59%) as a 
colourless oil. 
 
4.38, colourless oil, Rf = 0.31 ((Et2O + 2% AcOEt) developed with Hanessian stain. 
[α]22D= + 6.24 (c = 1,73 CH3Cl). 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 7.53 (d, J = 6.2 Hz, 1H, NHCH), 6.02 
(t, J = 6.5 Hz, 1H, NHCH2), 5.72 – 5.49 (m, 2H, CH=CHCHOTBS and 
CH=CHCHOTBS), 4.67 – 4.52 (m, 2H, CHNH and CHOTBS), 4.25 – 4.18 (m, 1H, 
CHCHOTBS), 4.14 – 4.08 (m, 1H, CHCHOCH3), 4.05 (d, J = 7.0 Hz, 1H, CHOCH3), 
3.34 (s, 3H, OCH3), 3.30 – 3.15 (m, 2H, CH2NH), 2.32 (m, 1H, CH(CH3)2), 2.15 – 
1.76 (m, 6H, 3 CH2 of caprolactam), 1.41 (s, 3H, CH3 of iPr), 1.29 (s, 3H, CH3 of iPr), 
1.01 (dd, J = 6.7, 2.3 Hz, 6H, 2 CH3 of CH(CH3)2), 0.90 (d, J = 2.5 Hz, 9H, 3 CH3 of 
tBu), 0.10 (s, 3H, CH3 of TBS), 0.07 (s, 3H, CH3 of TBS). 
13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 175.27 (C=ONH), 169.64 (C=ONH), 140.86 (CH=CHCHOTBS), 
127.28 (CH=CHCHOTBS), 108.55 (C(CH3)2), 81.04 (CHCHOCH3), 80.86 
(CHOCH3), 77.36 (CHCHOTBS), 73.33 (CHOTBS), 57.45 (OCH3), 51.98 (CHNH), 
42.23 (CH2NH), 31.54 (CH2 of caprolactam), 30.88 (CH(CH3)2), 29.11 (CH2 of 
caprolactam), 28.02 (CH2 of caprolactam), 27.22 (CH3 of iPr), 26.14 (3 CH3 of tBu), 
25.27 (CH3 of iPr), 22.43 (CH3 of CH(CH3)2), 22.04 (CH3 of CH(CH3)2), 18.48 (C quat 
of tBu), -3.48 (CH3 of TBS), -4.25 (CH3 of TBS). IR  (cm
-1) = 3383; 3292; 2955; 
2930; 2858; 1714; 1662; 1504; 1474; 1435; 1362; 1334; 1250; 1217; 1169; 1103; 
1073; 1047; 1017; 972; 941; 899; 875; 834; 808; 776; 754; 666. HRMS (ESI+): m/z 
calcd for C25H46N2O6Si [M+Na]






Colourless oil, Rf = 0.38 ((Et2O + 2% AcOEt) developed with Hanessian stain. 
 [α]22D= + 1.60 (c = 0.63 CH3Cl). 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 7.61 (d, J = 6.0 Hz, 1H, NHCH), 5.78 
– 5.46 (m, 2H, CH=CHCHOTBS and CH=CHCHOTBS), 4.70 (dd, J = 9.5, 6.3 Hz, 
1H, CHNH), 4.56 (dd, J = 6.4, 4.3 Hz, 1H, CHOTBS), 4.20 (dd, J = 7.4, 6.2 Hz, 1H, 
CHCHOTBS), 4.08 (dd, J = 6.0, 4.2 Hz, 1H, CHCHOCH3), 4.02 (d, J = 7.5 Hz, 1H, 
CHOCH3), 3.61 (dd, J = 15.3, 11.6 Hz, 1H, CH2NCH3), 3.33 (s, 3H, OCH3), 3.18 (dd, 
J = 15.0, 4.5 Hz, 1H, CH2NCH3), 3.04 (s, 3H, NCH3), 2.31 (dt, J = 12.0, 6.0 Hz, 1H, 
CH(CH3)2), 2.12 (d, J = 12.7 Hz, 1H, H of caprolactam), 2.00 – 1.72 (m, 4H, 2 CH2 of 
caprolactam), 1.42 (s, 3H, CH3 of iPr), 1.39-1.32 (m, 1H, H of caprolactam), 1.29 (s, 
3H, CH3 of iPr), 1.01 (dd, J = 6.7, 1.9 Hz, 6H, 2 CH3 of CH(CH3)2), 0.90 (s, 9H, 3 CH3 
of tBu), 0.10 (s, 3H, CH3 of TBS), 0.07 (s, 3H, CH3 of TBS). 
13C NMR (75 MHz, 





(CH=CHCHOTBS), 127.27 (CH=CHCHOTBS), 108.47 (C(CH3)2), 81.21 
(CHCHOCH3), 80.82 (CHOCH3), 77.46 (CHCHOTBS), 73.30 (CHOTBS), 57.34 
(OCH3), 51.95 (CHNH), 50.52 (CH2NMe), 36.04 (NCH3), 31.72 (CH2 of 
caprolactam), 30.89 (CH(CH3)2), 27.81 (CH2 of caprolactam), 27.32 (CH3 of iPr), 
26.79 (CH2 of caprolactam), 26.15 (3 CH3 of tBu), 25.34 (CH3 of iPr), 22.45 (CH3 of 
CH(CH3)2), 22.09 (CH3 of CH(CH3)2), 18.51 (C quat of tBu), -3.61 (CH3 of TBS), -
4.28 (CH3 of TBS). IR  (cm
-1) = 3388; 2955; 2930; 2858; 2246; 1648; 1495; 1461; 
1403; 1381; 1370; 1339; 1251; 1214; 1157; 1138; 1102; 1075; 1047; 1016; 973; 910; 
879; 834; 808; 777; 729; 646. HRMS (ESI+): m/z calcd for C27H50N2O6Si 






Colourless oil, Rf = 0.33 (Et2O + 2% AcOEt) developed with Hanessian stain. 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 7.87 (d, J = 5.8 Hz, 1H, NHCH), 5.63 
(dd, J = 15.3, 6.8 Hz, 1H, CH=CHOTBS), 5.55 – 5.41 (m, 1H, CH=CHOTBS), 4.74 – 
4.62 (m, 1H, CHNH), 4.62 – 4.54 (m, 1H, CHOTBS), 4.53 (d, J = 3.6 Hz, 1H, CHOH), 
4.21 (dd, J = 7.2, 4.4 Hz, 2H, CHCHOTBS and OH), 4.06 (t, J = 4.7 Hz, 1H, 
CHCHOH), 3.65 – 3.52 (m, 1H, CH2NCH3), 3.25 – 3.10 (m, 1H, CH2NCH3), 3.03 (s, 
3H, NCH3), 2.42 – 2.14 (m, 1H, CH(CH3)2), 2.19 – 1.67 (m, 4H, H of caprolactam), 
1.52 (s, 3H, CH3 of iPr), 1.48 – 1.36 (m, 2H, H of caprolactam) 1.33 (s, 2H, CH3 of 
iPr), 1.00 (dd, J = 6.7, 1.8 Hz, 6H, 2 CH3 of CH(CH3)2), 0.90 (s, 9H, 3 CH3 of tBu), 
0.13 (s, 3H, CH3 of TBS), 0.11 (s, 3H, CH3 of TBS). HRMS (ESI+): m/z calcd for 
C24H48N2O6Si [M+Na]





Compound 4.38 (38 mg, 0.07 mmol) was solubilized in 
THF (400 µL) and HCl 1M (800 µL) was added. The reaction was stirred for 6 h at 
room temperature. The reaction was quenched with NaHCO3 (sat.) (pH =9) and 
extracted with AcOEt (3 x 5 mL). The combined organic layers were dried (Na2SO4) 
and concentrated. The residue was purified by flash column chromatography on silica 
gel (AcOEt + 2% MeOH and AcOEt: MeOH 9:1) to afford 4.22 as a pale yellow foam 
(9.4 g, 35% yield).  
 
4.22, pale yellow foam, Rf = 0.42 (AcOEt + 2% MeOH) developed with Hanessian 
stain. [α]22D= +34.5 (c = 0.30, CH3Cl).  
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 7.63 (d, J = 7.0 Hz, 1H, NHCH), 6.22 





(ddd, J = 15.6, 7.2, 1.3 Hz, 1H, CH=CHCHOH), 4.59 (dd, J = 10.3, 7.0 Hz, 1H, 
CHNH), 4.26 (t, J = 5.26, 1H CH=CHCHOH), 4.07 (d, J = 3.3 Hz, 1H, CHOCH3), 
4.07 – 3.95 (m, 1H, CHCHOCH3), 3.77 (d, J = 4.7 Hz, 1H, CH(OH)CH(OH)CH(OH)), 
3.62 (d, J = 8.2 Hz, 1H, CH(OH)CH(OH)CH(OH)), 3.49 (s, 3H, OCH3), 3.49 (s, 1H, 
CH(OH)CHOCH3), 3.39 – 3.18 (m, 2H, CH2NH), 2.77 (broad s, 1H CH=CHCHOH,), 
2.33 (dq, J = 13.4, 6.8 Hz, 1H, CH(CH3)2), 2.13 – 1.98 (m, 3H, H of caprolactam), 
1.96 – 1.72 (m, 1H, H of caprolactam), 1.64 – 1.31 (m, 2H, H of caprolactam)., 1.01 
(d, J = 6.8 Hz, 6H, 2 CH3 of CH(CH3)2). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  
= 175.25 (C=ONH), 170.68 (C=ONH), 141.76 (CH=CHCHOH), 125.25 
(CH=CHCHOH), 82.60 (CHOCH3), 74.65 (CH=CHCHOH), 74.01 
(CH(OH)CH(OH)CH(OH)), 72.99 (CHCHOCH3), 58.88 (OCH3), 52.45 (CHNH), 
42.23 (CH2NH), 30.99 (CH(CH3)2), 30.76 (CH2 of caprolactam), 28.94 (CH2 of 
caprolactam), 28.09 (CH2 of caprolactam), 22.47 (CH3 of CH(CH3)2), 22.34 (CH3 of 
CH(CH3)2). IR  (cm
-1) = 3334; 2956; 2930; 2868; 1639; 1519; 1483; 1437; 1361; 
1334; 1291; 1261; 1066; 973; 943; 893; 800; 720. HRMS (ESI+): m/z calcd for 
C17H30N2O6 [M+Na]




Colourless oil, Rf = 0.81 ((AcOEt + 2% MeOH) developed with 
Hanessian stain. 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 5.82 (ddd, J = 15.8, 
6.8, 2.1 Hz, 1H, CH=CHCHO), 5.45 (ddd, J = 15.9, 4.1, 1.3 Hz, 1H, CH=CHCHO), 
5.02 (d, J = 1.8 Hz, 1H, CH=CHCHO), 4.82 (dd, J = 7.6, 3.5 Hz, 1H, CHCHOCH3), 
4.56 (dd, J = 7.6, 1.1 Hz, 1H, CH=CHCHCH), 4.07 (d, J = 3.5 Hz, 1H, CHOCH3), 
3.63 (s, 3H, OCH3), 2.37 (dq, J = 13.5, 6.8 Hz, 1H, CH(CH3)2), 1.50 (s, 3H, CH3 of 
iPr), 1.36 (s, 3H, CH3 of iPr), 1.02 (d, J = 6.7 Hz, 6H, 2 CH3 of CH(CH3)2). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 168.57 (C=O), 142.67 (CH=CHCHO), 
121.32 (CH=CHCHO), 111.00 (CH(CH3)2), 79.67 (CH=CHCHO), 76.16 (CHOCH3), 
75.71 (CH=CHCHCH), 74.77 (CHCHOCH3), 59.88 (OCH3), 31.29 (CH(CH3)2), 
26.24 (CH3 of iPr), 24.41 (CH3 of iPr), 22.05 (CH3 of CH(CH3)2), 21.96 (CH3 of 







Colourless oil, Rf = 0.38 (AcOEt + 2% MeOH) developed 
with Hanessian stain. 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 7.51 (d, J = 6.3 Hz, 1H, NHCH), 6.04 
(t, J = 6.0 Hz, 1H, NHCH2), 5.83 (dd, J = 15.6, 6.5 Hz, 1H, CH=CHCHOH), 5.56 (dd, 





(dd, J = 7.9, 5.1 Hz, 1H, CHCHOCH3), 4.24 – 4.15 (m, 1H, CHOH), 4.03 (dd, J = 9.0, 
5.2 Hz, 1H, CHCHOH), 3.92 (d, J = 8.0 Hz, 1H, CHOCH3), 3.68 (d, J = 3.4 Hz, 1H, 
OH), 3.45 (s, 3H, OCH3), 3.29 (dd, J = 10.3, 5.0 Hz, 2H, CH2NH), 2.45 – 2.23 (m, 1H, 
CH(CH3)2), 2.26 – 1.76 (m, 5H, H of caprolactam), 1.57 – 1.41 (m, 1H, H of 
caprolactam) 1.48 (s, 3H, CH3 of iPr), 1.32 (s, 3H, CH3 of iPr), 1.02 (d, J = 6.7 Hz, 6H, 
2 CH3 of CH(CH3)2). 
13C NMR (75 MHz, CDCl3, 25 °C, TMS): δ = 175.16 (C=ONH), 
168.57 (C=ONH), 139.85 (CH=CHCHOH), 126.01 (CH=CHCHOH), 109.46 
(C(CH3)2), 81.24 (CHCHOCH3), 81.04 (CHCHOCH3), 77.46 (CHCHOH), 69.21 
(CHOH), 58.36 (OCH3), 52.20 (CHNH), 42.30 (CH2NH), 31.43 (CH2 of caprolactam), 
30.99 (CH(CH3)2), 29.06 (CH2 of caprolactam), 28.01 (CH2 of caprolactam), 27.93 
(CH3 of iPr), 25.64 (CH3 of iPr), 22.51 (CH3 of CH(CH3)2), 22.39 (CH3 of CH(CH3)2). 
HRMS (ESI+): m/z calcd for C20H34N2O6 [M+Na]
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Bio-based building blocks in 




In this section, the second part of my doctoral research, carried out at the 
University of Stellenbosch (South Africa), will be discussed.  
In the time period occurring between 27th January 2019 and 27th July 2019, I 
had the pleasure of working in the group of Prof. Bert Klumperman and Dr. Rueben 
Pfukwa, at Stellenbosch University, in South Africa.  
During the internship, I was assigned to a project dedicated to the synthesis of 
a lactam- based monomer derived from bio-based starting materials and its subsequent 




This work was included in the Project “Synthesis, Characterization, Structure 
and Properties of Novel Biodegradable Polyesters (BIODEST)” that is funded under 







CHAPTER 5.  





5.1.1 BIODEST Programme 
 
BIODEST (Synthesis, Characterization, Structure and Properties of Novel 
Biodegradable Polyesters)[1] is a RISE (Research and Innovation Staff Exchange) 
project that promotes student and staff exchanges between European Research and 
non-EU Research partners and collaborators with the aim to improve skills and 
knowledge in the topic of novel biodegradable polyesters. The programme involves 
nine academic organizations (University of the Basque Country in Spain, University 
of Mons in Belgium, University of Genova in Italy, University of Warwick in U.K., 
University of Tulane in USA, Chinese Academy of Science in China, Simon Bolivar 
University in Venezuela, University of Stellenbosch in South Africa and Yamagata 





Figure 5.1 BIODEST consortium 
 
In detail, BIODEST project has as its objective the green production of novel 
sustainable plastics. It aims to contribute to preserve our environment by synthesizing 
or formulating bio-based and biodegradable polyesters (or copolyesters) that can 
substitute traditional plastics in commodity applications (like the ubiquitous plastic 
bags or water bottles) or biomedical applications (like drug delivery vehicles, devices 





The research activity in BIODEST project is divided into five Work Packages 




 Figure 5.2 Work packages in BIODEST Project 
 
The work of Free Radical group in the project belongs to Work Package 5 
(Study of synthesized materials for tissue engineering scaffolds, drug delivery and 
regenerative medicine applications). The general objective of this task involves the 
study of self-assembly of synthesized polymers for drug delivery applications and the 
production of polyesters and copolyesters that can be applied in the tissue engineering 
field. In this context, the role of Klumperman’s groups in the RISE project is 
summarized in the following three points: 1) Synthesis of lactam-based polymers-
polyester block copolymers drug delivery vehicles. 2) Development of antimicrobial 
nanofiber mats from functional polyesters. 3) Application of degradable polyesters in 
advanced macromolecular architectures. 
Related to this, the project in which I was involved during my secondment, 
focused the synthesis of degradable bio-based block copolymers composed of lactam-
based polymers and of polyesters, that can find application in drug delivery polymer 
materials. 
 
5.1.2 Lactam based polymers 
 
Lactams-based polymers present some important features, such as water 
solubility, biocompatibility, hydrogen bonding and coordination capacity that make 
them important in various application in the food, pharmaceutical and cosmetic 





group capable of forming hydrogen bonds, whereas the methylene group of the 
backbone have a non- polar character. As a result, lactam-based polymers are generally 
soluble in water and in a range of organic solvent.  
Most literature reports utilise N-substituted vinyl pyrrolidone, the preeminent 
example being poly(N-vinylpyrrolidone) (PVP), the polymer of N-vinylpyrrolidone 
(NVP) (Scheme 5.1). The high versatility of PVP can be explained by its diverse 
properties including its solubility in water and in a broad range of liquid media, high 
chemical and thermal resistance, and unique wetting, binding, and film-forming 
properties. Thanks to biocompatibility, absence of toxicity and high capacity to form 
interpolymer complexes, PVP is widely used for designing materials for different 




Scheme 5.1 NVP and PVP 
 
A much less reported system of pyrrolidone functional polymers is based on 
monomers in which the vinyl/methylene group is directly attached to the pyrrolidone 
ring in position 3 (Scheme 5.2, 3-methylene-2- pyrrolidone (3M2P) based monomers). 
Even though the 3M2P class of polymers did exhibit very interesting properties, regard 
to its aqueous solubility, non-toxicity, superior thermal properties and possibility of 
copolymerization, very few reports have been dedicated to the fundamental 
characterization of 3M2P-based polymers.  
In a previous work, conducted in Klumperman’s group, the synthesis and 
polymerization (by free radical and RAFT mechanism) of 3M2P monomer[3] and the 
thermoresponsive behaviour of poly(3M2P) polymers had been studied[4]. Then, the 
application of 3M2P derivatives as commercial low dosage hydrate inhibitors in the 
oil and gas industry has been evaluated[5]. Finally, the feasibility of using poly(3M2P) 




Scheme 5.2 3M2P 
 
Due to the importance of these kind of polymers, i.e. water soluble, 
biocompatible, it might be interesting to synthesize new 3M2P- based monomers and 





5.1.3 Research plan 
 
Among the possible lactam-based monomers, the work was carried out on 3-
methylene-2-piperidone (3M2Pip), which can be obtained from the reaction between 
diethyl malonate and acrylonitrile (Scheme 5.3). These are considered bio-based 
compounds since they derived from 3-hydroxypropionic acid (3-HP), a cellulose C3 




Scheme 5.3 3M2Pip from bio-based starting materials 
 
Malonic acid is a standard component for many products and processes in the 
petrochemical, pharmaceutical, and cosmetics industries. It is used as a precursor in 
speciality polyesters and polymers and it is used to control acidity by either acting as 
an excipient in pharmaceutical drug formulations or as a natural preservative additive 
for foods[7]. Acrylonitrile is a very important, versatile monomer and chemical 
intermediate, with many commercial applications. It is used in the production of fibres 
(carpets, draperies, fabrics, nylons), resins (polyacrylates automotive industry), and 
many speciality products (paints, caulking materials, cosmetics, etc.). 
Considering the importance of this bio-based lactam moiety, we have a long 
term interest in the synthesis and polymerization of 3-methylene-2-piperidone 
(3M2Pip) monomers, targeting the synthesis of well-defined hydroxyl end functional 
P(3M2Pip), i.e. HO-P(3M2Pip). Once obtained, HO-P(3M2Pip) can be used as a 
macro-initiator for the synthesis of degradable polyester second blocks, applicable in 
drug delivery polymer materials. 
In earlier work, in the Klumperman group, 3M2Pip was synthesized by the 
colleague Dr. Ingrid Heyns (more details about her work are discussed in Paragraphs 
5.2.1) and subsequently polymerized via FRP; however, monomer synthesis was 
achieved in low yields, and was not optimized. Therefore, this project mainly focused 
on two objectives, shown in Scheme 5.4:  
1) Optimization of the synthesis of 3M2Pip monomer, starting from intermediate 5.7. 
This, in particular, was the main part of this project. 









Scheme 5.4 Research plan 
 
 
5.2 Results and Discussion 
 
In the following paragraphs the results obtained and the problem encountered 
will be described. Firstly (Paragraph 5.2.1) the optimization of the synthesis of the 
desired monomer will be discussed, focusing on the application of a different synthetic 
strategy respect to the previously exploited by the group. Then, preliminary attempts 
of the polymerization reaction to obtain poly(2M3P) polymer will be described 
(Paragraph 5.2.2). 
 
5.2.1 Optimization of the synthesis of 3M2Pip  
 
In the work previously conducted in the Klumperman group[8] 3M2Pip was 
synthesized starting from commercially available 2-piperidone 5.9 in a 4 steps 
sequence (Scheme 5.5). 
 
 
Scheme 5.5 Previous synthesis of 3-methylene-2-piperidone 
 
N-Boc protection of 2- piperidone 5.9 was performed in acetonitrile/THF, with 
DMAP as catalyst, giving the product 5.10 in a good yield. Subsequently, N-Boc-2-
piperidone was treated with the base, LiHDMS, to form an enolate derivative which 
reacted with ethyl trifluoroacetate at position 3 of the ring. The successive reaction 





order to produce the 3-methylene derivatives 5.12. The methylenation by the release 
of oxalate was also attempted for the N-Boc protected 2-piperidone, however, the 
release of trifluoroacetate gave higher yields. Finally, the N-Boc deprotection was 
performed with trifluoroacetic acid in DCM to afford the final product 5.4.  
This approach gave the desired product in four steps, with two purification 
steps (of compounds 5.10 and 5.12), starting from commercially available 2-
piperidone 5.9. However, the main problems of this approach were the low yields of 
the two last steps. Moreover, the reaction involves the use of protecting groups with 
consequently more steps and the use of solvents such as benzene, something that is 
preferable to avoid. The main objective during the previous work was to obtain the 
monomer in enough yield in order to convert to the polymer at a later step. 
Consequently, no much time was spent on optimizing the monomer synthesis steps 
and only the approach in Scheme 6.5 was attempted. 
For this reason, the first aim accomplished during this investigation entailed 
the optimization of this synthesis. Initially, all the reactions were performed on a small 
scale (milligrams scale) in order to optimize the procedures. Then, since the objective 
of this part of the work was to obtain enough monomer to later perform polymerization 
reactions, a scale-up of the procedures was performed (grams scale). 
After a brief literature research, it was decided to completely change the 
synthetic strategy in order to reduce the synthetic steps. 
Among the different methodologies to introduce a double bond, an interesting 
approach involves a two steps sequence that could be applied in our case. As shown in 
Scheme 5.6, the α-methylene lactam 5.4 can be easily prepared by direct dehydration 
with N,N′-Dicyclohexylcarbodiimide (DCC) in the presence of catalytic amounts of 
cuprous iodide of the corresponding alcohol 5.13 obtained starting from the six-




Scheme 5.6 New synthesis of 3-methylene-2-piperidone 
 
This sequence affords the desired product in only two steps and there is no 
necessity of protecting groups. Starting material 5.7 is commercially available but it 
can be also prepared from acrylonitrile and diethyl malonate by Michael addition 








Scheme 5.7 Synthesis of starting material 
 
Initially, the synthesis of compound 5.7 was attempted, following the above 
procedure. Michael addition was performed with sodium ethoxide, prepared in situ 
from Na and dry EtOH, at room temperature under an argon atmosphere. During the 
reaction, the formation of a side-product deriving from the double attack to the 




Scheme 5.8 By-product of Michael addition 
 
To limit the formation of this undesired compound 5.15 and obtain, at the same 
time, a good conversion of the reaction, and, consequently, a good yield of the desired 
product 5.14, an optimization of the reaction time was performed. In fact, if the 
reaction time is too long the formation of product 5.15 increases, meanwhile if the 
reaction time is not enough, a significant amount of the starting material 5.5 remains 
unreacted, and the yield of the product is low. We found the optimal time reaction was 
about 5 hours. Under these conditions, only a little spot of starting material was 
detected by TLC and the reaction gave the desired product with a 75% yield and a 
small quantity of 5.15. However, the product can be easily purified from the other two 
compounds (5.15 and 5.6) by flash chromatography. 
 The second step involves the hydrogenation of the nitrile to an amine with 
Raney Ni and the direct cyclization to obtain the six-member ring. Raney Ni is a 
pyrophoric reagent so the reaction and the workup must be performed under inert 
atmosphere or with a suitable reactor for hydrogenation. Unfortunately, this reaction 
was not performed due to some problems with procuring Raney Ni. 
Thus, the project was continued starting from the commercially available 
compound 5.6, following the procedure shown above (Scheme 5.6).  
The first step involves the reduction of the ester to alcohol with freshly 








Scheme 5.9 Formation of calcium borohydride 
 
This reagent is more reactive than sodium borohydride and can easily reduce 
esters in addition to aldehydes and ketones. The increased reactivity can be attributed 
to the major Lewis acidity of the cation, which confers increased electrophilicity on 
the carbonyl group (by Lewis acid-Lewis base formation). Once the reaction is 
complete, acidic workup and extraction with DCM were performed to hydrolyse the 
borate complexes and recover the alcohol, and to remove NaCl formed during the 
reaction. The reaction proceeds with good yield but the workup was troublesome: the 
product is a highly polar compound and was difficult to isolate because of its poor 
solubility in organic solvents and strong affinity toward water. To completely recover 
the product, we tried to evaporate the aqueous phase and filter the solid obtained on a 
sintered funnel, but we were not able to separate the product from NaCl. In addition, 
we observed that the next reaction, the dehydration, could not occur if impurities are 
present. To solve this problem, a careful optimization of the workup conditions was 
performed. 
After some solubility tests, AcOEt was used as solvent for the extractive work 
up but, also in this case, only a small quantity of the product was recovered. 
Consequently, the aqueous phase was freeze-dried, divided into aliquots and different 
strategies were attempted in order to isolate the pure product. 
- Firstly, a purification by flash chromatography, using AcOEt: MeOH 8:2 as 
eluent, was performed but we could not elute the product, even increasing the 
polarity of the solvent. Probably, it was not stable on silica or it remained attached 
to the column due to the high polarity.  
- Thus, we tried to solubilize the lyophilized crude in AcOEt or iPrOH at reflux and 
filter on a sintered glass funnel. In both cases, only a small amount of product was 
obtained. In addition, using iPrOH, a gummy was obtained after filtration and 
additional acidic treatment was necessary to recover the product.  
- Another strategy attempted was the solid-liquid continuous extraction with 
Soxhlet. This technique is particularly useful when the desired compound has 
limited solubility in a solvent, as for our product, and the impurity (in our case 
NaCl) is insoluble in that solvent. The main advantage of this system is that just 
one batch of warm solvent is used instead of performing several classical 
extractions. The most significant drawback is the long extraction times. The 
procedure was performed using CHCl3 as solvent. After one week, the product 
was obtained with good quantity but, unfortunately, it was not pure. 
- We also tried to directly subject the lyophilized compound to the next reaction, 





Finally, we accomplished a different work up procedure described in 
literature[11]. After the reaction, the solids were filtered and washed with MeOH. The 
filtrate was concentrated and Et2O was added to precipitate a gummy material. After 
decantation, the gum was triturated with Et2O and decanted. Deionized water was 
added to the gum, and the solid was filtered and washed. The aqueous filtrates were 
saturated with potassium carbonate and extracted with DCM. Unfortunately, not even 
this procedure was successful; in fact, we observed from TLC analysis that the product 
remained in the aqueous phase. 
Due to these unsuccessful results, we decided to try to optimize the initial 
conditions. The problem was overcome performing a classical liquid-liquid extraction 
adding a solution of 3 N citric acid monohydrate until pH was between 2-3. It is very 
important to check the pH of the aqueous phase; in fact, if the pH is too acidic (pH< 
2) the lactam can be opened but if the pH is not enough acid the product can’t be 
extracted. Crude product was then stirred until all the solids had dissolved (about 10-
15 minutes) and extracted with DCM: MeOH 9:1 (v/v). To recover the product several 
extractions are required (9-12 times) but, under these conditions, the product 5.13 was 
obtained in good yield (89 %) as a pure white solid without any further purification 
needed. 
The same procedure was later applied on a big scale (4 grams) and the product 
was obtained with reproducible yields. 
The alcohol 5.13 was next subjected to the dehydration reaction with DCC in 
the presence of catalytic amounts of cuprous iodide in toluene. It is well known that 
DCC in presence of catalytic Cu(I) efficiently dehydrates alcohols with β-substituted 
acceptor groups[12]. The reaction of β- hydroxy ketone affords α,β-unsaturated ketone.  
During this step, difficulties were encountered with the separation of the by-
products (Cu and DCU) from the target monomer. This is a problem for the next 
polymerization since even a small amount of these by-products can interfere with the 
reaction. When the dehydration reaction was performed on a small scale (about 100 
mg), DCU and Cu were easily removed by filtration from Et2O and subsequent flash 
chromatography and the product 5.4 was obtained with a good yield (95%). Moving 
on to the scale-up of the reaction (about 3 g), however, these purification procedures 
were not adequate, and the product was obtained impure. The presence of DCU was 
detected by 1H-NMR spectroscopic analysis, meanwhile, it was possible to identify 
the presence of Cu from the colour of the product (yellow-green if contaminated, white 
if pure). In order to isolate the pure product 5.4, we tried to perform, on the 
chromatographed compound, an aqueous extraction with a 5:1 solution of EDTA 
(0.05M in deionized water): MeOH to remove copper and a further filtration to remove 
the remaining DCU. Unfortunately, product was still not pure and both DCU and 





purification procedure was finally achieved using sublimation technique. In this way, 
the pure monomer was obtained as a white solid with a good yield (78%).  
Therefore, the solubility of the monomer in different solvents was investigated. 
Overall, we observed that the purified monomer had good solubility in most organic 
solvents and was water-soluble, as indicated in Table 5.1 below. On the contrary, the 
product obtained before sublimation had a poor solubility in almost all solvents. 
 
Table 5.1 Solubility of pure 3M2Pip in various solvents 
 
Solvent Solubility Solvent Solubility 
Acetonitrile Ps Diethyl ether Is 
Chloroform S Diethyl acetate Is 
Dichloromethane Ps Dioxane S 
Dimethylformamide S Tetrahydrofuran Is 
Dimethyl sulfoxide S Methanol S 
Isopropanol Ps Water S 
S= soluble. Is= insoluble, Ps= partially soluble upon heating  
 
5.2.2 Study of polymerization of 3M2Pip 
 
In the second part of this study, preliminary investigations into the free-radical 
polymerizations of 3M2Pip were conducted. 
Conventional free radical polymerization is one of the most important 
commercial processes for the synthesis of high molecular weight polymers. The 
versatility of the technique derives from several advantages such as the functional 
group tolerance, adaptability to a wide range of reaction conditions, simplicity, and the 
ability to polymerize a wide range of vinyl monomers. Albeit, conventional free radical 
polymerization also has significant limitations as well, including poor control over 
molar mass and molar mass dispersity, poor control over macromolecule architecture 
and over copolymer composition[13]. This is ascribed to the very fast initiation and 
termination of the polymer chains, throughout the polymerization. Its mechanism 









Scheme 5.10 Mechanism of free radical polymerization 
 
In the initiation step, primary radicals are generated by thermal, redox or 
photochemical mechanism. The initiator radicals add to the monomer to produce the 
propagating radicals. In the propagation step, the successive addition of monomer units 
to the propagating radical results in a growing polymer chain. Chain growth is 
terminated via bimolecular reactions either by coupling of radicals or by 
disproportionation between radicals. 
The α-methylene-õ-valerolactam monomer can be polymerized by the free 




Scheme 5.11 Free radical polymerization of 3M2Pip 
 
Different conditions of solvent, temperature and initiator were tested in order 
to achieve a good conversion.  The choice of the initiator was done considering two 
factors: a) its solubility and b) its half-life (t1/2, time required to reduce the original 
initiator content of a solution by 50%, at a given temperature). During the 
polymerization, an important aspect is to avoid the presence of oxygen that can 
interfere with the radical mechanism. For this reason, the reaction flask was degassed 
with Ar for 30 minutes or via the freeze-pump-thaw procedure (4 cycles) before 
backfilling with Ar. 
Firstly, we decided to perform the polymerization reaction using the redox 
couple tBuOOH/Na2SO3. Redox initiation can be used to initiate polymerization 
relying on the free radicals producing in the course of oxidation-reduction reaction. 





mild conditions (aqueous system and low temperature) due to their lower activation 
energy[14]. The reaction was performed in distilled deionize water (2.5 M) using a 
monomer: tBuOOH ratio of 100:1 and tBuOOH: Na2SO3 ratio of 1.4:1. 1% DMF was 
also added as an internal reference to later determine the conversion of the reaction. 
To avoid the presence of the oxygen the reaction mixture was degassed with Ar. After 
24 h the reaction was stopped by opening the flask to air and cooling in ice and the 
polymer was isolated by freeze-drying. With these conditions, the polymerization 
reaction did not occur (checked by 1H-NMR spectroscopic analysis).   
Due to the unsuccessful result with the redox initiator, the homopolymerization 
of 3M2Pip was carried out using azo compounds as initiator. Depending on the 
reaction temperature, two different initiators were used: 4,4’-azobis(4-cyanovaleric 
acid) (ACVA, 10h half-life at 69°C in water) and 1,1′-azobis(cyclohexanecarbonitrile) 
(ABCN, 10h half-life at 88°C in toluene). The reactions were performed with a 
monomer: initiator ratio of 50:1 in the minimum quantity of solvent and were 




Scheme 5.12 Initiators 
 
The polymer was purified by dialysis against water (dialysis tubing with 
MWCO of 3 500 g/mol) and recovered by evaporation of the solvent. Preliminary 
results are reported in Table 5.2. 
 
Table 5.2 Preliminary results of free radical polymerization  
 
Entry Initiator Degassing method Solvent c Temperature Conversion a 
1 ACVAb Degassed with Ar DMSO (2 M) 80°C 23% 
2 ABCNd Degassed with Ar DMF (1.5 M) 100°C 24% 
3 ABCNd Degassed with Ar DMF (1.5 M) 120°C 44% 
4 ACVAb Freeze pump thaw DMF (1.5 M) 75°C 51% 
a Determined by 1H-NMR, b ACVA: 4,4’-azobis(4-cyanovaleric acid). c dried over MS 3Ǻ, d ABCN: 
1,1′-azobis(cyclohexanecarbonitrile) 
 
The conversion, determined by 1H-NMR analysis (Paragraph 5.4.1) was quite 
low, but these preliminary results demonstrated the possibility to polymerize 3M2Pip 





the reaction may involve the use of DMF as solvent, at 1.5 M, at temperatures 
progressively higher than 75 °C, with freeze pump thaw procedure. As the results 
show, this system is very oxygen sensitive, and, therefore, it must be treated to freeze-
pump thaw procedure, which is a very efficient method of degassing, instead of merely 
purging with argon. 
1H NMR spectra of 3M2Pip and poly(3M2Pip) in D2O are given in Figure 5.3 
and 5.4. The disappearance of the methylene protons in the chemical shift region of 
6.1-5.5 ppm and the broadening of the peaks in the lower chemical shift region are 
indicative of polymer formation. Integration of polymeric protons d (3.2 ppm) to 


















5.3 Conclusion and outlook 
 
In conclusion in this study, the synthesis of monomer 3M2Pip was optimized 
via a two steps sequence and the desired product was obtained with high yields and on 
grams scale. First attempts to perform the polymerization reaction were performed and 
although the reaction has still to be optimized, the preliminary results are promising. 
Considering the future work once obtained the lactam- based polymers they 
can be used as macroinitiator to prepare polyester block copolymers with well-
characterized segment lengths and narrow polydispersity. To this aim, well-defined 
end-functionalized polymer has to be prepared.  
Reversible-deactivation radical polymerization (RDRP) methods[15] are 
important tools for the synthesis of well-defined, end-functionalized polymers. The 
general concept behind RDRPs relies on suppressing termination reactions, in order to 
overcome the drawbacks of free radical polymerizations. Ideally, polymerisation will, 
therefore, continue until all the monomer has been consumed and can be restarted 
when more monomer is added to continue chain growth. These techniques allow the 
synthesis of precise and complex polymeric architectures with predictable molar 
masses, low molar mass dispersity as well as the introduction of various well-defined 
end functionalities.  
Reversible addition-fragmentation chain transfer (RAFT)[16] is considered to 
be one of the most versatile reversible deactivation radical polymerization protocols. 
This polymerization method requires the usage of chain transfer agents (CTA, based 
on thiocarbonylthio compounds), commonly referred to as RAFT agents, to gain 
control over the polymerization of various monomeric structures. RAFT agents 
generally consist of a leaving (R) group, and a thiocarbonyl thio functional (Z) group, 
both retained in the final polymer as α and ω end-groups, respectively. Therefore, by 
suitable choice of the RAFT agent is possible to introduce the desired well-defined 
end-groups in the polymer[17]. 
Therefore, in a continuation of the work, the monomer will be polymerized by 
controlled polymerization methods, like RAFT mediated polymerization, in order to 
target the synthesis of i.e. HO-P(3M2Pip) to be subsequently used for the synthesis of 







5.4 Experimental section 
 
5.4.1 General remarks  
 
All chemicals were reagent-grade and purchased from commercial sources. 
DCC was purified by solubilisation in DCM and filtration to eliminate the by-product 
DCU. The solid obtained was checked by 13C-NMR spectroscopy and dried under 
vacuum for one night before using. 
 DCM, DMSO and DMF were kept over activated molecular sieves. EtOH was 
dried by stirring over powdered KOH for one night; then it was distilled and kept over 
molecular sieves 3 Å.  MeOH was distilled over Mg/I2 and kept over molecular sieves 
3 Å. Toluene was distilled and kept over molecular sieves 3 Å. Distilled, deionized 
water was obtained from a Millipore Milli-Q purification system. 
Moisture and oxygen sensitive reactions were carried out under an inert 
atmosphere using argon gas.  
TLC analyses were carried out on silica gel plates and viewed at UV (254 nm) 
and developed with Hanessian stain (dipping into a solution of (NH4)4MoO4·4H2O (21 
g) and Ce(SO4)2·4H2O (1 g) in H2SO4 (31 mL) and H2O (469 mL) and warming) and 
KMnO4 (dipping into a solution of 1.5 g of KMnO4, 10 g K2CO3, and 1.25 mL 10% 
NaOH in 200 mL of water and warming). Rf values were measured after an elution of 
7-9 cm.  
All the products were characterized by NMR spectroscopy. 1H-NMR and 13C-
NMR spectra were recorded using a 300 MHz Varian VNMRS or 400 MHz Varian 
Unity Inova spectrometer with TMS (1H-NMR: 0.000 ppm) or the central peak of 
CDCl3 (
13C: 77.160 ppm) as internal standard. Compounds were dissolved in CDCl3, 
D2O or DMSO-d6. Chemical shifts are reported in ppm (δ scale). Coupling constants 
are reported in Hertz. Resonances are described as s (singlet), d (doublet), t (triplet), q 
(quartet), bs (broad singlet) and m (multiplet) or combinations thereof. 
Column chromatographies were done with the "flash" methodology using 400-
730 mesh silica.   
 
5.4.1.1 Degassing method for polymerization reactions 
 
Two main methods have been applied to degas the reaction environment and 
remove the oxygen. The first one involves the careful purging of the reaction wit Ar 
for 30 minutes. In the second method, the freeze-pump-thaw procedure, a solvent in a 
sealed Schlenk flask is frozen by immersion of the flask in liquid N2. When the solvent 
is completely frozen, the flask is opened to high vacuum and pumped 5-10 minutes, 
with the flask still immersed in liquid N2. The flask is then closed and warmed (dipping 
the flask in an acetone bath can accelerate the process) until the solvent has completely 
melted. During this procedure gas bubbles visibly evolve from the solvent. This 
process is repeated (usually three, four times) and after the last cycle the flask is 





5.4.1.2 Polymer isolation  
 
The polymer was first dialysed, to remove impurities, before freeze drying to 
remove solvent and isolate the solid polymer. 
Dialysis consists of placing the polymer in a porous tube (SnakeSkin® dialysis 
tubing), with a molecular weight cut-off of 3500 g/mol to enable diffusion of low 
molecular weight contaminants out of the tube with water entering the tube to 
compensate for the high osmotic pressure caused by the polymer. Polymerized samples 
were generally dialyzed for 16-24 h, changing the water every 6 hours. Water was 
removed from the purified polymer by freeze-drying.  
 
5.4.1.3 Determination of monomer conversion 
 
The monomer conversion was determined by 1H-NMR spectroscopy from 
monomer and polymer signals. Conversion is defined as the ratio between the 




𝐻 𝑝𝑜𝑙𝑦𝑚𝑒𝑟 + 𝐻 𝑚𝑜𝑛𝑜𝑚𝑒𝑟
 𝑥 100 
 
Considering the NMR spectrum, as the monomer is consumed, the methylene 
protons are converted, and the peaks become smaller. Therefore, the degree of 
conversion can be estimated by comparing the integration of the methylene protons (at 









As shown in Figure 5.5 the peak between 2.45 and 1.30 ppm involves 3 CH2 
of the polymer backbone (h, g, i) but also a further CH2 of the monomer (d). Therefore, 
in order to calculate the conversion, the integration of H monomer and of H polymer 
to insert in the equation reported above, is given by the following equations:  
 
𝐻 𝑚𝑜𝑛𝑜𝑚𝑒𝑟 = 𝐼 𝑎 = 1𝐻 
𝐻 𝑝𝑜𝑙𝑦𝑚𝑒𝑟 = 𝐼 𝑔, ℎ, 𝑖, 𝑑 − (𝐼𝑎 × 2) =
6𝐻
6
= 1 𝐻 
where I is the peak integration. 
 
To better explain a practical example is shown below. 
H monomer = 10.91 = Ia 
H polymer = I (g,h,i,d)  - (Ia x2) = 89.09 – (10.91 x 2) = 89.09 – 21.82 = 67.27 
 






  x 100 = 51% 
 
 
5.4.2 Experimental procedures 
 
5.4.2.1 Synthesis of 3M2Pip monomer  
 
Diethyl 2-(2-cyanoethyl)malonate 5.14 
A solution of diethyl malonate (236 L, 1.56 mmol) in dry EtOH (1.6 
mL) was cooled to 0°C under Ar atmosphere. EtONa (1 M, 1.6 mL, 
prepared in situ from Na (113 mg, 4.91 mmol) and EtOH dry (4.9 mL)) 
was added and the mixture was stirred for ten minutes. After ten minutes, acrylonitrile 
(102 L, 1.56 mmol) was added and the reaction was stirred at room temperature for 
5 h. Then, EtOH was evaporated. The reaction mixture was poured in 10 mL of NH4Cl 
(sat. sol.) and extracted with DCM (3 x 10 mL). The organic phase was washed with 
brine (10 mL), dried (MgSO4) and concentrated. The residue was purified by flash 
column chromatography on silica gel (hexane: AcOEt 9:1 and hexane: AcOEt 8:2) to 
give 246 mg (75% yield) of 5.14 as a colourless oil. 
 
5.14, colourless oil, Rf = 0.38 (hexane: AcOEt 8:2), developed with KMnO4. 
1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 4.16 (q, J = 7.1 Hz, 4H, 2 CH2CH3), 
3.44 (t, J = 7.2 Hz, 1H, CH), 2.44 (t, J = 7.3 Hz, 2H, CH2CN), 2.18 (q, J = 7.2 Hz, 2H, 
CHCH2), 1.22 (t, J = 7.1 Hz, 6H, 2 CH2CH3).
   
The analytical data conform to those reported in literature[18].  
 
3-(Hydroxymethyl)piperidin-2-one 5.13 
A stirred suspension of ethyl 2-oxopiperidine-3-carboxylate 5.7 (4 g, 23.36 





under Ar atmosphere was cooled at 0°C. NaBH4 (1. 768 g, 46.73 mmol)) was added 
and the reaction was stirred for 2 h at 0°C. Then the reaction was allowed to reach room 
temperature and stirred overnight. MeOH was evaporated under vacuum. 3 N aqueous 
citric acid monohydrate solution was added in small portions and stirred for 10 minutes 
until all solid material was dissolved (pH = 2/3). The solution was extracted with 
CH2Cl2: MeOH 9:1 (12 x 55 mL), dried (MgSO4) and concentrated. The pure product 
5.13 (2.676 g, 89% yield) was obtained as a white solid and used for the next reaction 
without any further purification. 
 
5.13, white solid, Rf = 0.42 (AcOEt: MeOH 8:2), developed with Hanessian stain. 
1H NMR (400 MHz, CDCl3, 25 °C, TMS): δ = 6.58 (s, 1H, NH), 4.18 (s, 1H, OH), 3.85 
– 3.53 (m, 2H, CH2OH ), 3.28 (m, 2H, CH2NH), 2.58 – 2.32 (m, 1H, CH), 1.97 – 1.82 
(m, 2H, CH2CH2NH), 1.82 – 1.67 (m, 1H, CH2CH), 1.57 – 1.40 (m, 1H, CH2CH). 
13C 
NMR (75 MHz, CDCl3, 25 °C, TMS) δ = 175.76 (C=ONH), 64.40 (CH2OH), 42.76 
(CH), 42.17 (CH2NH), 23.66 (CH2CH), 21.86 (CH2CH2NH). 
The analytical data conform to those reported in literature[9b]. 
 
3-Methylenepiperidin-2-one (3M2Pip) 5.4 
Synthesis on a small scale  
DCC (160 mg, 0.77 mmol) was added to a stirring solution of alcohol 5.13 
(77 mg, 0.59 mmol) in dry toluene (1 mL), under Ar atmosphere. The 
reaction was heated at 110°C and CuI (10 mg, 0.05 mmol) was added and the mixture 
was stirred at reflux for 2 h. Then, the reaction was cooled to room temperature and 
deionized water (1 mL) was added and stirring continued for 1 h. Et2O (2 mL) was 
added and the reaction was filtered in order to remove DCU. The solution was 
extracted with CH2Cl2 (3 x 5 mL), dried (MgSO4) and concentrated. The residue was 
purified by flash column chromatography on silica gel (AcOEt) to give 63 mg (95% 
yield) of 5.4 as a pale yellow solid. 
Synthesis on a larger scale 
DCC (4.642 g, 22.50 mmol) was added to a stirring solution of alcohol 5.13 (2.2352 
g, 17.31 mmol) in dry toluene (27 mL), under Ar atmosphere. The reaction was heated 
at 110°C and CuI (297 mg, 1.56 mmol) was added and the mixture was stirred at reflux 
for 2 h. Then, the reaction was cooled to room temperature and deionized water (25 
mL) was added and stirring continued for 1 h. Et2O (50 mL) was added and the reaction 
was filtered in order to remove DCU. The solution was extracted with CH2Cl2 (12 x 
40 mL), dried (MgSO4) and concentrated. The residue was purified by flash column 
chromatography on silica gel (AcOEt: MeOH 15:1) followed by sublimation for 6 
hours to give 1.504 g (78% yield) of 5.4 as a white solid. 
 
5.4, white solid, Rf = 0.67 (AcOEt: MeOH 5:1, UV). 
1H NMR (300 MHz, CDCl3, 25 °C, TMS) δ = 6.50 (s, 1H, NH), 6.24 – 6.05 (m, 1H, 





2.51 (ddt, J = 7.9, 4.5, 1.6 Hz, 2H, CH2C=), 1.84 – 1.74 (m, 2H, CH2CH2NH). The 
analytical data conform to those reported in literature[9b]. 
 
5.4.2.2 General procedure for conventional radical polymerization of 3M2Pip 
 
Homopolymerizations of 3M2Pip 5.4 were carried out in a 25 mL pear 
flask, where 3M2Pip (150 mg, 1.35 mmol for Entries 1 and 2, 50 mg, 0.45 
mmol for Entries 3 and 4, Table 5.2) and AIBN or ACVA, in a ratio of 
50:1 were added. Homopolymerizations were carried out in DMSO or 
DMF as solvent. Subsequently, the polymerization mixture was degassed with argon 
gas for 30 min or subjected to the freeze-pump-thaw procedure. The pear-shaped flask 
was placed in an oil bath for 24 h. Reaction temperatures are specified in Table 5.2. 
The polymerization was stopped by opening the flask to air and allowing to reach room 
temperature. The polymer was isolated by dialysis against water for 24 h, replacing 
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In the progression of modern society, the inevitable exhaustion of fossil 
resources becomes an increasingly concerning matter. These resources are not only the 
basis of the energy production of the world but also the precursor for many important 
platform chemicals. Therefore, development of green and renewable alternatives to the 
chemicals used in the current industry has become necessary[1]. From a chemical point 
of view the most important renewable resource for the synthesis of platform chemicals 
is lignocellulosic biomass since it is an economical, and widely available carbon source, 
apart from oil and coal. In addition, it is non-edible by humans and, consequently, its 
use avoids the undesirable competition between food and chemicals[2] (Chapter 1). 
Within this context, the aim of the present thesis was the development of new efficient 
methodologies for obtaining high added-value products starting from renewable 
sources. The bio-based building blocks obtained were subsequently employed for the 
synthesis of polyfunctionalized chemicals (Part A) and of polymers (Part B). 
The first part of the thesis (Part A, Chapters 2, 3, 4) describes the research 
carried out within the BioOrganic Chemistry Group at the University of Genova. It 
focuses on the utilization of a bio-based meso diol for the synthesis of sugar derived 
structures, through the coupling of biocatalysis and multicomponent reaction (MCRs). 
These two different approaches are able to satisfy the requirements of an ideal 
approach, regarding selectivity (stereocontrol), efficiency and sustainability 
(Paragraph 2.4)[3]. MCRs can afford higher molecular complexity in just one step, 
achieving at the same time atom and step economy with high tolerance of different 
functional groups. In addition, they usually need mild conditions and they are generally 
compatible with “green solvents”[4]. However, a major challenge in MCR chemistry is 
the overall poor stereocontrol in most of these reactions. Within this context, 
biocatalysis is an important tool since it is an efficient, selective and ecofriendly 
strategy for the enantiocontrolled synthesis of chiral substrates, which can be used to 
direct the stereochemical outcome of MCRs. The combination of biocatalytic 
principles with MCRs strategies would represent a highly desirable approach towards 
the green stereoselective synthesis of chiral, bio-based, densely functionalized 
compounds[5].  
The main scope of Part A of the present thesis was, therefore, to further 
investigate this field. In particular, my work focused on the synthetic elaboration of 
the chiral molecules obtained through biocatalysis to give enantiomerically pure 
building blocks to be used in diastereoselective Passerini reactions. In order to further 
establish the synthetic usefulness of this new method, we demonstrated its application 
to the diversity-oriented synthesis of chiral, bio-based, oxygen heterocycles and to the 
target-oriented synthesis of Bengamides. 
 





Scheme 1 Coupling of biocatalysis and MCRs for the synthesis of chiral, bio-based, 
densely functionalized compounds 
 
As stated before, common ground for these two studies is the bio-based 
compound, meso diol 1, derived from erythritol[6] 2 or D-isoascorbic acid 3, both 
obtainable from biomass. The first part of my project was, therefore, focused on the 




Scheme 2 Synthesis of meso diol  
 
In particular, a first period was dedicated to the optimization of the work up 
conditions of a procedure reported in literature[7] and already used in the research 
group[8], starting from erythritol 2. Two attempts for isolating the product 1 has been 
accomplished: the use of a strongly acid cation exchange resin (Amberlite® IR 120 
hydrogen form) to neutralize KOH, and a liquid-liquid continuous extraction. Both 
procedures presented some problems and afforded the product with a comparative 
yield of the reported method. The second strategy for the synthesis of diol uses D-
isoascorbic 3 acid as starting material. The first two steps to obtain compound 1 were 
performed following a procedure reported in literature[9], meanwhile a brief 
optimization of the reduction step occurred. This second approach has the main 
disadvantage of starting from a chiral substrate, D-isoascorbic acid, to afford an achiral 
product, the diol, which will be used for the synthesis of chiral building blocks in a 
later step of the project. On the other hand, this disadvantage is compensated for by 
the better yields obtained in the various steps. 
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The first application of the combination of biocatalysis and MCRs starting 
from meso-diol was directed to the synthesis of chiral, bio-based, oxygen heterocycles 
scaffolds (Chapter 3). 
Diol 1 is a symmetrical molecule, therefore it is not optically active. To access 
enantiomerically pure building blocks, it was subjected to lipase-mediated 
desymmetrization, following an optimized protocol previously developed by our 




Scheme 3 Enzymatic desymmetrization of diol 
 
Then, manipulation of the enantiomerically pure building block 5, in order to 
introduce a double bond that can be later used in cyclization reactions, was investigated 
(Paragraph 3.2.2). The chiral alcohol was oxidized to the corresponding aldehyde 
under Swern conditions and the crude was directly subjected to the following 
olefination, employing Horner-Wandsworth-Emmons conditions. Firstly, the reaction 
was performed on compound 5 but due to difficulty on removing the acetyl group in a 
later step of the synthesis, the reaction was, then, carried out on compound 6 which 
presents a TBS group. This group can be introduced into the monoacetate through a 
protection-deprotection sequence. Removal of the silyl ether was not as simple as we 
expected. After an extensive optimization we found the best conditions in the use of 




Scheme 4 Manipulation of functional groups 
 
With this functionalized molecule available, its use in the Passerini reaction as 
oxo-compound (with previous oxidation of alcohol functionality) was extensively 
studied (Paragraph 3.2.3). To achieve a better stereoinduction, a Lewis-acid (ZnBr2) 
mediated process was performed[8]. To avoid the overoxidation of aldehyde we 
decided to perform the oxidation reaction under Swern conditions. Passerini reaction 
was firstly studied using acetic acid and tBuNC but the d.r. was difficult to determine 
since the products were not separable by HPLC analysis. In addition, we observed the 
formation of truncated Passerini products. The reaction was finally optimized using 
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benzoic acid (1.1 eq), tBuNC (1.1 eq) and ZnBr2 (0.4 eq) at 20°C in dry THF, affording 




Scheme 5 Diastereoselective Passerini reaction 
 
The configuration of the new-formed stereogenic centre was determined at a 
later stage of the study, by 1H-NMR analysis on a cyclic derivative (Paragraph 
3.2.4.2). With these conditions, a small library of Passerini adducts was synthesized. 
The yields were moderate (from 46% to 78%) meanwhile the diastereoselective ratio 
was in all cases good, and even higher than for the first model compound, ranging 
from 77:23 to 96:4.  Finally, in order to broaden the scaffold diversity, the cyclization 





Scheme 6 Intramolecular Michael addition and synthesis of bicyclic lactone 
 
Intramolecular Michael addition, performed on both the diastereoisomers of 
Passerini product, afforded tetrahydrofuran with good yields (from 53% to 83 %) and 
high d.r. (from 83:17 to 92:8). Lactone 14 was obtained from tetrahydrofuran 12a upon 
acidic removal of the acetonide protecting group followed by spontaneous 
lactonization. We also attempted to perform a ring closing metathesis taking advantage 
of the α,β-unsaturated ester and of a double bond introduced on Passerini product using 
a suitable carboxylic acid. The reaction was performed on the corresponding protected 
allylic alcohol as well but, unfortunately, the obtainment of the 9 membered 
unsaturated lactones was unsuccessful. 
The general synthetic approach involving the coupling of bicatalysis and MCR 
was also applied to the target oriented synthesis of Bengamides, a wide family of 
natural products of marine origin (Chapter 4). 
Through a retrosynthetic analysis, a novel strategy for the total synthesis of 
Bengamides, and in particular of 4-epi-Bengamide E 15, has been developed by us. In 
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particular, the general structure of this compound can be obtained through a Passerini 
reaction between the chiral alcohol 16 derived from meso diol 1, on which the olefinic 
residue is introduced, and the aminocaprolactamic isocyanide 18 derived from the 




Scheme 7 Retrosynthetic analysis of 4-epi-Bengamide E 
 
The main advantages of this strategy are the possibility to use a renewable 
source as starting material and the flexibility and convergence of the approach. 
Bengamide analogues can be obtained modifying caprolactamic unit and the olefinic 
residue by suitable use of different reagents. 
Therefore, firstly my work focused on the synthesis of the substrates necessary 
to later performed Passerini reaction.  
The synthetic sequence to obtain chiral alcohol 16 starting from meso-diol 1 




Scheme 8 Steps for the synthesis of chiral alcohol 16 
 
In the first step a lipase-mediated desymmetrization reaction with vinyl 
butyrate was performed, following a procedure reported in literature[8a]. Then, 
compound 19 was subjected to the Mitsunobu reaction to introduce the p-
methoxyphenyl (PMP) group and the subsequent cleavage of the ester group.  The 
change of functional group is necessary to obtain the desired monomer because of the 
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instability of the acyl group in the subsequent reactions, as a previously study had 
demonstrated. Thus, PMP was chosen as protecting group since it has orthogonally 
cleavage conditions respect to the other protecting groups present on the molecule 
(Paragraph 4.2.1). Alcohol 20 was oxidized under Swern conditions and the 
corresponding aldehyde was subjected to the 1,2- addition of the acetylide (Paragraph 
4.2.2). A careful optimization of this procedure was necessary to make it efficient and 
reproducible. In fact, the corresponding aldehyde decomposes rapidly once it is dried 
and tends to remain in the hydrated form and, therefore, the presence of water within 
the reaction environment affects the success of the subsequent reaction. Once we 
obtained compound 21 (88% yield, d.r: 57:43 anti: syn), we decided to improve the 
d.r. by oxidation with Dess Martin periodinane and stereoselective reduction of the 
resulted ketone with K-selectride, affording the product with a d.r. of 76:24. Propargyl 
alcohol 21 was, then, reduced to alkenes with sodium bis(2- 
methoxyethoxy)aluminium hydride (Red-Al) in dry THF at reflux to afford the double 
bond with E configuration (Paragraph 4.2.3). Finally, the primary hydroxy group of 
compound 22 was protected with TBS group and PMP protecting group was removed, 
using the reagent ammonium cerium (IV) nitrate (CAN). This step is particularly 
delicate because the acid environment of the reaction can also promote the release of 
the silyl group. For this reason, the reaction must take place in a very short time, about 
10-15 minutes, and it is extremely important to block it promptly. The two last steps 
were performed only on the anti diastereoisomer, since it has the absolute and relative 
configuration of the final product. 
Isocyanide 18 was synthesized starting from commercially available L-(-)-α-
amino-ε-caprolactam via two steps sequence (Paragraph 4.2.4). The first step involves 
the formation of the formamide 23 through the coupling reaction with formic acid, in 
presence of DCC and Et3N. Then, the dehydration reaction was carried out with POCl3 
to obtain the final product 18. Particular attention was dedicated to the control of the 




Scheme 9 Synthesis of isocyanide 18 
 
The synthetized building blocks, chiral alcohol 16 and isocyanide 18 were 
subsequently used, with AcOH, to accomplish, after Swern oxidation to aldehyde, the 
diastereoselective Passerini multicomponent reaction (Paragraph 4.2.5). The reaction 
was performed in a tandem procedure with Swern oxidation and the subsequent 
deacetylation reaction to avoid the chromatography of the Passerini products (that are 
difficult to separate) and to directly determine the d.r. on the final products and, thus, 
not having the interference of the truncated Passerini products on the determination. 
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After a brief optimization we found the best condition for the Passerini reaction in the 




Scheme 10 Diastereoselective Passerini reaction 
 
To improve the diastereoisomeric ratio we decided to investigate the possible 
beneficial effect of catalytic amount of ZnBr2 but it did not lead to a significant 
improvement on the observed diastereoselectivity. 
The two last steps to obtain 4-epi-Bengamide E involve the methylation 
reaction and the final cleavage of protecting groups (Paragraph 4.2.6). After an 
extensively optimization, methylation reaction was carried out using NaH and MeI at 
0°C in THF. To avoid the formation of side- products, the N-methylated compound 
and the bis-methylated, it is important to conduct the reaction with a slightly excess of 




Scheme 11 Methylation reaction and final cleavage  
 
The second part of the thesis (Part B, Chapters 5), focuses on the project 
developed in the Free Radical Group at Stellenbosch University (South Africa). The 
secondment was included in the Project “Synthesis, Characterization, Structure and 
Properties of Novel Biodegradable Polyesters (BIODEST)” that is funded under the 
RISE (Research and Innovation Staff Exchange) Scheme (H2020-MSCA-RISE-2017-
778092)[10] (Paragraph 5.1.1). The project I worked on involved the synthesis and 
polymerization of 3-methylene-2-piperidone (3M2Pip) monomers, targeting the 
synthesis of well-defined hydroxyl end functional P(3M2Pip), i.e. HO-P(3M2Pip). 
Once obtained end-functionalized 3M2Pip-based polymers we will use them as a 
macro-initiator for the synthesis of degradable polyester second blocks, applicable in 
drug delivery polymer materials. 3M2Pip monomer is of particular interest; in fact, it 
can be obtained from the reaction between diethyl malonate and acrylonitrile, bio-
based compounds derived from 3-Hydroxypropionic acid (3-HP), a cellulose C3 
building blocks derivative[11] (Paragraph 5.1.3). 





Scheme 12 3M2Pip from bio-based starting materials 
 
My work was mainly focused on two objectives: 
1) Optimization of the synthesis of 3M2Pip monomer. In particular, the main part of 
my work was dedicated to this step. 
2) Preliminary study of polymerization of the 3M2Pip via conventional free radical 
mechanism. 
In a previous study conducted in Klumperman’s group[12] the desired monomer 
had been synthetized starting from commercially available 2- piperidone via a 4-steps 
sequence. The main problems of this approach were the low yields of the two last 
steps. Therefore, the first aim accomplished consisted in the optimization of this 
synthesis. In particular, a new strategy was developed starting from the six-member 




Scheme 13 New synthesis of 3-methylene-2-piperidone 
 
The first step involves the reduction of the ester to alcohol with freshly 
prepared calcium borohydride. The reactions proceed with good yield, but the product 
is difficult to isolate because of its poor solubility in organic solvents and strong 
affinity toward water. The problem was overcome by addition of a citric acid solution 
until pH 3. Then the crude was stirred until all the solid was dissolved and extracted 
with DCM: MeOH 9:1. The alcohol was next subjected to the dehydration reaction 
with DCC in the presence of catalytic amounts of cuprous iodide in toluene. 
Difficulties were encountered with the separation of the by-products, Cu and DCU, 
from the target monomer. An optimization of the purification procedure was achieved 
using sublimation technique. In this way, the pure monomer was obtained as a white 
solid. Both the two steps of the synthesis above gave good results in terms of yield and 
they were applied in large scale (4 g).  
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In the second part of the secondment, preliminary polymerizations were 
conducted via conventional radical polymerization conditions[13] using 4,4’-azobis(4-
cyanovaleric acid) (ACVA) or 1,1′-azobis(cyclohexanecarbonitrile) (ABCN) as the 




Scheme 14 Polymerization of 3M2Pip 
 
Polymerizations were carried out under an inert Ar atmosphere using DMF, 
DMSO or 1,4-dioxane as solvent, at different temperatures (70°C, 80°C, 100°C and 
120°C). After 24 h and the polymer was purified by dialysis against water (dialysis 
tubing with MWCO of 3 500 g/mol) and then recovered by evaporation of the solvent. 
The conversion, determined by 1H-NMR analysis(Paragraph 5.4.1) was quite low 
(ranging from 23% to 51%), but these preliminary results demonstrated the possibility 
to polymerize 3M2Pip monomer. In particular, best results were obtained using DMF 
(1.5 M) as solvent at 75°C (with ACVA initiator) or 120°C (with ABCN initiator). 
 
In conclusion, with this thesis different applications of bio-based building 
blocks derived from renewable sources in organic synthesis and materials science have 
been developed, with the aim of enhancing their value by increasing complexity. These 
starting materials represent a plausible replacement of their petrol-based analogues, 
hereby laying parts of the groundwork for a more sustainable and renewable future.  
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